data_1w4k_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1w4k _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.459 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.23 95.07 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.673 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.405 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 17.5 ptp -46.31 167.42 0.14 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.02 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.92 -48.5 2.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.816 2.344 . . . . 0.0 112.944 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.03 70.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -71.34 -34.19 70.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -46.41 71.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.309 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.11 -56.0 27.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.535 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.81 -39.61 74.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -29.83 55.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -81.93 -25.35 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -90.52 -28.58 18.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.714 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.14 41.64 9.27 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.933 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.61 127.38 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.79 0.328 . . . . 0.0 110.949 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 103.12 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.45 79.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.073 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -49.88 71.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.192 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -28.24 62.43 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 158' ' ' ILE . 49.7 t -83.54 85.29 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.992 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -50.92 92.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -65.49 141.98 43.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.796 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 13.41 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.696 0.284 . . . . 0.0 111.146 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.5 154.98 50.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.727 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.72 106.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.022 2.481 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.96 18.95 25.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.248 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.13 74.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.459 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.79 124.6 40.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.035 0.418 . . . . 0.0 111.053 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.2 pt -64.3 111.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 81.0 p -75.16 156.51 35.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.443 0.64 . . . . 0.0 111.439 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.436 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.28 -43.29 60.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.1 -179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -27.66 69.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.1 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -69.99 -48.17 59.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.535 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.81 -41.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.734 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.11 94.64 1.97 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.3 ptp -45.08 163.6 0.2 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.57 -49.83 2.19 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 138' ' ' LEU . . . -54.25 -48.3 71.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.17 -34.9 75.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.291 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -69.6 -49.5 53.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -57.03 -55.64 32.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.74 -39.54 89.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.503 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.02 -41.11 74.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -30.09 55.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.083 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.93 -18.71 39.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.66 -28.84 13.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.85 35.16 11.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.047 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 149' ' ' VAL . 0.1 OUTLIER -108.73 125.8 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.301 . . . . 0.0 110.578 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -60.32 101.07 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.69 -45.58 89.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -48.58 66.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.26 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.38 -33.44 67.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.471 HG22 ' CD1' ' A' ' 144' ' ' ILE . 55.1 t -79.37 82.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.856 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.82 92.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.02 139.46 43.44 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.356 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.4 13.86 13.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.648 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -77.22 157.28 46.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.34 106.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.129 2.552 . . . . 0.0 112.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.71 20.11 22.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.05 22.16 77.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.612 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.51 125.62 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.122 0.461 . . . . 0.0 111.331 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 158' ' ' ILE . 12.0 pt -62.21 111.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 30.6 p -74.98 156.26 36.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.441 0.639 . . . . 0.0 111.641 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.485 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -55.26 -39.18 50.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.588 -178.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.45 -30.54 70.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.94 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.462 ' HB2' ' O ' ' A' ' 159' ' ' THR . 93.6 m-20 -65.37 -57.99 6.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.637 . . . . 0.0 110.1 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.501 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -56.68 -42.61 77.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.565 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.466 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.22 95.46 2.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.84 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.4 ptp -48.33 166.26 0.22 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.89 -47.65 3.56 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.878 2.386 . . . . 0.0 112.972 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.9 65.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.429 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.93 -34.49 75.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.096 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.83 -48.58 65.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.231 0.539 . . . . 0.0 110.423 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -57.77 -55.94 28.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.037 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.513 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.18 -41.59 97.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.63 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.416 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.06 -38.44 70.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.916 0.388 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.35 56.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.006 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -81.91 -21.43 37.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 111.041 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.2 mt -94.8 -28.8 15.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.601 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.03 42.8 10.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.856 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -117.16 129.23 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 111.057 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -56.52 101.07 0.05 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.58 92.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.767 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -48.53 78.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.992 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -25.72 63.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 158' ' ' ILE . 40.3 t -85.78 85.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -50.9 100.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -74.63 141.62 28.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.94 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 12.92 13.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.645 0.26 . . . . 0.0 111.155 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.43 156.67 53.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.854 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.403 ' O ' HG12 ' A' ' 157' ' ' VAL . 83.5 Cg_exo -44.68 104.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.103 2.535 . . . . 0.0 112.907 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.7 22.11 14.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.168 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.35 22.18 78.95 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.61 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.74 124.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.064 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.4 pt -63.61 111.49 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.55 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.2 p -75.25 156.57 35.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.648 0.737 . . . . 0.0 111.624 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.445 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.93 -42.83 55.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.118 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -64.57 -27.61 69.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.121 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 159' ' ' THR . 64.0 m-20 -69.5 -49.15 57.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.727 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.513 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.35 -46.83 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.871 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 mttp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.359 -179.44 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.485 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.419 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.59 95.14 1.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.825 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 14.3 ptm -46.42 164.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.6 -49.29 2.47 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.774 2.316 . . . . 0.0 112.789 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.409 ' O ' HD22 ' A' ' 138' ' ' LEU . . . -54.14 -49.12 69.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.407 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.2 -34.46 74.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.337 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.31 -49.33 56.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -57.79 -55.39 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.62 -38.66 85.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.396 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.51 77.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -76.72 -29.82 56.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -85.11 -16.59 40.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.442 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -99.77 -28.82 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.66 10.0 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.485 HG23 ' CG1' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -111.36 126.41 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.634 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 3.2 t0 -61.78 100.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.457 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.29 -44.87 88.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.39 67.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.155 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.35 -33.37 65.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 158' ' ' ILE . 54.8 t -79.34 84.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.084 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.96 91.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.31 138.22 46.2 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.241 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.37 13.9 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.28 159.09 49.97 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.4 ' O ' HG12 ' A' ' 157' ' ' VAL . 92.7 Cg_exo -43.85 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.166 2.577 . . . . 0.0 112.953 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.16 11.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.192 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.45 22.19 79.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.633 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.485 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.56 125.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.228 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.579 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.4 pt -61.04 110.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 24.2 p -75.19 156.54 35.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.337 0.589 . . . . 0.0 111.6 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.49 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.24 -40.47 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.423 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.67 -28.31 69.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 159' ' ' THR . 95.7 m-20 -68.91 -58.03 4.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.485 0.66 . . . . 0.0 109.821 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -57.38 -41.17 77.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.38 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.455 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 121.035 0.445 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.31 94.55 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.638 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.9 ptm -47.11 167.77 0.15 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.419 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.5 Cg_exo -65.7 -45.78 6.09 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.837 2.358 . . . . 0.0 113.02 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.45 61.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.396 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.47 -32.97 72.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -46.73 71.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.24 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -59.67 -55.5 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.134 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.553 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.38 -42.11 99.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.422 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.69 -38.99 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -76.87 -29.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -81.31 -25.31 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.056 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.7 mt -90.29 -29.01 18.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.8 31.62 9.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.025 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.453 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -111.81 146.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.94 0.37 . . . . 0.0 111.323 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -79.81 101.01 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.098 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.414 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.22 -32.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -35.03 79.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.969 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.64 -19.32 61.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 54.8 t -95.54 88.08 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.064 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.78 100.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.22 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.41 141.91 28.41 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.954 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.03 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.579 0.228 . . . . 0.0 111.088 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.83 153.91 50.57 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 107.74 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.144 2.562 . . . . 0.0 112.811 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 18.41 27.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.205 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.08 73.93 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.659 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.464 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -86.44 124.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 117.069 0.435 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.8 pt -65.15 111.81 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.5 p -75.35 156.57 35.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.557 0.694 . . . . 0.0 111.586 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -55.46 -42.73 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.121 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -27.73 69.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.982 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 92.0 m-20 -70.36 -51.72 27.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -69.52 -38.84 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.78 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 8.5 pttt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.166 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.46 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.8 94.86 2.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.766 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.5 ptp -46.82 167.08 0.16 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.028 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.2 -48.04 2.9 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.904 2.403 . . . . 0.0 113.028 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -49.94 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.77 -34.57 73.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.028 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -47.97 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.342 0.592 . . . . 0.0 110.369 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.6 -55.95 28.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.5 -41.54 97.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.39 -37.8 70.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -77.12 -31.43 55.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.33 -21.74 35.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.021 0.438 . . . . 0.0 111.048 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.416 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.57 -28.23 16.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.679 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.77 42.0 11.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.875 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.71 127.19 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -57.82 101.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.65 -40.82 80.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.43 -49.94 71.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.199 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.418 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.53 62.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 158' ' ' ILE . 50.6 t -83.2 85.82 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.806 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 1.1 ptpp? -50.81 91.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 111.814 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.437 ' CA ' HG23 ' A' ' 158' ' ' ILE . . . -59.08 138.51 49.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.69 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 15.09 13.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.44 156.81 47.12 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.79 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.7 104.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.159 2.573 . . . . 0.0 112.907 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.64 20.98 17.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.225 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.23 22.14 78.06 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.54 123.62 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.065 0.432 . . . . 0.0 111.189 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 158' ' ' ILE . 9.1 pt -63.16 110.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.8 p -75.15 156.51 35.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 0.0 111.522 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.23 -42.82 58.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.156 -179.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -64.83 -27.52 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.138 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.4 m-20 -70.0 -48.7 57.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.721 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.07 -46.08 68.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.562 -179.193 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.76 95.65 2.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.972 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 ptp -46.35 166.75 0.16 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.961 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.59 -48.54 3.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.861 2.374 . . . . 0.0 112.829 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -49.87 68.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.355 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.74 -35.02 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -48.87 67.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.231 0.538 . . . . 0.0 110.509 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -58.93 -54.23 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.928 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.525 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.32 -39.76 95.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.49 -38.88 72.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.956 0.408 . . . . 0.0 110.729 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.98 -32.13 57.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.99 -21.52 40.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.01 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.23 -28.62 16.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 40.71 11.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.876 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.48 127.13 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 0.0 110.904 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.06 101.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.61 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.402 ' CB ' HD11 ' A' ' 158' ' ' ILE . . . -57.63 -41.13 80.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -50.2 68.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.199 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 158' ' ' ILE . 51.1 t -82.07 83.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.94 91.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 111.315 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.437 ' CA ' HG23 ' A' ' 158' ' ' ILE . . . -60.6 142.47 48.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.009 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.91 13.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 110.842 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -74.92 156.75 49.6 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.7 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -43.74 103.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.876 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.13 23.41 11.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.159 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.56 22.15 78.67 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.5 125.31 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.981 0.39 . . . . 0.0 111.001 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 158' ' ' ILE . 12.9 pt -63.74 111.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 63.4 p -75.16 156.52 35.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.521 0.677 . . . . 0.0 111.474 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.98 -42.19 53.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.247 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.81 -27.75 68.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.2 m-20 -68.79 -46.73 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.31 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.525 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.96 -42.19 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.704 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.471 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.66 94.1 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.59 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.3 ptp -46.28 166.46 0.16 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.089 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.36 -48.43 2.45 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.938 2.425 . . . . 0.0 112.977 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.69 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.515 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.25 -35.09 73.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -67.81 -47.27 69.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.302 0.572 . . . . 0.0 110.24 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -56.64 19.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.27 -40.74 95.22 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.63 -39.72 71.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -31.71 56.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.971 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.77 -20.65 42.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -96.19 -28.82 14.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.717 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.85 40.91 10.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.149 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.35 126.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 0.0 110.916 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.33 101.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.676 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.41 78.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -49.91 70.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.196 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -28.5 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 158' ' ' ILE . 52.8 t -83.75 84.52 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.154 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -50.87 96.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.408 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -64.59 141.96 44.83 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.49 12.01 13.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.647 0.26 . . . . 0.0 111.113 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.75 155.66 51.21 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.779 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 157' ' ' VAL . 81.8 Cg_exo -44.76 106.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.123 2.549 . . . . 0.0 112.905 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.05 19.19 24.7 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.159 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.17 75.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.629 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.22 123.51 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.064 0.432 . . . . 0.0 111.177 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.596 ' O ' HG13 ' A' ' 158' ' ' ILE . 12.6 pt -63.12 110.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.14 156.54 35.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.526 0.679 . . . . 0.0 111.724 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.431 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.14 -42.92 58.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.231 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -27.75 69.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.4 m-20 -69.54 -48.95 58.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.604 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.09 -46.11 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.817 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.487 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.452 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.903 0.383 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.48 94.6 2.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 15.9 ptp -46.74 166.78 0.17 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.975 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.25 -47.36 3.37 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.84 2.36 . . . . 0.0 112.772 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.13 65.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.455 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.59 -33.75 73.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -68.32 -47.82 66.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.415 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.01 -56.02 27.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.553 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.0 -40.57 94.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.676 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.406 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.28 -41.65 76.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -75.77 -29.95 58.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.87 -26.9 40.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.7 mt -89.02 -29.01 19.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.13 33.9 7.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.238 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.1 tt -115.81 146.88 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.428 ' N ' HG12 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -79.93 100.92 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.39 -32.87 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -35.07 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.958 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.82 -20.39 61.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 53.8 t -95.55 87.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.136 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -50.76 107.52 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 111.402 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -76.1 140.59 25.86 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.274 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 110.839 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.35 156.07 46.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.869 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 0.0 112.892 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 19.55 23.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.208 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.99 22.21 77.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.66 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.452 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.87 124.77 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 117.023 0.412 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 158' ' ' ILE . 21.3 pt -64.17 111.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 49.3 p -75.32 156.54 35.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.625 0.726 . . . . 0.0 111.732 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.433 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -42.78 65.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.924 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.51 -27.68 69.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.5 m-20 -69.69 -49.33 54.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.21 -40.71 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.916 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.165 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.74 95.38 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.808 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.4 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 19.3 ptp -47.02 167.25 0.17 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.88 -48.08 3.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.827 2.351 . . . . 0.0 112.906 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.13 67.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.442 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.64 -34.16 73.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.178 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -68.46 -47.94 65.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.382 0.61 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.37 -55.92 28.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.526 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.1 pp -61.97 -41.27 97.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.639 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.413 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.06 -40.38 70.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.364 . . . . 0.0 111.017 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -31.46 56.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.989 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -80.45 -21.54 41.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.92 0.39 . . . . 0.0 111.015 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.406 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -95.92 -28.68 14.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.664 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.02 42.64 10.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -117.26 129.7 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 0.0 111.037 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.07 101.03 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.91 -42.85 94.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.687 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -48.76 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -27.33 63.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' ILE . 42.2 t -84.17 85.89 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.013 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 95.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.6 140.92 32.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.651 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.83 13.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.289 . . . . 0.0 111.143 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.4 156.21 53.26 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.809 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 157' ' ' VAL . 83.6 Cg_exo -44.69 105.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.14 2.56 . . . . 0.0 112.891 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.45 21.45 17.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.155 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.8 22.1 78.56 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.62 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.84 125.19 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.139 0.47 . . . . 0.0 111.014 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 158' ' ' ILE . 10.7 pt -64.35 111.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.521 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.1 p -75.07 156.56 35.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.46 -42.38 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.113 -179.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -64.07 -27.65 69.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.1 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.0 m-20 -70.91 -49.6 44.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.897 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.28 -43.49 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.972 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.881 -179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.51 94.77 2.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 13.2 ptp -46.48 166.92 0.16 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.061 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.06 -48.31 2.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.24 71.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.469 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -71.93 -34.27 68.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -68.69 -45.89 70.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.241 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -60.28 -55.66 30.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.953 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.561 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.54 -40.48 94.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.412 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.7 -37.51 73.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.383 . . . . 0.0 110.743 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -31.21 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.28 -25.4 36.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.429 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -91.62 -28.77 17.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.6 42.94 9.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.933 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.407 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -117.86 129.95 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.063 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -60.03 101.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.765 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.0 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -49.25 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.135 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.27 -26.76 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 158' ' ' ILE . 45.7 t -84.52 85.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.88 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.67 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.566 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -64.22 144.64 48.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.647 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 1.35 11.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 111.163 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -62.14 152.5 43.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.457 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -44.54 118.68 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.043 2.495 . . . . 0.0 112.983 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.94 0.09 72.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.25 22.16 23.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.628 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.49 125.62 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 117.089 0.444 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.637 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.0 pt -64.74 111.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 69.2 p -75.15 156.5 35.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.59 0.71 . . . . 0.0 111.588 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.439 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.62 -41.96 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.273 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -27.86 69.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.939 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.3 m-20 -69.3 -47.09 65.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.273 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -76.0 -34.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.091 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.885 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.479 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.059 0.456 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -154.68 96.33 1.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.904 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.593 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 11.8 ptp -45.36 165.68 0.16 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 48.5 Cg_endo -71.61 -32.35 12.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.072 1.848 . . . . 0.0 112.507 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.07 -51.5 63.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.749 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.487 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.4 -35.02 75.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.13 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 1.1 mtt180 -66.44 -48.56 69.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.323 0.582 . . . . 0.0 110.415 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -55.61 32.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.5 -41.31 98.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.414 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.59 -37.73 68.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -33.31 56.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -79.98 -19.96 46.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.423 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.2 mt -96.7 -28.81 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.591 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.15 43.16 10.98 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.858 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.41 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -117.43 130.08 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.771 0.32 . . . . 0.0 111.058 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 5.1 t70 -58.74 101.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.73 -41.63 91.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.767 0.317 . . . . 0.0 110.761 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -49.05 76.89 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.6 -27.34 62.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.41 ' CG2' HD13 ' A' ' 144' ' ' ILE . 41.8 t -84.35 86.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.73 92.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.561 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -67.02 139.88 36.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.683 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 14.29 13.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.433 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.71 156.7 52.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.41 104.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.511 . . . . 0.0 112.863 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.55 22.46 14.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.211 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.05 22.08 79.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.479 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -86.11 125.43 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 117.058 0.429 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.62 ' O ' HG13 ' A' ' 158' ' ' ILE . 16.7 pt -63.64 111.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 74.6 p -75.12 156.54 35.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.493 0.663 . . . . 0.0 111.555 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.61 -42.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.144 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.9 -27.68 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.876 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.3 m-20 -69.9 -46.94 64.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.362 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.519 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.83 -36.8 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.939 0.4 . . . . 0.0 110.908 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.429 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.79 95.73 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.402 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 17.7 ptp -46.55 167.47 0.15 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.746 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.51 -47.99 3.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.713 2.275 . . . . 0.0 112.902 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.82 66.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.52 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.62 -33.01 72.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.223 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -69.75 -47.81 61.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 110.325 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -57.51 -54.93 41.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.816 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.537 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.78 -41.09 99.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.56 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.25 -39.15 75.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -29.95 55.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -83.49 -16.57 45.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -97.68 -28.84 13.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.94 33.68 8.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.944 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.458 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.6 tt -116.44 147.2 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.438 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.429 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -81.15 101.01 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.804 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -47.81 -34.06 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.33 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -63.7 -35.72 81.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.885 0.374 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -70.38 -19.93 62.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 48.2 t -93.63 87.94 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.055 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -50.7 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.272 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -74.38 143.35 31.57 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.868 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.23 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -69.77 153.39 52.24 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.85 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.03 107.46 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.072 2.515 . . . . 0.0 112.848 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 18.64 26.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.263 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.16 21.96 74.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.467 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -86.66 125.89 40.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.892 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.1 pt -66.5 111.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.2 p -75.1 156.51 35.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.513 0.673 . . . . 0.0 111.489 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.425 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.97 -42.97 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.07 -179.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -27.58 69.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.075 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -70.83 -48.17 55.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.718 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.63 -41.9 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.466 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.57 95.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.971 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.666 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 18.4 ptm -46.65 167.89 0.14 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.611 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 49.2 Cg_endo -71.42 -33.56 10.82 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.112 1.874 . . . . 0.0 112.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.36 46.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.93 -33.16 71.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.69 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.15 -46.89 72.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.173 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -59.12 -55.58 33.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.731 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.512 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.7 -41.13 98.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.25 -39.66 76.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -76.46 -29.85 57.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -81.1 -24.88 37.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.917 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.434 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.6 mt -89.78 -28.89 19.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.45 12.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.967 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.3 tt -110.52 146.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.386 . . . . 0.0 111.327 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -78.94 100.92 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.861 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.427 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.81 -32.33 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -34.43 77.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 109.93 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.46 -20.08 61.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 55.1 t -94.89 88.19 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.051 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -50.8 99.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.64 140.57 25.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.17 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 12.97 13.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 111.034 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -69.8 155.81 53.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.843 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.403 ' O ' HG12 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -44.81 105.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.136 2.558 . . . . 0.0 112.893 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.55 20.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.142 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.5 22.05 77.91 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.657 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.42 125.11 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.109 0.454 . . . . 0.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.644 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.3 pt -63.89 111.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 66.9 p -75.3 156.52 35.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.587 0.708 . . . . 0.0 111.802 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.453 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.01 -41.8 60.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.92 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -27.52 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.037 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -71.26 -49.77 39.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.44 -41.6 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.334 -0.104 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.082 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.47 95.26 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.907 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.408 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.3 ptp -46.04 167.57 0.13 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.037 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.52 -48.12 3.52 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.801 2.334 . . . . 0.0 112.83 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.48 67.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.54 -34.61 72.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -66.79 -46.74 74.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.3 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -60.05 -56.48 21.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.078 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.502 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.94 -41.81 96.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.01 -40.08 75.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -76.41 -29.76 57.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -81.96 -22.56 36.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.6 mt -92.71 -28.88 16.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.1 30.09 10.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.104 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 144' ' ' ILE . 2.1 tt -111.64 146.48 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.335 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -80.5 100.99 8.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.065 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -48.06 -34.04 8.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.273 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 72.4 m -63.69 -34.49 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.21 -19.73 61.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 53.1 t -94.95 88.61 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.081 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -50.72 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.514 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.86 142.26 28.44 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.745 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.34 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.29 153.79 51.16 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.83 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 157' ' ' VAL . 80.9 Cg_exo -44.74 108.62 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.145 2.563 . . . . 0.0 112.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.09 17.45 32.12 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.245 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.16 71.68 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.458 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -86.72 126.05 40.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.03 0.415 . . . . 0.0 110.935 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.7 pt -66.94 111.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.5 p -75.11 156.56 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.415 0.626 . . . . 0.0 111.374 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.433 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.95 -42.46 63.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.061 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -63.39 -27.68 69.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.6 m-20 -70.38 -53.84 14.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.648 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.34 -43.44 94.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.517 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.816 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.469 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.18 95.95 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.881 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.4 ptp -48.79 166.8 0.22 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.791 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.8 -48.05 3.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 112.962 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -50.52 66.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.93 -34.51 75.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.165 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -48.79 64.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.312 0.577 . . . . 0.0 110.41 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -55.59 32.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.981 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.01 -41.24 97.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.566 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.418 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.28 -39.49 69.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -77.07 -32.04 56.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -80.25 -19.61 46.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -97.7 -28.81 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.23 42.53 10.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.988 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.409 HD11 ' CG2' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -117.19 129.25 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.743 0.306 . . . . 0.0 111.107 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 2.9 t70 -57.34 101.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.832 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.21 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -48.47 78.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.98 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.416 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.48 -26.93 63.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 158' ' ' ILE . 41.7 t -84.5 85.9 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.15 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -50.76 96.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.558 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.31 140.61 32.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.802 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 14.2 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.724 0.297 . . . . 0.0 110.979 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.76 161.5 54.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.746 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.412 ' O ' HG12 ' A' ' 157' ' ' VAL . 1.8 Cg_endo -44.84 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.421 2.748 . . . . 0.0 112.887 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.28 24.82 11.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.218 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.4 22.22 78.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.646 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.481 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -85.17 124.14 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 117.097 0.448 . . . . 0.0 111.038 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.634 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.6 pt -63.23 111.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.7 p -75.19 156.51 35.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.483 0.658 . . . . 0.0 111.481 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.17 -42.73 57.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.986 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -64.02 -27.73 69.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.928 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.4 m-20 -69.66 -48.04 61.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.517 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.29 -40.12 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 1.5 pttm . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 111.131 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.463 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.69 95.25 2.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.681 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 19.2 ptp -47.47 165.99 0.21 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.63 0.253 . . . . 0.0 110.875 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.73 -47.71 3.68 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.938 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -50.13 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.42 -34.11 73.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -48.47 63.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -57.21 -55.14 38.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.66 -40.24 94.22 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.451 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.405 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.77 -36.83 70.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.06 -33.2 57.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.872 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.64 -20.58 42.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.83 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -95.62 -28.65 14.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.24 12.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.903 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.416 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -118.42 129.42 74.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.73 0.3 . . . . 0.0 111.06 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.54 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.677 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.46 79.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -49.93 72.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.218 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.24 -27.24 61.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 144' ' ' ILE . 46.1 t -84.3 85.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.168 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -50.74 94.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.546 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -67.69 140.42 36.68 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.741 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 12.95 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.982 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.94 156.49 53.26 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.697 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.27 104.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.097 2.532 . . . . 0.0 112.861 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.93 22.16 14.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.275 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.36 22.18 78.94 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.603 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.49 124.68 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 117.046 0.423 . . . . 0.0 111.068 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.8 pt -63.79 111.55 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 68.1 p -75.18 156.66 35.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.563 0.697 . . . . 0.0 111.684 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.424 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.1 -43.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.121 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.06 -27.65 68.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.006 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.9 m-20 -68.82 -46.99 67.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.521 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.35 -43.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.495 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.547 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.466 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.966 0.413 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.26 95.59 2.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.0 ptp -47.21 166.17 0.19 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.771 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.1 -48.02 3.03 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.819 2.346 . . . . 0.0 112.912 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -50.54 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.387 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.03 -34.92 76.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.238 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -49.13 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.623 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -54.74 43.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.519 ' C ' HD11 ' A' ' 138' ' ' LEU . 4.3 pp -62.31 -39.9 94.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.541 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.85 -36.69 72.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -77.03 -32.41 57.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.945 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -20.84 35.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -93.6 -27.61 16.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.588 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.34 42.63 18.09 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.736 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 132.56 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 111.09 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.91 101.02 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.632 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.93 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.532 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -47.43 80.73 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -27.8 66.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 158' ' ' ILE . 43.0 t -83.8 85.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.82 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -50.83 90.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.711 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -57.92 137.64 49.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.74 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 15.01 13.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.65 158.03 48.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.754 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.9 102.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.183 2.588 . . . . 0.0 112.836 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.96 23.35 11.67 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.269 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.14 79.05 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.63 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.25 124.61 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 117.065 0.433 . . . . 0.0 111.108 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 158' ' ' ILE . 13.7 pt -62.72 111.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.9 p -75.14 156.48 35.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.567 0.699 . . . . 0.0 111.635 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.458 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.34 -42.69 59.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.938 -179.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.7 68.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.6 m-20 -68.99 -46.13 68.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.79 -43.67 46.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.323 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.43 -178.795 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.444 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.895 0.379 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.53 96.32 1.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.4 ptm -47.77 167.58 0.18 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.3 -47.09 4.77 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.723 2.282 . . . . 0.0 112.786 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.9 63.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.463 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.95 -32.92 72.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -48.9 60.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 110.372 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -57.21 -54.32 48.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.504 ' C ' HD11 ' A' ' 138' ' ' LEU . 4.3 pp -63.15 -40.89 98.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.03 -36.73 73.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.66 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -77.11 -31.38 55.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -82.24 -21.78 36.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.423 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -94.07 -28.78 15.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.8 43.2 9.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.008 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.95 128.21 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.022 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -59.63 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.656 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.29 -40.85 78.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.003 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -50.16 70.84 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.05 61.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 158' ' ' ILE . 49.5 t -83.24 85.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.88 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -50.77 92.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.281 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -66.64 142.33 41.98 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.964 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 13.56 13.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.64 156.34 51.86 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.806 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.62 103.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.174 2.583 . . . . 0.0 112.903 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.5 23.2 11.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.201 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.59 22.12 78.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.605 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.444 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.71 126.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.2 pt -64.52 112.02 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.7 p -75.28 156.56 35.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.424 0.631 . . . . 0.0 111.591 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.442 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.24 -42.71 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.115 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -64.02 -27.69 69.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -70.14 -47.39 61.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.497 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.08 -40.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.099 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.465 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.93 94.41 1.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.6 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 17.5 ptp -45.56 165.47 0.17 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.978 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.5 -47.22 4.4 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.769 2.313 . . . . 0.0 112.809 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.78 63.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.488 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.87 -33.47 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -68.55 -49.58 58.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -58.51 -55.31 36.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.12 -40.77 95.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.4 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.11 -42.94 73.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 110.919 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -29.7 59.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -79.51 -24.42 42.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.8 mt -91.41 -28.85 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.745 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.88 34.5 6.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.073 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.454 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.3 tt -117.84 147.15 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -82.22 101.15 10.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.101 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -47.89 -33.19 7.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.168 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -34.94 79.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -18.68 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 55.1 t -96.94 88.08 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.271 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.74 98.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.1 142.16 35.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 11.23 12.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.92 153.35 49.88 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.718 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.56 112.91 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.129 2.552 . . . . 0.0 112.775 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.11 10.56 57.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.334 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.05 55.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.774 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.23 124.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 117.181 0.49 . . . . 0.0 111.207 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.655 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.7 pt -63.58 111.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 52.5 p -75.32 156.57 35.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.662 0.744 . . . . 0.0 111.89 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -41.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.941 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLU . . . . . 0.494 ' HA ' ' CG ' ' A' ' 164' ' ' LYS . 3.3 mt-10 -63.62 -27.84 69.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.304 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 159' ' ' THR . 78.1 m-20 -70.82 -52.1 22.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.099 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.24 -48.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.494 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.286 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 p -131.18 143.34 50.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.943 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.7 22.69 10.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 56.57 169.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.018 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.79 125.96 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.459 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -97.97 151.79 19.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.23 95.07 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.673 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.405 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 17.5 ptp -46.31 167.42 0.14 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.02 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.405 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.92 -48.5 2.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.816 2.344 . . . . 0.0 112.944 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.03 70.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.459 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -71.34 -34.19 70.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.99 -46.41 71.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.309 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.11 -56.0 27.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.535 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.81 -39.61 74.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -29.83 55.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -81.93 -25.35 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.4 mt -90.52 -28.58 18.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.714 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.14 41.64 9.27 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.933 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.61 127.38 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.79 0.328 . . . . 0.0 110.949 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 103.12 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.59 -40.45 79.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.073 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -49.88 71.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.192 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.44 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.08 -28.24 62.43 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 158' ' ' ILE . 49.7 t -83.54 85.29 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.992 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -50.92 92.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.444 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -65.49 141.98 43.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.796 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 13.41 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.696 0.284 . . . . 0.0 111.146 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.447 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.5 154.98 50.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.727 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.72 106.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.022 2.481 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.96 18.95 25.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.248 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.13 74.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.459 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.79 124.6 40.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.035 0.418 . . . . 0.0 111.053 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.557 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.2 pt -64.3 111.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 81.0 p -75.16 156.51 35.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.443 0.64 . . . . 0.0 111.439 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.436 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.28 -43.29 60.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.1 -179.225 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -27.66 69.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.1 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.532 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -69.99 -48.17 59.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.535 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.81 -41.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.734 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.91 -48.43 81.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 28.7 ptt180 -68.42 -42.64 78.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.297 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.44 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 1.6 t-105 -65.4 -49.16 70.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.656 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.85 94.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.544 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.13 -36.32 83.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 110.851 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -44.98 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.0 110.48 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 10.6 p -54.97 -52.06 64.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.738 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -26.57 64.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 110.292 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -34.42 78.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.596 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.31 113.31 2.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -31.39 8.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.129 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.7 m 60.54 177.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 111.65 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.62 -57.06 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.83 88.5 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.495 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -80.39 149.89 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.042 0.449 . . . . 0.0 110.853 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.11 94.64 1.97 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 18.3 ptp -45.08 163.6 0.2 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.57 -49.83 2.19 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 138' ' ' LEU . . . -54.25 -48.3 71.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 -179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.482 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.17 -34.9 75.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.291 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -69.6 -49.5 53.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -57.03 -55.64 32.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.501 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.74 -39.54 89.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.503 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.02 -41.11 74.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -30.09 55.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.083 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.93 -18.71 39.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.1 mt -98.66 -28.84 13.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.85 35.16 11.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.047 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.529 HG13 ' N ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -108.73 125.8 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.301 . . . . 0.0 110.578 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -60.32 101.07 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.69 -45.58 89.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -48.58 66.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.26 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.38 -33.44 67.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.575 HG12 ' CD1' ' A' ' 166' ' ' TRP . 55.1 t -79.37 82.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.856 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.82 92.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.02 139.46 43.44 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.356 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.4 13.86 13.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.648 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.443 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -77.22 157.28 46.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.34 106.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.129 2.552 . . . . 0.0 112.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.71 20.11 22.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.05 22.16 77.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.612 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.51 125.62 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.122 0.461 . . . . 0.0 111.331 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 158' ' ' ILE . 12.0 pt -62.21 111.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 30.6 p -74.98 156.26 36.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.441 0.639 . . . . 0.0 111.641 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.485 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -55.26 -39.18 50.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.588 -178.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.474 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 3.4 mt-10 -67.45 -30.54 70.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.94 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' O ' ' CD1' ' A' ' 166' ' ' TRP . 93.6 m-20 -65.37 -57.99 6.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.637 . . . . 0.0 110.1 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.501 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -56.68 -42.61 77.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.565 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -35.4 75.83 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.474 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 5.7 mmt85 -65.91 -49.87 66.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.615 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.597 ' O ' ' CG2' ' A' ' 170' ' ' THR . 14.5 m95 -73.9 -50.97 17.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.84 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.529 ' N ' HG13 ' A' ' 144' ' ' ILE . . . -50.1 -34.38 21.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.852 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.415 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 5.3 pt-20 -77.47 -36.99 52.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.773 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.44 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 0.1 OUTLIER -74.26 -42.42 59.68 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.868 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.597 ' CG2' ' O ' ' A' ' 166' ' ' TRP . 3.3 p -53.52 -52.14 60.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.975 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.11 61.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.461 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 169' ' ' GLU . 13.1 mmtt -61.12 -33.4 73.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.591 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.35 108.16 4.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.3 p 53.22 79.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.065 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m 61.18 31.78 19.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.14 -59.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.856 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.98 132.71 46.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.43 111.46 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -96.92 151.98 19.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 110.87 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.22 95.46 2.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.84 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 11.4 ptp -48.33 166.26 0.22 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.966 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.89 -47.65 3.56 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.878 2.386 . . . . 0.0 112.972 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.9 65.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.429 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.474 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.93 -34.49 75.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.096 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -67.83 -48.58 65.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.231 0.539 . . . . 0.0 110.423 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -57.77 -55.94 28.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.037 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.513 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.18 -41.59 97.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.63 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.416 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.06 -38.44 70.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.916 0.388 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.35 56.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.006 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -81.91 -21.43 37.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 111.041 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.413 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.2 mt -94.8 -28.8 15.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.601 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.03 42.8 10.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.856 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -117.16 129.23 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 111.057 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -56.52 101.07 0.05 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.39 -42.58 92.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.767 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -48.53 78.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.992 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.433 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -58.8 -25.72 63.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.434 ' O ' HG23 ' A' ' 158' ' ' ILE . 40.3 t -85.78 85.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -50.9 100.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -74.63 141.62 28.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.94 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 12.92 13.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.645 0.26 . . . . 0.0 111.155 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.432 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.43 156.67 53.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.854 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.403 ' O ' HG12 ' A' ' 157' ' ' VAL . 83.5 Cg_exo -44.68 104.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.103 2.535 . . . . 0.0 112.907 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.7 22.11 14.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.168 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.35 22.18 78.95 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.61 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.74 124.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.064 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.605 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.4 pt -63.61 111.49 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.55 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.2 p -75.25 156.57 35.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.648 0.737 . . . . 0.0 111.624 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.445 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.93 -42.83 55.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.118 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -64.57 -27.61 69.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.121 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.55 ' HB2' ' O ' ' A' ' 159' ' ' THR . 64.0 m-20 -69.5 -49.15 57.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.727 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.513 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.35 -46.83 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.871 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.68 -46.09 81.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.359 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -68.26 -41.33 81.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.433 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 1.3 t-105 -65.42 -49.62 68.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.488 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.92 79.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.58 -36.37 78.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 110.739 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -61.91 -27.44 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.9 p -68.71 -52.01 35.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.21 -24.3 43.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -29.11 64.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.887 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -55.37 -68.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.8 p -123.73 -74.84 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.141 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 p -100.7 -34.53 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.374 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.36 124.51 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.62 144.64 56.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.55 98.17 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.485 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -81.83 151.55 27.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.715 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.59 95.14 1.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.825 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 14.3 ptm -46.42 164.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.6 -49.29 2.47 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.774 2.316 . . . . 0.0 112.789 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.409 ' O ' HD22 ' A' ' 138' ' ' LEU . . . -54.14 -49.12 69.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.407 -179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.2 -34.46 74.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.337 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.31 -49.33 56.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -57.79 -55.39 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.62 -38.66 85.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.396 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -57.09 -40.51 77.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -76.72 -29.82 56.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -85.11 -16.59 40.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.442 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.407 HD13 ' HB2' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -99.77 -28.82 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.66 10.0 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.499 HG13 ' N ' ' A' ' 167' ' ' ALA . 0.1 OUTLIER -111.36 126.41 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.634 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 3.2 t0 -61.78 100.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.457 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -58.29 -44.87 88.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.39 67.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.155 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.35 -33.37 65.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.573 HG12 ' CD1' ' A' ' 166' ' ' TRP . 54.8 t -79.34 84.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.084 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.96 91.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.508 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.31 138.22 46.2 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.241 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.37 13.9 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.28 159.09 49.97 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.4 ' O ' HG12 ' A' ' 157' ' ' VAL . 92.7 Cg_exo -43.85 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.166 2.577 . . . . 0.0 112.953 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.16 11.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.192 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.45 22.19 79.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.633 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.485 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.56 125.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.228 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.579 ' O ' HG13 ' A' ' 158' ' ' ILE . 11.4 pt -61.04 110.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.49 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 24.2 p -75.19 156.54 35.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.337 0.589 . . . . 0.0 111.6 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.49 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.24 -40.47 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.423 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.67 -28.31 69.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.61 ' O ' ' CD1' ' A' ' 166' ' ' TRP . 95.7 m-20 -68.91 -58.03 4.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.485 0.66 . . . . 0.0 109.821 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -57.38 -41.17 77.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.38 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -45.38 88.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -62.61 -47.37 84.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.61 ' CD1' ' O ' ' A' ' 162' ' ' ASP . 19.5 m95 -72.78 -50.96 21.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.5 ' HA ' HG22 ' A' ' 170' ' ' THR . . . -50.18 -35.11 24.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.213 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 15.7 pt-20 -77.62 -38.26 48.44 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.424 ' N ' ' HG3' ' A' ' 168' ' ' GLU . 41.0 mt-10 -76.95 -26.84 54.47 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.418 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.589 ' CG2' ' O ' ' A' ' 166' ' ' TRP . 29.0 p -62.87 -52.13 64.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.46 -26.32 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.401 ' HB3' ' HA ' ' A' ' 169' ' ' GLU . 8.1 tttt -65.54 -36.14 82.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.57 69.09 5.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.23 164.49 20.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.071 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -79.39 80.5 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -125.85 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.78 -40.42 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.12 102.55 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.455 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -90.71 149.6 21.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.035 0.445 . . . . 0.0 110.962 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.31 94.55 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.638 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.419 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.9 ptm -47.11 167.77 0.15 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.419 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.5 Cg_exo -65.7 -45.78 6.09 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.837 2.358 . . . . 0.0 113.02 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.45 61.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.396 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.468 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.47 -32.97 72.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -46.73 71.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.24 179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -59.67 -55.5 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.134 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.553 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.38 -42.11 99.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.422 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.69 -38.99 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -76.87 -29.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -81.31 -25.31 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.056 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.7 mt -90.29 -29.01 18.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.8 31.62 9.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.025 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.453 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -111.81 146.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.94 0.37 . . . . 0.0 111.323 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.428 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -79.81 101.01 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.098 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.414 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.22 -32.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -35.03 79.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.969 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.428 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.64 -19.32 61.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.402 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.453 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 54.8 t -95.54 88.08 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.064 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.78 100.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.22 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.41 141.91 28.41 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.954 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.03 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.579 0.228 . . . . 0.0 111.088 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.464 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.83 153.91 50.57 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 107.74 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.144 2.562 . . . . 0.0 112.811 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 18.41 27.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.205 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.38 22.08 73.93 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.659 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.464 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -86.44 124.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 117.069 0.435 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.641 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.8 pt -65.15 111.81 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.5 p -75.35 156.57 35.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.557 0.694 . . . . 0.0 111.586 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.436 ' O ' ' HB3' ' A' ' 164' ' ' LYS . 0.2 OUTLIER -55.46 -42.73 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.121 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -27.73 69.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.982 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 92.0 m-20 -70.36 -51.72 27.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -69.52 -38.84 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.78 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 8.5 pttt -61.39 -49.88 75.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.166 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.1 OUTLIER -67.44 -35.83 80.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.014 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.417 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 2.1 t-105 -71.96 -38.19 69.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.342 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.52 -45.27 60.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.29 -41.32 98.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -53.58 -27.21 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.1 p -73.2 -51.95 15.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.44 63.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -30.68 71.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.64 115.35 22.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 68.8 p -104.98 -36.04 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.105 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.68 -55.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.11 -63.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -149.39 -81.82 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.88 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.77 119.32 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.46 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -96.86 150.09 21.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.8 94.86 2.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.766 179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.5 ptp -46.82 167.08 0.16 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.028 -179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.2 -48.04 2.9 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.904 2.403 . . . . 0.0 113.028 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -49.94 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.77 -34.57 73.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.028 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.34 -47.97 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.342 0.592 . . . . 0.0 110.369 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.6 -55.95 28.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.518 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.5 -41.54 97.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.411 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.39 -37.8 70.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -77.12 -31.43 55.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.33 -21.74 35.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.021 0.438 . . . . 0.0 111.048 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.416 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.57 -28.23 16.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.679 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.77 42.0 11.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.875 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -117.71 127.19 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -57.82 101.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.65 -40.82 80.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.43 -49.94 71.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.199 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.427 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -56.9 -28.53 62.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 158' ' ' ILE . 50.6 t -83.2 85.82 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.806 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.454 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 1.1 ptpp? -50.81 91.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 111.814 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.437 ' CA ' HG23 ' A' ' 158' ' ' ILE . . . -59.08 138.51 49.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.69 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 15.09 13.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.434 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.44 156.81 47.12 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.79 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.7 104.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.159 2.573 . . . . 0.0 112.907 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.64 20.98 17.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.225 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.23 22.14 78.06 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.63 -179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.46 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.54 123.62 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.065 0.432 . . . . 0.0 111.189 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.546 ' O ' HG13 ' A' ' 158' ' ' ILE . 9.1 pt -63.16 110.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.526 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.8 p -75.15 156.51 35.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 0.0 111.522 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.23 -42.82 58.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.156 -179.177 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -64.83 -27.52 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.138 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.526 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.4 m-20 -70.0 -48.7 57.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.721 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.518 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.07 -46.08 68.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -58.6 -46.56 86.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.562 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -37.25 75.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.206 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.427 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 1.9 t-105 -70.3 -46.18 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.592 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.98 -40.79 87.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.41 -39.36 81.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.388 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.72 -29.97 67.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.018 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.2 p -68.34 -52.12 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.568 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.3 -24.61 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -71.94 -31.32 66.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.14 -30.5 64.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.95 107.25 15.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.016 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.67 -56.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' A' ' 128' ' ' GLU . 69.3 mtm180 -87.93 -28.46 21.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.978 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 127' ' ' ARG . 7.1 pt-20 48.24 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.24 132.42 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -90.95 153.9 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.76 95.65 2.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.972 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 ptp -46.35 166.75 0.16 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.961 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.59 -48.54 3.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.861 2.374 . . . . 0.0 112.829 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -49.87 68.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.355 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.463 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.74 -35.02 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -48.87 67.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.231 0.538 . . . . 0.0 110.509 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -58.93 -54.23 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.928 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.525 HD12 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.32 -39.76 95.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.49 -38.88 72.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.956 0.408 . . . . 0.0 110.729 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.98 -32.13 57.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.99 -21.52 40.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.01 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.415 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.23 -28.62 16.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 40.71 11.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.876 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.48 127.13 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 0.0 110.904 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.06 101.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.61 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.402 ' CB ' HD11 ' A' ' 158' ' ' ILE . . . -57.63 -41.13 80.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -50.2 68.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.199 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.443 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.568 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 158' ' ' ILE . 51.1 t -82.07 83.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.94 91.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 111.315 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.437 ' CA ' HG23 ' A' ' 158' ' ' ILE . . . -60.6 142.47 48.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.009 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.91 13.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 110.842 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.437 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -74.92 156.75 49.6 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.7 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -43.74 103.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.876 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.13 23.41 11.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.159 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.56 22.15 78.67 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.5 125.31 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.981 0.39 . . . . 0.0 111.001 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.582 ' O ' HG13 ' A' ' 158' ' ' ILE . 12.9 pt -63.74 111.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 63.4 p -75.16 156.52 35.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.521 0.677 . . . . 0.0 111.474 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.464 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.98 -42.19 53.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.247 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.44 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.9 mm-40 -65.81 -27.75 68.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.069 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.2 m-20 -68.79 -46.73 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.31 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.525 ' HB ' HD12 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.96 -42.19 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -47.9 84.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.704 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.44 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 73.8 mtp180 -73.68 -41.85 62.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.571 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.443 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 t90 -67.1 -45.08 78.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.321 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.09 70.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.317 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -60.75 -37.7 82.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.908 0.385 . . . . 0.0 110.721 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -30.67 67.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.954 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 7.0 p -68.49 -52.08 36.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.12 -28.45 66.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.53 72.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.631 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.16 115.76 21.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.5 t -147.46 121.94 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.161 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p -158.1 146.56 18.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 149.33 35.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.73 -80.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.49 100.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.471 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -95.47 148.09 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.092 0.472 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.66 94.1 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.59 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 18.3 ptp -46.28 166.46 0.16 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.089 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -66.36 -48.43 2.45 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.938 2.425 . . . . 0.0 112.977 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.69 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.515 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.25 -35.09 73.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.2 mtt-85 -67.81 -47.27 69.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.302 0.572 . . . . 0.0 110.24 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -56.64 19.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.533 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.27 -40.74 95.22 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.407 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.63 -39.72 71.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -31.71 56.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.971 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.77 -20.65 42.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.425 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -96.19 -28.82 14.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.717 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.85 40.91 10.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.149 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -117.35 126.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 0.0 110.916 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.33 101.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.676 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.4 -40.41 78.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.857 179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -49.91 70.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.196 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.489 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.52 -28.5 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.431 ' O ' HG23 ' A' ' 158' ' ' ILE . 52.8 t -83.75 84.52 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.154 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -50.87 96.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.408 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.43 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -64.59 141.96 44.83 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.49 12.01 13.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.647 0.26 . . . . 0.0 111.113 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.453 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.75 155.66 51.21 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.779 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 157' ' ' VAL . 81.8 Cg_exo -44.76 106.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.123 2.549 . . . . 0.0 112.905 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.05 19.19 24.7 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.159 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 75.66 22.17 75.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.629 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.22 123.51 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.064 0.432 . . . . 0.0 111.177 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.596 ' O ' HG13 ' A' ' 158' ' ' ILE . 12.6 pt -63.12 110.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.14 156.54 35.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.526 0.679 . . . . 0.0 111.724 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.431 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.14 -42.92 58.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.231 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -27.75 69.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.519 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.4 m-20 -69.54 -48.95 58.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.604 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.533 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.09 -46.11 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.817 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -45.41 82.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.487 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 2.3 ptm180 -69.69 -43.48 72.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.489 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 1.7 t-105 -65.45 -49.84 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.551 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.92 75.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.574 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -59.98 -38.74 83.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.58 -27.73 66.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.915 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.1 p -69.74 -52.12 28.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.74 -28.51 65.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.562 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -31.65 72.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.639 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.7 -68.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.1 p -62.47 130.42 45.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.1 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.6 m 59.41 27.5 16.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -113.29 -29.03 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.73 156.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.819 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.21 106.85 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.452 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -90.67 150.73 21.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 110.843 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.48 94.6 2.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.4 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 15.9 ptp -46.74 166.78 0.17 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.975 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -66.25 -47.36 3.37 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.84 2.36 . . . . 0.0 112.772 -178.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.13 65.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.455 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.59 -33.75 73.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 9.0 mmm180 -68.32 -47.82 66.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.415 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.01 -56.02 27.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.553 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.0 -40.57 94.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.676 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.406 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.28 -41.65 76.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -75.77 -29.95 58.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.87 -26.9 40.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.432 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.7 mt -89.02 -29.01 19.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.13 33.9 7.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.238 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.444 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.1 tt -115.81 146.88 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.428 ' N ' HG12 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -79.93 100.92 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.418 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.39 -32.87 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -35.07 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.958 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.82 -20.39 61.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.444 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 53.8 t -95.55 87.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.136 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.427 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -50.76 107.52 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 111.402 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.49 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -76.1 140.59 25.86 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.274 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 110.839 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.35 156.07 46.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.869 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 0.0 112.892 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 19.55 23.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.208 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.99 22.21 77.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.66 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.452 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.87 124.77 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 117.023 0.412 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.659 ' O ' HG13 ' A' ' 158' ' ' ILE . 21.3 pt -64.17 111.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.552 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 49.3 p -75.32 156.54 35.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.625 0.726 . . . . 0.0 111.732 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.433 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -42.78 65.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.924 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.51 -27.68 69.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.552 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.5 m-20 -69.69 -49.33 54.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.553 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.21 -40.71 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.916 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -59.02 -50.23 74.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.165 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.421 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -67.44 -39.93 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -66.71 -37.37 84.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.083 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.52 26.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.406 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 22.4 pt-20 -58.62 -37.26 75.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -44.74 88.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.131 0.491 . . . . 0.0 110.542 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.5 p -58.93 -52.24 66.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.781 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.45 -28.61 66.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.93 -31.34 72.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.75 98.12 8.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.31 -33.03 17.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.109 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -96.58 110.3 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 0.0 110.84 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.66 30.88 6.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.67 179.4 5.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.56 122.6 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.955 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.45 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -93.7 153.07 18.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.388 . . . . 0.0 110.952 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.74 95.38 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.808 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.4 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 19.3 ptp -47.02 167.25 0.17 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.4 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.88 -48.08 3.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.827 2.351 . . . . 0.0 112.906 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.13 67.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.442 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.492 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.64 -34.16 73.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.178 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -68.46 -47.94 65.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.382 0.61 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.37 -55.92 28.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.526 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.1 pp -61.97 -41.27 97.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.639 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.413 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.06 -40.38 70.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.364 . . . . 0.0 111.017 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -31.46 56.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.989 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -80.45 -21.54 41.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.92 0.39 . . . . 0.0 111.015 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.406 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -95.92 -28.68 14.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.664 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.02 42.64 10.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.404 HD11 HG22 ' A' ' 144' ' ' ILE . 0.0 OUTLIER -117.26 129.7 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 0.0 111.037 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.07 101.03 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.91 -42.85 94.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.687 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -48.76 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.97 -27.33 63.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 158' ' ' ILE . 42.2 t -84.17 85.89 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.013 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 95.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.497 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.6 140.92 32.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.651 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.83 13.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.289 . . . . 0.0 111.143 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.4 156.21 53.26 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.809 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.405 ' O ' HG12 ' A' ' 157' ' ' VAL . 83.6 Cg_exo -44.69 105.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.14 2.56 . . . . 0.0 112.891 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.45 21.45 17.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.155 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.8 22.1 78.56 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.62 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.45 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.84 125.19 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.139 0.47 . . . . 0.0 111.014 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.529 ' O ' HG13 ' A' ' 158' ' ' ILE . 10.7 pt -64.35 111.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.521 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.1 p -75.07 156.56 35.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.427 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.46 -42.38 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.113 -179.25 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -64.07 -27.65 69.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.1 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.521 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.0 m-20 -70.91 -49.6 44.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.897 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.28 -43.49 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.972 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -60.15 -49.43 77.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.881 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 17.5 ptt180 -62.95 -41.48 99.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.426 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 1.4 t-105 -67.39 -48.34 67.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.599 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.36 -44.33 71.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.393 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -61.35 -40.63 94.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.31 -29.24 63.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.995 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.7 p -66.61 -52.08 49.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.55 -27.06 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.748 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -35.16 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.81 92.9 6.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.7 p -91.4 168.63 11.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.097 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.3 m -159.57 31.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 128' ' ' GLU . 7.8 ttm180 -172.9 127.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 127' ' ' ARG . 18.2 tt0 83.55 -16.3 0.56 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.671 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.89 122.32 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.457 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -100.29 152.02 20.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.918 0.389 . . . . 0.0 111.004 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.51 94.77 2.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.796 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.404 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 13.2 ptp -46.48 166.92 0.16 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.061 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.06 -48.31 2.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.24 71.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.469 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.467 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -71.93 -34.27 68.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 2.7 mmm180 -68.69 -45.89 70.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.241 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -60.28 -55.66 30.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.953 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.561 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.54 -40.48 94.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.412 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.7 -37.51 73.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.383 . . . . 0.0 110.743 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -31.21 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.28 -25.4 36.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.429 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -91.62 -28.77 17.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.6 42.94 9.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.933 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.407 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -117.86 129.95 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.063 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.464 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -60.03 101.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.765 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.87 -40.0 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.932 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -49.25 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.135 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.27 -26.76 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 158' ' ' ILE . 45.7 t -84.52 85.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.88 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.67 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.566 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -64.22 144.64 48.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.647 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 1.35 11.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 111.163 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -62.14 152.5 43.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.457 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' O ' HG12 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -44.54 118.68 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.043 2.495 . . . . 0.0 112.983 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.94 0.09 72.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 95.25 22.16 23.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.628 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.457 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.49 125.62 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 117.089 0.444 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.637 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.0 pt -64.74 111.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.509 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 69.2 p -75.15 156.5 35.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.59 0.71 . . . . 0.0 111.588 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.439 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.62 -41.96 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.273 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.507 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -64.61 -27.86 69.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.939 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.509 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.3 m-20 -69.3 -47.09 65.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.273 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.561 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -76.0 -34.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.091 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.436 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -64.08 -48.55 75.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.885 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 7.6 mtt180 -72.38 -41.29 66.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.279 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 1.9 t-105 -68.73 -43.67 75.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.573 -179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.43 74.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.51 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -69.09 -36.86 78.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.984 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.93 -44.49 91.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.664 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 9.5 p -56.05 -52.17 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.967 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.64 -23.79 58.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.296 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 2.3 tptm -69.49 -35.21 75.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.7 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.23 126.19 35.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.044 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 p -79.1 -45.89 19.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.126 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.4 p -106.41 31.47 5.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.69 -171.31 3.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.22 150.7 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.12 135.02 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.479 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -86.14 154.77 21.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 110.875 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.4 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -154.68 96.33 1.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.904 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.593 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 11.8 ptp -45.36 165.68 0.16 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.593 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 48.5 Cg_endo -71.61 -32.35 12.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.072 1.848 . . . . 0.0 112.507 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.07 -51.5 63.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.749 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.487 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.4 -35.02 75.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.13 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.4 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 1.1 mtt180 -66.44 -48.56 69.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.323 0.582 . . . . 0.0 110.415 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -55.61 32.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.519 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.5 -41.31 98.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.414 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.59 -37.73 68.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -33.31 56.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -79.98 -19.96 46.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.423 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.2 mt -96.7 -28.81 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.591 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.15 43.16 10.98 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.858 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.41 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -117.43 130.08 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.771 0.32 . . . . 0.0 111.058 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.436 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 5.1 t70 -58.74 101.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.73 -41.63 91.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.767 0.317 . . . . 0.0 110.761 179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -49.05 76.89 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.6 -27.34 62.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.41 ' CG2' HD13 ' A' ' 144' ' ' ILE . 41.8 t -84.35 86.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.73 92.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.561 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -67.02 139.88 36.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.683 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 14.29 13.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.433 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.71 156.7 52.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.41 104.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.511 . . . . 0.0 112.863 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.55 22.46 14.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.211 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.05 22.08 79.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.669 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.479 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -86.11 125.43 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 117.058 0.429 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.62 ' O ' HG13 ' A' ' 158' ' ' ILE . 16.7 pt -63.64 111.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 74.6 p -75.12 156.54 35.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.493 0.663 . . . . 0.0 111.555 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.471 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.61 -42.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.144 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.43 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.7 mt-10 -63.9 -27.68 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.876 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.3 m-20 -69.9 -46.94 64.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.362 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.519 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.83 -36.8 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.42 ' HG2' ' HG3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -63.35 -48.42 78.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.939 0.4 . . . . 0.0 110.908 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 6.3 mtt85 -71.12 -39.69 71.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.46 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.409 ' NE1' ' HD2' ' A' ' 148' ' ' LYS . 1.6 t-105 -70.35 -50.07 42.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.322 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.56 99.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.438 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.14 -41.36 90.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.941 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -57.61 -27.17 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.219 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.7 p -71.91 -51.98 19.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.82 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.48 -28.75 66.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -31.56 72.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.54 -68.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.1 p -77.26 179.77 6.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.086 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.1 p -76.69 -31.3 57.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 110.967 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 -67.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -110.11 -175.14 2.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.11 115.1 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.429 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -81.1 151.23 28.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.79 95.73 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.402 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 17.7 ptp -46.55 167.47 0.15 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.746 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.402 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.51 -47.99 3.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.713 2.275 . . . . 0.0 112.902 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.82 66.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.52 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.491 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.62 -33.01 72.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.223 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -69.75 -47.81 61.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 110.325 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -57.51 -54.93 41.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.816 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.537 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.78 -41.09 99.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.56 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.41 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.25 -39.15 75.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -29.95 55.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -83.49 -16.57 45.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.431 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -97.68 -28.84 13.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.94 33.68 8.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.944 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.458 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.6 tt -116.44 147.2 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.438 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.429 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -81.15 101.01 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.804 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -47.81 -34.06 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.33 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -63.7 -35.72 81.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.885 0.374 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -70.38 -19.93 62.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 48.2 t -93.63 87.94 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.055 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -50.7 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.272 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.544 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -74.38 143.35 31.57 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.868 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.23 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.467 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -69.77 153.39 52.24 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.85 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.03 107.46 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.072 2.515 . . . . 0.0 112.848 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 18.64 26.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.263 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 76.16 21.96 74.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.467 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -86.66 125.89 40.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.892 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.645 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.1 pt -66.5 111.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.53 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.2 p -75.1 156.51 35.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.513 0.673 . . . . 0.0 111.489 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.425 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.97 -42.97 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.07 -179.192 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -27.58 69.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.075 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.53 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -70.83 -48.17 55.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.718 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.537 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.63 -41.9 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.428 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -59.46 -50.39 74.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -65.11 -42.09 94.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.636 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.418 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.3 t-105 -65.4 -37.99 88.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.08 -53.89 8.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.95 -38.19 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.054 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.66 -27.93 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.4 p -70.66 -52.0 24.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.761 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.6 63.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.64 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -64.17 -31.78 73.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.7 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.7 94.32 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.4 p -105.48 -31.42 9.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.141 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.2 m -91.81 110.78 22.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -113.46 31.77 6.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.03 -167.68 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.6 128.81 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -91.96 155.15 18.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.827 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.57 95.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.971 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.666 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 18.4 ptm -46.65 167.89 0.14 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.611 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.666 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 49.2 Cg_endo -71.42 -33.56 10.82 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.112 1.874 . . . . 0.0 112.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.36 46.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.471 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.93 -33.16 71.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.69 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.15 -46.89 72.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.173 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -59.12 -55.58 33.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.731 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.7 -41.13 98.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.25 -39.66 76.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -76.46 -29.85 57.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -81.1 -24.88 37.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.917 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.434 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.6 mt -89.78 -28.89 19.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.45 12.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.967 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.45 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.3 tt -110.52 146.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.386 . . . . 0.0 111.327 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.426 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -78.94 100.92 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.861 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.427 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -49.81 -32.33 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -34.43 77.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 109.93 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.46 -20.08 61.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.45 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 55.1 t -94.89 88.19 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.051 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -50.8 99.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -76.64 140.57 25.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.17 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 12.97 13.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 111.034 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -69.8 155.81 53.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.843 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.403 ' O ' HG12 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -44.81 105.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.136 2.558 . . . . 0.0 112.893 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.55 20.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.142 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 74.5 22.05 77.91 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.657 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.42 125.11 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.109 0.454 . . . . 0.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.644 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.3 pt -63.89 111.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 66.9 p -75.3 156.52 35.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.587 0.708 . . . . 0.0 111.802 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.453 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.01 -41.8 60.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.92 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -27.52 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.037 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.513 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -71.26 -49.77 39.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.512 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.44 -41.6 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.36 -49.77 75.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.082 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.425 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -66.03 -35.48 80.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.674 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.402 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.6 t-105 -70.59 -42.05 71.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.28 -39.16 89.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -45.43 77.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.6 p -55.37 -52.13 64.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.871 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.0 61.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.47 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -37.49 80.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.789 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.79 3.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.012 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 66.0 p -79.09 150.51 31.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.134 -179.989 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -170.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.853 0.359 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.91 103.74 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -166.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.9 115.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.982 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.43 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -87.49 150.78 23.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -149.47 95.26 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.907 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.408 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 9.3 ptp -46.04 167.57 0.13 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.037 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.52 -48.12 3.52 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.801 2.334 . . . . 0.0 112.83 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -50.48 67.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.472 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -70.54 -34.61 72.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 10.2 mmt180 -66.79 -46.74 74.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.3 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -60.05 -56.48 21.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.078 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.502 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.94 -41.81 96.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.415 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.01 -40.08 75.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -76.41 -29.76 57.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -81.96 -22.56 36.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.6 mt -92.71 -28.88 16.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.1 30.09 10.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.104 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.461 HG22 HD11 ' A' ' 144' ' ' ILE . 2.1 tt -111.64 146.48 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.335 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -80.5 100.99 8.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.065 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.429 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -48.06 -34.04 8.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.273 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 72.4 m -63.69 -34.49 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.412 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.21 -19.73 61.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.204 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.456 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 53.1 t -94.95 88.61 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.081 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -50.72 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.514 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.503 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -75.86 142.26 28.44 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.745 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.34 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.458 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.29 153.79 51.16 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.83 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.409 ' O ' HG12 ' A' ' 157' ' ' VAL . 80.9 Cg_exo -44.74 108.62 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.145 2.563 . . . . 0.0 112.856 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.09 17.45 32.12 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.245 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 77.18 22.16 71.68 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.714 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.458 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -86.72 126.05 40.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.03 0.415 . . . . 0.0 110.935 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.646 ' O ' HG13 ' A' ' 158' ' ' ILE . 15.7 pt -66.94 111.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.536 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.5 p -75.11 156.56 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.415 0.626 . . . . 0.0 111.374 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.433 HG12 HD22 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.95 -42.46 63.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.061 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -63.39 -27.68 69.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.536 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.6 m-20 -70.38 -53.84 14.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.648 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.34 -43.44 94.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.517 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -57.28 -48.4 79.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.816 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.486 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -63.13 -36.66 84.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.74 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.486 ' N ' ' HG3' ' A' ' 165' ' ' ARG . 1.8 t-105 -70.94 -41.42 71.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.49 -48.74 59.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.168 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.13 -42.66 98.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.0 -27.93 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.038 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 4.3 p -70.1 -52.02 27.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.683 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.29 -27.06 60.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -34.45 74.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.812 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.53 104.17 0.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.9 p -131.29 135.7 47.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.053 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t -69.71 157.48 37.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -84.19 -76.5 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.88 153.74 43.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.95 122.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.469 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -106.24 153.56 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 110.888 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.18 95.95 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.881 179.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 16.4 ptp -48.79 166.8 0.22 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.791 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.8 -48.05 3.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 112.962 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -50.52 66.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.481 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.93 -34.51 75.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.165 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -67.97 -48.79 64.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.312 0.577 . . . . 0.0 110.41 179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -55.59 32.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.981 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.528 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.01 -41.24 97.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.566 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.418 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.28 -39.49 69.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -77.07 -32.04 56.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -80.25 -19.61 46.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.42 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.3 mt -97.7 -28.81 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.23 42.53 10.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.988 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.409 HD11 ' CG2' ' A' ' 149' ' ' VAL . 0.1 OUTLIER -117.19 129.25 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.743 0.306 . . . . 0.0 111.107 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.416 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 2.9 t70 -57.34 101.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.832 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -59.63 -42.21 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -48.47 78.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.98 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.418 ' HD2' ' NE1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -58.48 -26.93 63.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 158' ' ' ILE . 41.7 t -84.5 85.9 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.15 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -50.76 96.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.558 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.445 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.31 140.61 32.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.802 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 14.2 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.724 0.297 . . . . 0.0 110.979 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.481 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.76 161.5 54.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.746 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.412 ' O ' HG12 ' A' ' 157' ' ' VAL . 1.8 Cg_endo -44.84 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.421 2.748 . . . . 0.0 112.887 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.28 24.82 11.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.218 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.4 22.22 78.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.646 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.481 HG21 ' HA2' ' A' ' 153' ' ' GLY . 1.2 m -85.17 124.14 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 117.097 0.448 . . . . 0.0 111.038 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.634 ' O ' HG13 ' A' ' 158' ' ' ILE . 17.6 pt -63.23 111.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.551 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.7 p -75.19 156.51 35.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.483 0.658 . . . . 0.0 111.481 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.452 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.17 -42.73 57.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.986 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -64.02 -27.73 69.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.928 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.4 m-20 -69.66 -48.04 61.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.517 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.528 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.29 -40.12 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 1.5 pttm -59.38 -48.41 81.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 111.131 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.412 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 1.6 ppt_? -71.12 -39.64 71.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.524 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.418 ' NE1' ' HD2' ' A' ' 148' ' ' LYS . 1.4 t-105 -69.11 -47.62 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.633 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.45 79.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.548 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -64.52 -41.87 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.65 -30.93 67.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.9 p -71.62 -51.82 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.526 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -64.01 -31.34 72.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.691 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.19 -31.26 68.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 68.5 p -76.49 -65.69 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.096 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.138 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.23 116.83 28.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -90.36 -67.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.8 118.81 33.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.463 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -95.32 151.61 19.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 111.08 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.69 95.25 2.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.681 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 19.2 ptp -47.47 165.99 0.21 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.63 0.253 . . . . 0.0 110.875 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.73 -47.71 3.68 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.938 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -50.13 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.483 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.42 -34.11 73.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -48.47 63.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -57.21 -55.14 38.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.521 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.66 -40.24 94.22 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.451 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.405 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -56.77 -36.83 70.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.06 -33.2 57.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.872 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.64 -20.58 42.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.83 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.421 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.1 mt -95.62 -28.65 14.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.24 12.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.903 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.416 HD13 ' CG2' ' A' ' 149' ' ' VAL . 0.0 OUTLIER -118.42 129.42 74.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.73 0.3 . . . . 0.0 111.06 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -59.54 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.677 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.64 -40.46 79.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.946 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -49.93 72.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.218 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.45 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.24 -27.24 61.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.416 ' CG2' HD13 ' A' ' 144' ' ' ILE . 46.1 t -84.3 85.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.168 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -50.74 94.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.546 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.449 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -67.69 140.42 36.68 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.741 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 12.95 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.982 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.445 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -70.94 156.49 53.26 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.697 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.27 104.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.097 2.532 . . . . 0.0 112.861 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.93 22.16 14.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.275 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 73.36 22.18 78.94 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.603 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.463 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.49 124.68 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 117.046 0.423 . . . . 0.0 111.068 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.622 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.8 pt -63.79 111.55 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 68.1 p -75.18 156.66 35.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.563 0.697 . . . . 0.0 111.684 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.424 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.1 -43.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.121 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.4 mt-10 -65.06 -27.65 68.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.006 179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.9 m-20 -68.82 -46.99 67.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.521 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.35 -43.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.495 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -43.68 98.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.547 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 41.8 mtp180 -74.92 -40.12 61.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.26 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.45 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 t-105 -68.05 -42.9 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.18 61.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.374 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.94 -38.52 86.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.01 -29.07 65.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.154 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 3.4 p -68.56 -52.02 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.732 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.05 -23.78 58.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -73.12 -28.02 62.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.34 104.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.265 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.0 p 55.27 102.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.036 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 m -155.01 -171.41 3.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -58.45 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.69 158.22 21.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.66 117.84 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.98 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.466 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -97.25 152.5 18.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.966 0.413 . . . . 0.0 110.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.26 95.59 2.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 6.0 ptp -47.21 166.17 0.19 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.771 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.1 -48.02 3.03 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.819 2.346 . . . . 0.0 112.912 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -50.54 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.387 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.462 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -69.03 -34.92 76.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.238 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -49.13 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.623 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -54.74 43.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.519 HD11 ' C ' ' A' ' 138' ' ' LEU . 4.3 pp -62.31 -39.9 94.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.541 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.402 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -57.85 -36.69 72.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -77.03 -32.41 57.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.945 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -20.84 35.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.408 ' CD1' HD11 ' A' ' 138' ' ' LEU . 0.9 OUTLIER -93.6 -27.61 16.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.588 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.34 42.63 18.09 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.736 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 132.56 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 111.09 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.91 101.02 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.632 179.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.36 -41.93 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.532 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -47.43 80.73 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.437 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -59.21 -27.8 66.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 158' ' ' ILE . 43.0 t -83.8 85.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.82 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.43 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -50.83 90.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.711 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.444 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -57.92 137.64 49.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.74 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 15.01 13.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.42 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -76.65 158.03 48.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.754 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.9 102.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.183 2.588 . . . . 0.0 112.836 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.96 23.35 11.67 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.269 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 72.36 22.14 79.05 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.63 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.466 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.25 124.61 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 117.065 0.433 . . . . 0.0 111.108 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.617 ' O ' HG13 ' A' ' 158' ' ' ILE . 13.7 pt -62.72 111.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.9 p -75.14 156.48 35.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.567 0.699 . . . . 0.0 111.635 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.458 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.34 -42.69 59.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.938 -179.233 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.06 -27.7 68.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.6 m-20 -68.99 -46.13 68.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.504 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.79 -43.67 46.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.323 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.43 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 45.2 mtp180 -74.65 -41.68 59.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.457 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 t-105 -66.95 -41.52 86.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.58 -45.46 62.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 111.391 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.404 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 12.5 pt-20 -61.77 -37.15 83.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.99 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 170' ' ' THR . 0.6 OUTLIER -54.83 -45.63 74.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.107 0.48 . . . . 0.0 110.764 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.405 ' N ' ' CG ' ' A' ' 169' ' ' GLU . 15.3 p -54.49 -52.0 63.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.4 -23.96 61.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.445 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -38.88 80.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.7 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.92 26.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.155 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 70.7 p -74.39 111.69 9.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.103 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -60.3 -66.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 60.19 98.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -84.51 158.03 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.55 150.32 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.444 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -86.84 159.05 19.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.895 0.379 . . . . 0.0 110.778 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.53 96.32 1.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 8.4 ptm -47.77 167.58 0.18 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.585 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -65.3 -47.09 4.77 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.723 2.282 . . . . 0.0 112.786 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.9 63.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.463 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.496 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.95 -32.92 72.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -48.9 60.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 110.372 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -57.21 -54.32 48.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.504 ' C ' HD11 ' A' ' 138' ' ' LEU . 4.3 pp -63.15 -40.89 98.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.408 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -58.03 -36.73 73.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.66 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -77.11 -31.38 55.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -82.24 -21.78 36.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.423 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.5 mt -94.07 -28.78 15.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.8 43.2 9.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.008 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -118.95 128.21 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.022 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.424 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -59.63 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.656 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -57.29 -40.85 78.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.003 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -50.16 70.84 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.424 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.05 61.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 158' ' ' ILE . 49.5 t -83.24 85.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.88 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -50.77 92.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.281 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.482 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -66.64 142.33 41.98 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.964 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 13.56 13.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.43 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -72.64 156.34 51.86 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.806 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.62 103.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.174 2.583 . . . . 0.0 112.903 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.5 23.2 11.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.201 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 71.59 22.12 78.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.605 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.444 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.71 126.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.631 ' O ' HG13 ' A' ' 158' ' ' ILE . 19.2 pt -64.52 112.02 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.7 p -75.28 156.56 35.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.424 0.631 . . . . 0.0 111.591 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.442 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.24 -42.71 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.115 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -64.02 -27.69 69.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -70.14 -47.39 61.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.497 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.502 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.08 -40.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -59.7 -49.41 77.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.099 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 1.0 OUTLIER -69.76 -40.83 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.532 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . 0.413 ' NE1' ' HD2' ' A' ' 148' ' ' LYS . 1.5 t-105 -67.56 -48.67 66.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.461 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.87 -46.26 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.371 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -58.88 -41.42 87.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.88 0.371 . . . . 0.0 110.724 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.66 -26.9 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.045 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.4 p -72.54 -52.13 16.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.612 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.57 58.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -77.14 -31.99 56.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.723 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.3 54.63 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.106 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.7 p -128.33 144.97 51.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.076 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.9 t -73.62 100.74 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -127.78 -169.5 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.51 134.41 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -92.26 114.56 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.465 ' C ' ' HA ' ' A' ' 157' ' ' VAL . . . -92.81 149.82 21.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 111.242 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.93 94.41 1.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.6 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 17.5 ptp -45.56 165.47 0.17 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.978 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.5 -47.22 4.4 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.769 2.313 . . . . 0.0 112.809 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.78 63.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.488 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.447 ' HA ' ' CD2' ' A' ' 138' ' ' LEU . . . -68.87 -33.47 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -68.55 -49.58 58.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -58.51 -55.31 36.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.489 ' CD1' ' HB ' ' A' ' 163' ' ' VAL . 4.4 pp -61.12 -40.77 95.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.4 ' N ' ' CD1' ' A' ' 138' ' ' LEU . . . -55.11 -42.94 73.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 110.919 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -29.7 59.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -79.51 -24.42 42.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.411 ' CD1' HD11 ' A' ' 138' ' ' LEU . 1.8 mt -91.41 -28.85 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.745 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.88 34.5 6.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.073 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.454 ' CD1' ' CG2' ' A' ' 149' ' ' VAL . 2.3 tt -117.84 147.15 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.414 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -82.22 101.15 10.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.101 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.41 ' CB ' ' CD1' ' A' ' 158' ' ' ILE . . . -47.89 -33.19 7.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.168 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -34.94 79.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.44 -18.68 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.454 ' CG2' ' CD1' ' A' ' 144' ' ' ILE . 55.1 t -96.94 88.08 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.271 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.74 98.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . 0.462 ' HA2' ' HA ' ' A' ' 158' ' ' ILE . . . -70.1 142.16 35.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 11.23 12.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA2' HG21 ' A' ' 157' ' ' VAL . . . -71.92 153.35 49.88 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.718 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -45.56 112.91 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.129 2.552 . . . . 0.0 112.775 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.11 10.56 57.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.334 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 84.41 22.05 55.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.774 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.465 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -87.23 124.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 117.181 0.49 . . . . 0.0 111.207 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.655 ' O ' HG13 ' A' ' 158' ' ' ILE . 14.7 pt -63.58 111.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 52.5 p -75.32 156.57 35.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.662 0.744 . . . . 0.0 111.89 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -41.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.941 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLU . . . . . 0.494 ' HA ' ' CG ' ' A' ' 164' ' ' LYS . 3.3 mt-10 -63.62 -27.84 69.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.304 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.524 ' HB2' ' O ' ' A' ' 159' ' ' THR . 78.1 m-20 -70.82 -52.1 22.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.099 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.489 ' HB ' ' CD1' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.24 -48.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.494 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -58.23 -51.21 70.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.286 -179.251 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 18.4 ptt180 -57.81 -37.9 74.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TRP . . . . . . . . . . . . . 2.7 t-105 -69.22 -48.06 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.908 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.96 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.07 -39.39 93.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -58.5 -31.27 67.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.9 p -70.21 -51.98 26.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.639 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.6 68.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.414 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -63.67 -31.25 72.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.739 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.2 104.7 16.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 t -145.94 -50.53 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.111 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.23 95.07 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.458 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -46.31 167.42 0.14 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.02 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.415 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.92 -48.5 2.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.816 2.344 . . . . 0.0 112.944 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.03 70.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.34 -34.19 70.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -67.99 -46.41 71.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.309 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.11 -56.0 27.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.82 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.81 -39.61 74.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -29.83 55.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -81.93 -25.35 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -90.52 -28.58 18.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.714 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.14 41.64 9.27 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.933 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.61 127.38 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.79 0.328 . . . . 0.0 110.949 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 103.12 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.59 -40.45 79.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -49.88 71.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.192 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -28.24 62.43 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 149' ' ' VAL . 49.7 t -83.54 85.29 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.992 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -50.92 92.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.638 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -65.49 141.98 43.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.796 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 13.41 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.696 0.284 . . . . 0.0 111.146 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.5 154.98 50.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.727 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.72 106.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.022 2.481 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.96 18.95 25.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.248 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.1 22.13 74.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.79 124.6 40.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.035 0.418 . . . . 0.0 111.053 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.2 pt -64.3 111.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 81.0 p -75.16 156.51 35.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.443 0.64 . . . . 0.0 111.439 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.28 -43.29 60.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.1 -179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -27.66 69.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.1 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -69.99 -48.17 59.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.82 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.81 -41.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.734 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.622 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.11 94.64 1.97 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.494 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -45.08 163.6 0.2 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.57 -49.83 2.19 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -48.3 71.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.17 -34.9 75.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.291 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -69.6 -49.5 53.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -57.03 -55.64 32.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.74 -39.54 89.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.503 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.02 -41.11 74.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -30.09 55.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.083 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.93 -18.71 39.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.66 -28.84 13.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.85 35.16 11.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.047 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.992 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -108.73 125.8 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.301 . . . . 0.0 110.578 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -60.32 101.07 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.69 -45.58 89.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.836 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -48.58 66.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.26 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.38 -33.44 67.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.644 HG21 HD12 ' A' ' 144' ' ' ILE . 55.1 t -79.37 82.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.856 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.82 92.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.02 139.46 43.44 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.356 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.4 13.86 13.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.648 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.22 157.28 46.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.34 106.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.129 2.552 . . . . 0.0 112.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.71 20.11 22.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.622 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.05 22.16 77.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.612 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.507 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.51 125.62 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.122 0.461 . . . . 0.0 111.331 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.0 pt -62.21 111.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 30.6 p -74.98 156.26 36.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.441 0.639 . . . . 0.0 111.641 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -55.26 -39.18 50.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.588 -178.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.45 -30.54 70.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.94 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' THR . 93.6 m-20 -65.37 -57.99 6.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.637 . . . . 0.0 110.1 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -56.68 -42.61 77.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.565 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.591 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -150.22 95.46 2.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.84 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 11.4 ptp -48.33 166.26 0.22 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.966 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.89 -47.65 3.56 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.878 2.386 . . . . 0.0 112.972 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.9 65.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.429 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.49 75.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.096 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -67.83 -48.58 65.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.231 0.539 . . . . 0.0 110.423 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -57.77 -55.94 28.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.037 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.18 -41.59 97.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.63 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.06 -38.44 70.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.916 0.388 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.35 56.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.006 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -81.91 -21.43 37.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 111.041 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -94.8 -28.8 15.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.601 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.03 42.8 10.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.856 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.541 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.16 129.23 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 111.057 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -56.52 101.07 0.05 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.39 -42.58 92.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -48.53 78.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.992 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -25.72 63.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 149' ' ' VAL . 40.3 t -85.78 85.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -50.9 100.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.642 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -74.63 141.62 28.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.94 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 12.92 13.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.645 0.26 . . . . 0.0 111.155 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.43 156.67 53.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.854 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -44.68 104.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.103 2.535 . . . . 0.0 112.907 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.7 22.11 14.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.168 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.591 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.35 22.18 78.95 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.61 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.74 124.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.064 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.664 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.4 pt -63.61 111.49 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.2 p -75.25 156.57 35.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.648 0.737 . . . . 0.0 111.624 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.449 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.93 -42.83 55.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.118 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -64.57 -27.61 69.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.121 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 64.0 m-20 -69.5 -49.15 57.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.727 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.35 -46.83 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.871 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 mttp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.359 -179.44 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.617 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.419 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 158' ' ' ILE . . . -152.59 95.14 1.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.825 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 14.3 ptm -46.42 164.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.6 -49.29 2.47 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.774 2.316 . . . . 0.0 112.789 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.14 -49.12 69.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.407 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.2 -34.46 74.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.337 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.31 -49.33 56.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -57.79 -55.39 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.62 -38.66 85.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.396 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.74 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.09 -40.51 77.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -76.72 -29.82 56.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -85.11 -16.59 40.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.442 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -99.77 -28.82 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.66 10.0 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 1.003 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -111.36 126.41 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.634 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 3.2 t0 -61.78 100.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.457 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.29 -44.87 88.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.39 67.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.155 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.35 -33.37 65.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.616 HG21 HD12 ' A' ' 144' ' ' ILE . 54.8 t -79.34 84.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.084 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.96 91.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.31 138.22 46.2 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.241 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.37 13.9 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 159' ' ' THR . . . -76.28 159.09 49.97 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.85 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.166 2.577 . . . . 0.0 112.953 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.16 11.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.192 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.45 22.19 79.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.633 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.497 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.56 125.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.228 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.4 pt -61.04 110.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 24.2 p -75.19 156.54 35.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.337 0.589 . . . . 0.0 111.6 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.62 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.24 -40.47 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.423 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.67 -28.31 69.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 159' ' ' THR . 95.7 m-20 -68.91 -58.03 4.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.485 0.66 . . . . 0.0 109.821 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.003 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -57.38 -41.17 77.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.38 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.62 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 121.035 0.445 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.31 94.55 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.638 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.426 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.9 ptm -47.11 167.77 0.15 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.5 Cg_exo -65.7 -45.78 6.09 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.837 2.358 . . . . 0.0 113.02 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.45 61.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.396 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.47 -32.97 72.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.79 -46.73 71.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.24 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -59.67 -55.5 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.134 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.38 -42.11 99.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.69 -38.99 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -76.87 -29.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -81.31 -25.31 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.056 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.29 -29.01 18.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.8 31.62 9.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.025 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.59 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -111.81 146.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.94 0.37 . . . . 0.0 111.323 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -79.81 101.01 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.098 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.986 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.22 -32.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -35.03 79.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.969 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.64 -19.32 61.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.402 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.59 ' CG2' HD13 ' A' ' 144' ' ' ILE . 54.8 t -95.54 88.08 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.064 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.78 100.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.22 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.594 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.41 141.91 28.41 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.954 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.03 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.579 0.228 . . . . 0.0 111.088 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.83 153.91 50.57 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 107.74 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.144 2.562 . . . . 0.0 112.811 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 18.41 27.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.205 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.62 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.38 22.08 73.93 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.659 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.44 124.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 117.069 0.435 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.986 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.8 pt -65.15 111.81 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.5 p -75.35 156.57 35.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.557 0.694 . . . . 0.0 111.586 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.46 -42.73 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.121 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -27.73 69.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.982 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 92.0 m-20 -70.36 -51.72 27.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -69.52 -38.84 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.78 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 8.5 pttt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.166 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.41 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.8 94.86 2.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.766 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.517 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.5 ptp -46.82 167.08 0.16 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.028 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.3 Cg_exo -66.2 -48.04 2.9 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.904 2.403 . . . . 0.0 113.028 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -49.94 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.77 -34.57 73.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.028 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.41 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.34 -47.97 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.342 0.592 . . . . 0.0 110.369 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.6 -55.95 28.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.5 -41.54 97.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.39 -37.8 70.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -77.12 -31.43 55.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.33 -21.74 35.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.021 0.438 . . . . 0.0 111.048 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.57 -28.23 16.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.679 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.77 42.0 11.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.875 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.71 127.19 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -57.82 101.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.65 -40.82 80.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.43 -49.94 71.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.199 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.53 62.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 149' ' ' VAL . 50.6 t -83.2 85.82 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.806 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 1.1 ptpp? -50.81 91.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 111.814 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.679 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -59.08 138.51 49.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.69 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 15.09 13.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.44 156.81 47.12 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.79 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.7 104.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.159 2.573 . . . . 0.0 112.907 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.64 20.98 17.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.225 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.23 22.14 78.06 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.63 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.54 123.62 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.065 0.432 . . . . 0.0 111.189 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 9.1 pt -63.16 110.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.8 p -75.15 156.51 35.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 0.0 111.522 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.23 -42.82 58.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.156 -179.177 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -64.83 -27.52 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.138 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.4 m-20 -70.0 -48.7 57.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.721 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.07 -46.08 68.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.562 -179.193 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.76 95.65 2.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.972 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 ptp -46.35 166.75 0.16 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.961 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.59 -48.54 3.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.861 2.374 . . . . 0.0 112.829 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -49.87 68.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.355 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.74 -35.02 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.459 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -66.95 -48.87 67.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.231 0.538 . . . . 0.0 110.509 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -58.93 -54.23 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.928 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.781 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.32 -39.76 95.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -38.88 72.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.956 0.408 . . . . 0.0 110.729 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.98 -32.13 57.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.99 -21.52 40.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.01 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.23 -28.62 16.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 40.71 11.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.876 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.589 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.48 127.13 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 0.0 110.904 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' N ' HD13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -59.06 101.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.61 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.908 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.63 -41.13 80.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -50.2 68.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.199 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 149' ' ' VAL . 51.1 t -82.07 83.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.94 91.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 111.315 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.531 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -60.6 142.47 48.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.009 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.91 13.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 110.842 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.92 156.75 49.6 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.7 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -43.74 103.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.876 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.13 23.41 11.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.159 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.56 22.15 78.67 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.5 125.31 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.981 0.39 . . . . 0.0 111.001 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.9 pt -63.74 111.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 63.4 p -75.16 156.52 35.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.521 0.677 . . . . 0.0 111.474 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.98 -42.19 53.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.247 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.81 -27.75 68.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.2 m-20 -68.79 -46.73 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.31 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.781 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.96 -42.19 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.704 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.635 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -150.66 94.1 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.59 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.512 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -46.28 166.46 0.16 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.089 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 20.9 Cg_exo -66.36 -48.43 2.45 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.938 2.425 . . . . 0.0 112.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.69 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.515 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.25 -35.09 73.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 26.2 mtt-85 -67.81 -47.27 69.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.302 0.572 . . . . 0.0 110.24 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -56.64 19.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.27 -40.74 95.22 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.63 -39.72 71.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -31.71 56.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.971 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.77 -20.65 42.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -96.19 -28.82 14.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.717 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.85 40.91 10.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.149 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.35 126.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 0.0 110.916 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.33 101.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.676 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.4 -40.41 78.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.857 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -49.91 70.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.196 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -28.5 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 149' ' ' VAL . 52.8 t -83.75 84.52 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.154 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -50.87 96.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.408 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.624 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.59 141.96 44.83 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.49 12.01 13.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.647 0.26 . . . . 0.0 111.113 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.75 155.66 51.21 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.779 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.76 106.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.123 2.549 . . . . 0.0 112.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.05 19.19 24.7 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.159 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.635 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.66 22.17 75.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.629 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.512 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.22 123.51 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.064 0.432 . . . . 0.0 111.177 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.6 pt -63.12 110.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.14 156.54 35.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.526 0.679 . . . . 0.0 111.724 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.459 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.14 -42.92 58.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.231 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -27.75 69.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.4 m-20 -69.54 -48.95 58.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.604 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.855 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.09 -46.11 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.817 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.487 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.576 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.903 0.383 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.48 94.6 2.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 15.9 ptp -46.74 166.78 0.17 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.975 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.6 Cg_exo -66.25 -47.36 3.37 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.84 2.36 . . . . 0.0 112.772 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.13 65.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.455 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.59 -33.75 73.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.501 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -68.32 -47.82 66.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.415 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.01 -56.02 27.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.0 -40.57 94.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.676 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.28 -41.65 76.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -75.77 -29.95 58.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.87 -26.9 40.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -89.02 -29.01 19.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.13 33.9 7.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.238 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 149' ' ' VAL . 2.1 tt -115.81 146.88 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -79.93 100.92 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.976 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.39 -32.87 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -35.07 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.958 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.82 -20.39 61.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 144' ' ' ILE . 53.8 t -95.55 87.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.136 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -50.76 107.52 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 111.402 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.562 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -76.1 140.59 25.86 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.274 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 110.839 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.35 156.07 46.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.869 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 0.0 112.892 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 19.55 23.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.208 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.576 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.99 22.21 77.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.66 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.87 124.77 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 117.023 0.412 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.976 HD13 ' HB1' ' A' ' 146' ' ' ALA . 21.3 pt -64.17 111.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 49.3 p -75.32 156.54 35.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.625 0.726 . . . . 0.0 111.732 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -42.78 65.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.924 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.51 -27.68 69.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.5 m-20 -69.69 -49.33 54.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.21 -40.71 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.916 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.165 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.74 95.38 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.808 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.527 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.3 ptp -47.02 167.25 0.17 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.88 -48.08 3.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.827 2.351 . . . . 0.0 112.906 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.13 67.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.442 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.64 -34.16 73.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.178 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -68.46 -47.94 65.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.382 0.61 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.37 -55.92 28.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.845 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.1 pp -61.97 -41.27 97.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.639 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.06 -40.38 70.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.364 . . . . 0.0 111.017 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -31.46 56.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.989 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -80.45 -21.54 41.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.92 0.39 . . . . 0.0 111.015 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -95.92 -28.68 14.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.664 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.02 42.64 10.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.503 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.26 129.7 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 0.0 111.037 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.07 101.03 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.772 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.91 -42.85 94.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -48.76 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -27.33 63.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 149' ' ' VAL . 42.2 t -84.17 85.89 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.013 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 95.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.654 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.6 140.92 32.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.651 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.83 13.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.289 . . . . 0.0 111.143 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.4 156.21 53.26 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.809 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.69 105.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.14 2.56 . . . . 0.0 112.891 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.45 21.45 17.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.155 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.8 22.1 78.56 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.62 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.527 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.84 125.19 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.139 0.47 . . . . 0.0 111.014 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.772 HD13 ' HB1' ' A' ' 146' ' ' ALA . 10.7 pt -64.35 111.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.1 p -75.07 156.56 35.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.46 -42.38 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.113 -179.25 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 164' ' ' LYS . 14.3 mt-10 -64.07 -27.65 69.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.1 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.0 m-20 -70.91 -49.6 44.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.897 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.845 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.28 -43.49 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.972 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.881 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.51 94.77 2.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.796 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.412 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 13.2 ptp -46.48 166.92 0.16 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.061 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.06 -48.31 2.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.24 71.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.469 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.93 -34.27 68.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.462 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 2.7 mmm180 -68.69 -45.89 70.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.241 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -60.28 -55.66 30.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.953 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.824 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.54 -40.48 94.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.7 -37.51 73.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.383 . . . . 0.0 110.743 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -31.21 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.28 -25.4 36.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -91.62 -28.77 17.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.6 42.94 9.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.933 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.454 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.86 129.95 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.063 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -60.03 101.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.765 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.87 -40.0 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -49.25 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.135 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.27 -26.76 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 149' ' ' VAL . 45.7 t -84.52 85.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.88 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.67 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.566 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.615 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.22 144.64 48.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.647 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 1.35 11.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 111.163 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -62.14 152.5 43.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.457 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -44.54 118.68 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.043 2.495 . . . . 0.0 112.983 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.94 0.09 72.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 95.25 22.16 23.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.628 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -87.49 125.62 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 117.089 0.444 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.0 pt -64.74 111.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 69.2 p -75.15 156.5 35.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.59 0.71 . . . . 0.0 111.588 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.498 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.62 -41.96 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.273 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -27.86 69.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.939 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.3 m-20 -69.3 -47.09 65.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.273 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.824 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -76.0 -34.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.091 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.885 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.059 0.456 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -154.68 96.33 1.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.904 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.614 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 11.8 ptp -45.36 165.68 0.16 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.614 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 48.5 Cg_endo -71.61 -32.35 12.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.072 1.848 . . . . 0.0 112.507 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.07 -51.5 63.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.749 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.4 -35.02 75.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.13 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 1.1 mtt180 -66.44 -48.56 69.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.323 0.582 . . . . 0.0 110.415 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -55.61 32.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.784 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.5 -41.31 98.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.59 -37.73 68.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -33.31 56.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -79.98 -19.96 46.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -96.7 -28.81 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.591 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.15 43.16 10.98 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.858 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.43 130.08 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.771 0.32 . . . . 0.0 111.058 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 5.1 t70 -58.74 101.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.73 -41.63 91.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.767 0.317 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -49.05 76.89 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.6 -27.34 62.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 149' ' ' VAL . 41.8 t -84.35 86.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.73 92.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.561 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.548 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.02 139.88 36.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.683 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 14.29 13.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.71 156.7 52.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.41 104.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.511 . . . . 0.0 112.863 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.55 22.46 14.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.211 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.05 22.08 79.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.669 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -86.11 125.43 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 117.058 0.429 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.966 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.7 pt -63.64 111.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 74.6 p -75.12 156.54 35.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.493 0.663 . . . . 0.0 111.555 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.61 -42.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.144 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.9 -27.68 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.876 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.3 m-20 -69.9 -46.94 64.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.362 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.784 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.83 -36.8 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.939 0.4 . . . . 0.0 110.908 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.61 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.79 95.73 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.464 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.7 ptp -46.55 167.47 0.15 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.746 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.51 -47.99 3.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.713 2.275 . . . . 0.0 112.902 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.82 66.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.52 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.62 -33.01 72.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.223 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -69.75 -47.81 61.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 110.325 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -57.51 -54.93 41.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.816 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.812 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.78 -41.09 99.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.56 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.15 75.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -29.95 55.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -83.49 -16.57 45.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -97.68 -28.84 13.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.94 33.68 8.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.944 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.6 tt -116.44 147.2 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.438 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -81.15 101.01 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.804 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.96 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.81 -34.06 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.33 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -63.7 -35.72 81.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.885 0.374 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -70.38 -19.93 62.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 144' ' ' ILE . 48.2 t -93.63 87.94 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.055 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -50.7 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.272 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -74.38 143.35 31.57 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.868 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.23 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.77 153.39 52.24 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.85 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.03 107.46 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.072 2.515 . . . . 0.0 112.848 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 18.64 26.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.263 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.61 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.16 21.96 74.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.66 125.89 40.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.892 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.96 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.1 pt -66.5 111.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.2 p -75.1 156.51 35.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.513 0.673 . . . . 0.0 111.489 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.97 -42.97 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.07 -179.192 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -27.58 69.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.075 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -70.83 -48.17 55.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.718 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.812 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.63 -41.9 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.57 95.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.971 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.689 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 18.4 ptm -46.65 167.89 0.14 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.611 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 49.2 Cg_endo -71.42 -33.56 10.82 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.112 1.874 . . . . 0.0 112.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.36 46.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.93 -33.16 71.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.69 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.15 -46.89 72.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.173 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -59.12 -55.58 33.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.731 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.766 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.7 -41.13 98.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.735 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.66 76.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -76.46 -29.85 57.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -81.1 -24.88 37.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.917 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -89.78 -28.89 19.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.45 12.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.967 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -110.52 146.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.386 . . . . 0.0 111.327 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -78.94 100.92 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.861 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.81 -32.33 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -34.43 77.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 109.93 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.46 -20.08 61.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -94.89 88.19 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.051 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -50.8 99.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -76.64 140.57 25.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.17 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 12.97 13.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 111.034 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.8 155.81 53.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.843 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.81 105.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.136 2.558 . . . . 0.0 112.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.55 20.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.142 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.592 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.5 22.05 77.91 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.657 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.42 125.11 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.109 0.454 . . . . 0.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -63.89 111.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 66.9 p -75.3 156.52 35.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.587 0.708 . . . . 0.0 111.802 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.01 -41.8 60.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.92 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -27.52 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.037 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -71.26 -49.77 39.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.44 -41.6 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.334 -0.104 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.082 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.47 95.26 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.907 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 9.3 ptp -46.04 167.57 0.13 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.037 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.52 -48.12 3.52 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.801 2.334 . . . . 0.0 112.83 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.24 -50.48 67.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -70.54 -34.61 72.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 10.2 mmt180 -66.79 -46.74 74.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.3 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -60.05 -56.48 21.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.078 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.777 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.94 -41.81 96.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.01 -40.08 75.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -76.41 -29.76 57.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -81.96 -22.56 36.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.638 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.71 -28.88 16.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.1 30.09 10.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.104 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.599 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.1 tt -111.64 146.48 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.335 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -80.5 100.99 8.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.065 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.977 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -48.06 -34.04 8.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.273 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 72.4 m -63.69 -34.49 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.21 -19.73 61.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.204 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.599 ' CG2' HD13 ' A' ' 144' ' ' ILE . 53.1 t -94.95 88.61 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.081 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -50.72 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.514 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.86 142.26 28.44 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.745 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.34 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.29 153.79 51.16 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.83 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 108.62 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.145 2.563 . . . . 0.0 112.856 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.09 17.45 32.12 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.245 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 77.18 22.16 71.68 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.714 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.469 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.72 126.05 40.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.03 0.415 . . . . 0.0 110.935 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.977 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.7 pt -66.94 111.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.5 p -75.11 156.56 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.415 0.626 . . . . 0.0 111.374 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.95 -42.46 63.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.061 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -63.39 -27.68 69.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.6 m-20 -70.38 -53.84 14.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.648 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.777 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.34 -43.44 94.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.517 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.816 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . . . -150.18 95.95 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.881 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.505 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 16.4 ptp -48.79 166.8 0.22 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.791 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.8 -48.05 3.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 112.962 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -50.52 66.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.51 75.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.165 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ARG . . . . . 0.572 ' NH1' ' HB3' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -67.97 -48.79 64.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.312 0.577 . . . . 0.0 110.41 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -55.59 32.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.981 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.825 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.01 -41.24 97.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.566 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.748 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.28 -39.49 69.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -77.07 -32.04 56.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -80.25 -19.61 46.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -97.7 -28.81 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.23 42.53 10.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.988 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.54 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.19 129.25 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.743 0.306 . . . . 0.0 111.107 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 144' ' ' ILE . 2.9 t70 -57.34 101.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.832 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.63 -42.21 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -48.47 78.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.98 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.48 -26.93 63.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 149' ' ' VAL . 41.7 t -84.5 85.9 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.15 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -50.76 96.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.558 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.58 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.31 140.61 32.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.802 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 14.2 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.724 0.297 . . . . 0.0 110.979 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.76 161.5 54.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.746 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.84 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.421 2.748 . . . . 0.0 112.887 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.28 24.82 11.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.218 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.4 22.22 78.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.646 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.505 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.17 124.14 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 117.097 0.448 . . . . 0.0 111.038 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.808 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -63.23 111.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.7 p -75.19 156.51 35.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.483 0.658 . . . . 0.0 111.481 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.17 -42.73 57.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.986 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -64.02 -27.73 69.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.928 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.4 m-20 -69.66 -48.04 61.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.517 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.825 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.29 -40.12 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 1.5 pttm . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 111.131 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.606 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.69 95.25 2.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.681 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.439 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.2 ptp -47.47 165.99 0.21 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.63 0.253 . . . . 0.0 110.875 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.73 -47.71 3.68 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.938 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -50.13 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.42 -34.11 73.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -48.47 63.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -57.21 -55.14 38.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.66 -40.24 94.22 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.451 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.745 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.77 -36.83 70.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.06 -33.2 57.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.872 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.64 -20.58 42.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.83 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -95.62 -28.65 14.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.24 12.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.903 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.42 129.42 74.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.73 0.3 . . . . 0.0 111.06 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -59.54 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.677 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.64 -40.46 79.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.946 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -49.93 72.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.218 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.24 -27.24 61.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 149' ' ' VAL . 46.1 t -84.3 85.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.168 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -50.74 94.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.546 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.69 140.42 36.68 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.741 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 12.95 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.982 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.94 156.49 53.26 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.697 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.27 104.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.097 2.532 . . . . 0.0 112.861 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.93 22.16 14.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.275 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.606 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.36 22.18 78.94 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.603 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.49 124.68 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 117.046 0.423 . . . . 0.0 111.068 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.889 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.8 pt -63.79 111.55 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 68.1 p -75.18 156.66 35.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.563 0.697 . . . . 0.0 111.684 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.443 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.1 -43.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.121 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.06 -27.65 68.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.006 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.9 m-20 -68.82 -46.99 67.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.806 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.35 -43.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.495 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.547 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.966 0.413 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.26 95.59 2.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 6.0 ptp -47.21 166.17 0.19 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.771 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.1 -48.02 3.03 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.819 2.346 . . . . 0.0 112.912 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -50.54 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.387 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.03 -34.92 76.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.238 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -49.13 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.623 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -54.74 43.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.77 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.31 -39.9 94.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.541 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.85 -36.69 72.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -77.03 -32.41 57.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.945 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -20.84 35.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -93.6 -27.61 16.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.588 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.34 42.63 18.09 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.736 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -116.84 132.56 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 111.09 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 144' ' ' ILE . 5.8 t70 -59.91 101.02 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -61.36 -41.93 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.532 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -47.43 80.73 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -27.8 66.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 149' ' ' VAL . 43.0 t -83.8 85.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.82 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -50.83 90.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.711 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.599 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -57.92 137.64 49.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.74 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 15.01 13.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.65 158.03 48.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.754 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.9 102.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.183 2.588 . . . . 0.0 112.836 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.96 23.35 11.67 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.269 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.36 22.14 79.05 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.63 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.25 124.61 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 117.065 0.433 . . . . 0.0 111.108 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.789 HD13 ' HB1' ' A' ' 146' ' ' ALA . 13.7 pt -62.72 111.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.9 p -75.14 156.48 35.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.567 0.699 . . . . 0.0 111.635 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.34 -42.69 59.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.938 -179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.7 68.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.6 m-20 -68.99 -46.13 68.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.77 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.79 -43.67 46.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.323 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.43 -178.795 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.531 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.895 0.379 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.53 96.32 1.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.4 ptm -47.77 167.58 0.18 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.585 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.0 Cg_exo -65.3 -47.09 4.77 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.723 2.282 . . . . 0.0 112.786 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.9 63.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.463 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -68.95 -32.92 72.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -48.9 60.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 110.372 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -57.21 -54.32 48.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.762 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.15 -40.89 98.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.03 -36.73 73.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.66 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -77.11 -31.38 55.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -82.24 -21.78 36.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.07 -28.78 15.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.8 43.2 9.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.008 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.514 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.95 128.21 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.022 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -59.63 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.656 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.29 -40.85 78.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -50.16 70.84 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.05 61.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.556 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 149' ' ' VAL . 49.5 t -83.24 85.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.88 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -50.77 92.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.281 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.64 142.33 41.98 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.964 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 13.56 13.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.64 156.34 51.86 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.806 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.62 103.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.174 2.583 . . . . 0.0 112.903 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.5 23.2 11.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.201 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.59 22.12 78.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.605 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.71 126.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.982 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.2 pt -64.52 112.02 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.7 p -75.28 156.56 35.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.424 0.631 . . . . 0.0 111.591 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.487 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.24 -42.71 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.115 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -64.02 -27.69 69.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -70.14 -47.39 61.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.497 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.08 -40.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.099 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.636 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.93 94.41 1.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.6 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.561 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -45.56 165.47 0.17 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.978 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.5 -47.22 4.4 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.769 2.313 . . . . 0.0 112.809 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.78 63.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.488 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.87 -33.47 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -68.55 -49.58 58.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -58.51 -55.31 36.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.12 -40.77 95.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.759 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.11 -42.94 73.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 110.919 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -29.7 59.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -79.51 -24.42 42.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.8 mt -91.41 -28.85 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.745 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.88 34.5 6.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.073 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -117.84 147.15 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -82.22 101.15 10.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.101 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.89 -33.19 7.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.168 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -34.94 79.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.44 -18.68 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.386 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -96.94 88.08 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.271 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.74 98.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.1 142.16 35.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 11.23 12.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.92 153.35 49.88 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.718 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -45.56 112.91 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.129 2.552 . . . . 0.0 112.775 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.11 10.56 57.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.334 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.636 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.41 22.05 55.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.774 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.561 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -87.23 124.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 117.181 0.49 . . . . 0.0 111.207 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.7 pt -63.58 111.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 52.5 p -75.32 156.57 35.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.662 0.744 . . . . 0.0 111.89 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -41.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.941 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 164' ' ' LYS . 3.3 mt-10 -63.62 -27.84 69.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.304 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 78.1 m-20 -70.82 -52.1 22.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.099 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.24 -48.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.503 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.286 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 p -131.18 143.34 50.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.943 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.7 22.69 10.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 56.57 169.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.018 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.79 125.96 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -97.97 151.79 19.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.23 95.07 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.458 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -46.31 167.42 0.14 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.02 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.415 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.92 -48.5 2.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.816 2.344 . . . . 0.0 112.944 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.03 70.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.34 -34.19 70.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -67.99 -46.41 71.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.309 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.11 -56.0 27.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.82 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.81 -39.61 74.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -29.83 55.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -81.93 -25.35 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -90.52 -28.58 18.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.714 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.14 41.64 9.27 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.933 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.61 127.38 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.79 0.328 . . . . 0.0 110.949 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 103.12 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.59 -40.45 79.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -49.88 71.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.192 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.08 -28.24 62.43 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 149' ' ' VAL . 49.7 t -83.54 85.29 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.992 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -50.92 92.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.638 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -65.49 141.98 43.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.796 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 13.41 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.696 0.284 . . . . 0.0 111.146 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.5 154.98 50.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.727 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.72 106.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.022 2.481 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.96 18.95 25.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.248 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.1 22.13 74.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.79 124.6 40.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.035 0.418 . . . . 0.0 111.053 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.2 pt -64.3 111.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 81.0 p -75.16 156.51 35.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.443 0.64 . . . . 0.0 111.439 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.28 -43.29 60.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.1 -179.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -27.66 69.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.1 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -69.99 -48.17 59.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.82 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.81 -41.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.734 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -58.91 -48.43 81.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 28.7 ptt180 -68.42 -42.64 78.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.613 ' O ' HG23 ' A' ' 170' ' ' THR . 1.6 t-105 -65.4 -49.16 70.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.656 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.85 94.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.544 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 11.6 pt-20 -64.13 -36.32 83.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -44.98 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.0 110.48 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 166' ' ' TRP . 10.6 p -54.97 -52.06 64.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.738 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -26.57 64.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 110.292 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -34.42 78.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.596 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.31 113.31 2.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -31.39 8.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.129 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.7 m 60.54 177.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 111.65 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.62 -57.06 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.83 88.5 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.622 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -80.39 149.89 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.042 0.449 . . . . 0.0 110.853 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.11 94.64 1.97 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.494 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -45.08 163.6 0.2 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.57 -49.83 2.19 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -48.3 71.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.17 -34.9 75.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.291 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -69.6 -49.5 53.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -57.03 -55.64 32.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.74 -39.54 89.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.503 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.02 -41.11 74.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -30.09 55.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.083 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.93 -18.71 39.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.66 -28.84 13.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.85 35.16 11.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.047 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.992 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -108.73 125.8 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.301 . . . . 0.0 110.578 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -60.32 101.07 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.69 -45.58 89.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.836 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -48.58 66.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.26 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.38 -33.44 67.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.921 HG13 ' NE1' ' A' ' 166' ' ' TRP . 55.1 t -79.37 82.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.856 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.82 92.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.02 139.46 43.44 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.356 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.4 13.86 13.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.648 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.22 157.28 46.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.34 106.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.129 2.552 . . . . 0.0 112.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.71 20.11 22.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.622 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.05 22.16 77.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.612 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.507 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.51 125.62 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.122 0.461 . . . . 0.0 111.331 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.0 pt -62.21 111.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 30.6 p -74.98 156.26 36.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.441 0.639 . . . . 0.0 111.641 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -55.26 -39.18 50.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.588 -178.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.474 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 3.4 mt-10 -67.45 -30.54 70.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.94 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' O ' ' HD1' ' A' ' 166' ' ' TRP . 93.6 m-20 -65.37 -57.99 6.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.637 . . . . 0.0 110.1 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -56.68 -42.61 77.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.565 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -35.4 75.83 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.474 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 5.7 mmt85 -65.91 -49.87 66.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.615 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 1.071 ' O ' HG23 ' A' ' 170' ' ' THR . 14.5 m95 -73.9 -50.97 17.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.84 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.543 ' N ' HG13 ' A' ' 144' ' ' ILE . . . -50.1 -34.38 21.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.852 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 5.3 pt-20 -77.47 -36.99 52.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.773 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 0.1 OUTLIER -74.26 -42.42 59.68 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.868 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.071 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.3 p -53.52 -52.14 60.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.975 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.11 61.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.461 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 169' ' ' GLU . 13.1 mmtt -61.12 -33.4 73.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.591 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.35 108.16 4.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.3 p 53.22 79.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.065 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m 61.18 31.78 19.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.14 -59.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.856 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.98 132.71 46.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.43 111.46 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.591 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.92 151.98 19.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 110.87 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -150.22 95.46 2.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.84 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 11.4 ptp -48.33 166.26 0.22 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.966 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.89 -47.65 3.56 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.878 2.386 . . . . 0.0 112.972 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.9 65.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.429 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.49 75.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.096 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -67.83 -48.58 65.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.231 0.539 . . . . 0.0 110.423 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -57.77 -55.94 28.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.037 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.18 -41.59 97.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.63 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.06 -38.44 70.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.916 0.388 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.35 56.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.006 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -81.91 -21.43 37.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 111.041 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -94.8 -28.8 15.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.601 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.03 42.8 10.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.856 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.541 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.16 129.23 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 111.057 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -56.52 101.07 0.05 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.39 -42.58 92.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -48.53 78.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.992 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -58.8 -25.72 63.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 166' ' ' TRP . 40.3 t -85.78 85.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -50.9 100.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.642 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -74.63 141.62 28.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.94 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 12.92 13.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.645 0.26 . . . . 0.0 111.155 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.43 156.67 53.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.854 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -44.68 104.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.103 2.535 . . . . 0.0 112.907 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.7 22.11 14.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.168 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.591 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.35 22.18 78.95 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.61 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.74 124.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.064 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.664 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.4 pt -63.61 111.49 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.2 p -75.25 156.57 35.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.648 0.737 . . . . 0.0 111.624 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.449 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.93 -42.83 55.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.118 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -64.57 -27.61 69.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.121 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 64.0 m-20 -69.5 -49.15 57.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.727 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.35 -46.83 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.871 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.68 -46.09 81.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.359 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.9 ptm180 -68.26 -41.33 81.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.537 ' CG ' HG22 ' A' ' 149' ' ' VAL . 1.3 t-105 -65.42 -49.62 68.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.488 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.92 79.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.58 -36.37 78.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 110.739 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -61.91 -27.44 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 166' ' ' TRP . 5.9 p -68.71 -52.01 35.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.21 -24.3 43.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -29.11 64.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.887 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -55.37 -68.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.8 p -123.73 -74.84 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.141 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 p -100.7 -34.53 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.374 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.36 124.51 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.62 144.64 56.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.55 98.17 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.617 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -81.83 151.55 27.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.715 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 158' ' ' ILE . . . -152.59 95.14 1.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.825 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 14.3 ptm -46.42 164.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.6 -49.29 2.47 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.774 2.316 . . . . 0.0 112.789 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.14 -49.12 69.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.407 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.2 -34.46 74.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.337 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.31 -49.33 56.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -57.79 -55.39 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.62 -38.66 85.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.396 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.74 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.09 -40.51 77.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -76.72 -29.82 56.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -85.11 -16.59 40.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.442 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -99.77 -28.82 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.66 10.0 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 1.003 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -111.36 126.41 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.634 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 3.2 t0 -61.78 100.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.457 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.29 -44.87 88.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.39 67.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.155 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.35 -33.37 65.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.934 HG13 ' NE1' ' A' ' 166' ' ' TRP . 54.8 t -79.34 84.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.084 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.96 91.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.31 138.22 46.2 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.241 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.37 13.9 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 159' ' ' THR . . . -76.28 159.09 49.97 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.85 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.166 2.577 . . . . 0.0 112.953 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.16 11.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.192 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.45 22.19 79.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.633 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.497 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.56 125.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.228 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.4 pt -61.04 110.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 24.2 p -75.19 156.54 35.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.337 0.589 . . . . 0.0 111.6 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.62 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.24 -40.47 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.423 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.67 -28.31 69.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.61 ' O ' ' CD1' ' A' ' 166' ' ' TRP . 95.7 m-20 -68.91 -58.03 4.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.485 0.66 . . . . 0.0 109.821 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.003 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -57.38 -41.17 77.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.38 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -58.43 -45.38 88.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -62.61 -47.37 84.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 1.099 ' O ' HG23 ' A' ' 170' ' ' THR . 19.5 m95 -72.78 -50.96 21.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.516 ' N ' HG13 ' A' ' 144' ' ' ILE . . . -50.18 -35.11 24.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.213 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 15.7 pt-20 -77.62 -38.26 48.44 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 41.0 mt-10 -76.95 -26.84 54.47 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.418 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 1.099 HG23 ' O ' ' A' ' 166' ' ' TRP . 29.0 p -62.87 -52.13 64.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.46 -26.32 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 169' ' ' GLU . 8.1 tttt -65.54 -36.14 82.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.57 69.09 5.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.23 164.49 20.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.071 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -79.39 80.5 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -125.85 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.78 -40.42 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.12 102.55 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.62 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.71 149.6 21.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.035 0.445 . . . . 0.0 110.962 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.31 94.55 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.638 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.426 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.9 ptm -47.11 167.77 0.15 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.5 Cg_exo -65.7 -45.78 6.09 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.837 2.358 . . . . 0.0 113.02 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.45 61.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.396 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.47 -32.97 72.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.79 -46.73 71.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.24 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -59.67 -55.5 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.134 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.38 -42.11 99.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.69 -38.99 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -76.87 -29.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -81.31 -25.31 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.056 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.29 -29.01 18.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.8 31.62 9.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.025 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.59 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -111.81 146.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.94 0.37 . . . . 0.0 111.323 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -79.81 101.01 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.098 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.986 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.22 -32.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -35.03 79.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.969 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.64 -19.32 61.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.402 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.59 ' CG2' HD13 ' A' ' 144' ' ' ILE . 54.8 t -95.54 88.08 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.064 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.78 100.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.22 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.594 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.41 141.91 28.41 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.954 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.03 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.579 0.228 . . . . 0.0 111.088 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.83 153.91 50.57 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 107.74 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.144 2.562 . . . . 0.0 112.811 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 18.41 27.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.205 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.62 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.38 22.08 73.93 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.659 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.44 124.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 117.069 0.435 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.986 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.8 pt -65.15 111.81 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.5 p -75.35 156.57 35.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.557 0.694 . . . . 0.0 111.586 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.46 -42.73 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.121 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -27.73 69.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.982 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 92.0 m-20 -70.36 -51.72 27.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -69.52 -38.84 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.78 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 8.5 pttt -61.39 -49.88 75.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.166 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.415 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -67.44 -35.83 80.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.014 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 170' ' ' THR . 2.1 t-105 -71.96 -38.19 69.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.342 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.52 -45.27 60.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.29 -41.32 98.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -53.58 -27.21 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 166' ' ' TRP . 5.1 p -73.2 -51.95 15.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.44 63.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -30.68 71.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.64 115.35 22.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 68.8 p -104.98 -36.04 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.105 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.68 -55.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.11 -63.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -149.39 -81.82 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.88 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.77 119.32 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.86 150.09 21.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.41 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.8 94.86 2.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.766 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.517 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.5 ptp -46.82 167.08 0.16 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.028 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.3 Cg_exo -66.2 -48.04 2.9 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.904 2.403 . . . . 0.0 113.028 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -49.94 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.77 -34.57 73.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.028 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.41 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.34 -47.97 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.342 0.592 . . . . 0.0 110.369 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.6 -55.95 28.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.5 -41.54 97.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.39 -37.8 70.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -77.12 -31.43 55.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.33 -21.74 35.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.021 0.438 . . . . 0.0 111.048 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.57 -28.23 16.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.679 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.77 42.0 11.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.875 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.71 127.19 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -57.82 101.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.65 -40.82 80.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.43 -49.94 71.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.199 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.447 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -56.9 -28.53 62.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 149' ' ' VAL . 50.6 t -83.2 85.82 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.806 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 1.1 ptpp? -50.81 91.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 111.814 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.679 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -59.08 138.51 49.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.69 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 15.09 13.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.44 156.81 47.12 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.79 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.7 104.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.159 2.573 . . . . 0.0 112.907 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.64 20.98 17.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.225 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.23 22.14 78.06 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.63 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.54 123.62 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.065 0.432 . . . . 0.0 111.189 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 9.1 pt -63.16 110.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.8 p -75.15 156.51 35.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 0.0 111.522 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.23 -42.82 58.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.156 -179.177 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -64.83 -27.52 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.138 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.4 m-20 -70.0 -48.7 57.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.721 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.07 -46.08 68.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -58.6 -46.56 86.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.562 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.19 -37.25 75.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.206 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.693 ' O ' HG23 ' A' ' 170' ' ' THR . 1.9 t-105 -70.3 -46.18 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.592 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.98 -40.79 87.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.41 -39.36 81.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.388 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.72 -29.97 67.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.018 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.2 p -68.34 -52.12 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.568 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.3 -24.61 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -71.94 -31.32 66.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.14 -30.5 64.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.95 107.25 15.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.016 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.67 -56.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' A' ' 128' ' ' GLU . 69.3 mtm180 -87.93 -28.46 21.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.978 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 127' ' ' ARG . 7.1 pt-20 48.24 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.24 132.42 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.95 153.9 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.76 95.65 2.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.972 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 ptp -46.35 166.75 0.16 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.961 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.59 -48.54 3.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.861 2.374 . . . . 0.0 112.829 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -49.87 68.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.355 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.74 -35.02 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.459 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -66.95 -48.87 67.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.231 0.538 . . . . 0.0 110.509 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -58.93 -54.23 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.928 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.781 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.32 -39.76 95.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -38.88 72.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.956 0.408 . . . . 0.0 110.729 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.98 -32.13 57.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.99 -21.52 40.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.01 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.23 -28.62 16.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 40.71 11.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.876 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.589 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.48 127.13 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 0.0 110.904 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' N ' HD13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -59.06 101.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.61 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.908 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.63 -41.13 80.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -50.2 68.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.199 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 149' ' ' VAL . 51.1 t -82.07 83.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.94 91.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 111.315 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.531 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -60.6 142.47 48.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.009 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.91 13.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 110.842 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.92 156.75 49.6 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.7 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -43.74 103.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.876 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.13 23.41 11.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.159 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.56 22.15 78.67 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.5 125.31 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.981 0.39 . . . . 0.0 111.001 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.9 pt -63.74 111.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 63.4 p -75.16 156.52 35.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.521 0.677 . . . . 0.0 111.474 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.98 -42.19 53.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.247 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.9 mm-40 -65.81 -27.75 68.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.069 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.2 m-20 -68.79 -46.73 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.31 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.781 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.96 -42.19 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -47.9 84.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.704 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 73.8 mtp180 -73.68 -41.85 62.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.571 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 170' ' ' THR . 2.0 t90 -67.1 -45.08 78.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.321 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.09 70.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.317 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -60.75 -37.7 82.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.908 0.385 . . . . 0.0 110.721 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -30.67 67.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.954 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 166' ' ' TRP . 7.0 p -68.49 -52.08 36.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.12 -28.45 66.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.53 72.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.631 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.16 115.76 21.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.5 t -147.46 121.94 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.161 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p -158.1 146.56 18.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 149.33 35.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.73 -80.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.49 100.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.635 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.47 148.09 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.092 0.472 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -150.66 94.1 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.59 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.512 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -46.28 166.46 0.16 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.089 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 20.9 Cg_exo -66.36 -48.43 2.45 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.938 2.425 . . . . 0.0 112.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.69 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.515 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.25 -35.09 73.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 26.2 mtt-85 -67.81 -47.27 69.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.302 0.572 . . . . 0.0 110.24 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -56.64 19.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.27 -40.74 95.22 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.63 -39.72 71.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -31.71 56.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.971 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.77 -20.65 42.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -96.19 -28.82 14.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.717 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.85 40.91 10.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.149 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.35 126.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 0.0 110.916 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.33 101.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.676 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.4 -40.41 78.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.857 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -49.91 70.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.196 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.52 -28.5 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 149' ' ' VAL . 52.8 t -83.75 84.52 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.154 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -50.87 96.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.408 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.624 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.59 141.96 44.83 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.49 12.01 13.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.647 0.26 . . . . 0.0 111.113 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.75 155.66 51.21 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.779 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.76 106.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.123 2.549 . . . . 0.0 112.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.05 19.19 24.7 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.159 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.635 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.66 22.17 75.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.629 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.512 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.22 123.51 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.064 0.432 . . . . 0.0 111.177 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.6 pt -63.12 110.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.14 156.54 35.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.526 0.679 . . . . 0.0 111.724 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.459 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.14 -42.92 58.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.231 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -27.75 69.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.4 m-20 -69.54 -48.95 58.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.604 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.855 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.09 -46.11 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.817 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -45.41 82.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.487 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 2.3 ptm180 -69.69 -43.48 72.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.508 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 1.7 t-105 -65.45 -49.84 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.551 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.92 75.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.574 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 10.6 pt-20 -59.98 -38.74 83.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.58 -27.73 66.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.915 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.1 p -69.74 -52.12 28.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.74 -28.51 65.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.562 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -31.65 72.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.639 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.7 -68.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.1 p -62.47 130.42 45.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.1 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.6 m 59.41 27.5 16.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -113.29 -29.03 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.73 156.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.819 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.21 106.85 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.576 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.67 150.73 21.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 110.843 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.48 94.6 2.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 15.9 ptp -46.74 166.78 0.17 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.975 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.6 Cg_exo -66.25 -47.36 3.37 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.84 2.36 . . . . 0.0 112.772 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.13 65.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.455 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.59 -33.75 73.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.501 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -68.32 -47.82 66.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.415 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.01 -56.02 27.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.0 -40.57 94.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.676 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.28 -41.65 76.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -75.77 -29.95 58.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.87 -26.9 40.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -89.02 -29.01 19.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.13 33.9 7.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.238 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 149' ' ' VAL . 2.1 tt -115.81 146.88 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -79.93 100.92 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.976 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.39 -32.87 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -35.07 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.958 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.82 -20.39 61.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 144' ' ' ILE . 53.8 t -95.55 87.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.136 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -50.76 107.52 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 111.402 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.562 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -76.1 140.59 25.86 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.274 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 110.839 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.35 156.07 46.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.869 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 0.0 112.892 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 19.55 23.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.208 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.576 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.99 22.21 77.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.66 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.87 124.77 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 117.023 0.412 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.976 HD13 ' HB1' ' A' ' 146' ' ' ALA . 21.3 pt -64.17 111.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 49.3 p -75.32 156.54 35.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.625 0.726 . . . . 0.0 111.732 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -42.78 65.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.924 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.51 -27.68 69.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.5 m-20 -69.69 -49.33 54.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.21 -40.71 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.916 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -59.02 -50.23 74.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.165 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.421 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -67.44 -39.93 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.658 ' O ' HG23 ' A' ' 170' ' ' THR . 1.9 t-105 -66.71 -37.37 84.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.083 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.52 26.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 22.4 pt-20 -58.62 -37.26 75.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -44.74 88.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.131 0.491 . . . . 0.0 110.542 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.5 p -58.93 -52.24 66.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.781 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.45 -28.61 66.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.93 -31.34 72.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.75 98.12 8.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.31 -33.03 17.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.109 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -96.58 110.3 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 0.0 110.84 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.66 30.88 6.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.67 179.4 5.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.56 122.6 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.955 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -93.7 153.07 18.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.388 . . . . 0.0 110.952 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.74 95.38 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.808 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.527 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.3 ptp -47.02 167.25 0.17 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.88 -48.08 3.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.827 2.351 . . . . 0.0 112.906 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.13 67.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.442 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.64 -34.16 73.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.178 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -68.46 -47.94 65.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.382 0.61 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.37 -55.92 28.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.845 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.1 pp -61.97 -41.27 97.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.639 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.06 -40.38 70.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.364 . . . . 0.0 111.017 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -31.46 56.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.989 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -80.45 -21.54 41.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.92 0.39 . . . . 0.0 111.015 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -95.92 -28.68 14.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.664 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.02 42.64 10.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.503 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.26 129.7 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 0.0 111.037 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.07 101.03 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.772 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.91 -42.85 94.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -48.76 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.447 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.97 -27.33 63.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.507 HG22 ' CG ' ' A' ' 166' ' ' TRP . 42.2 t -84.17 85.89 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.013 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 95.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.654 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.6 140.92 32.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.651 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.83 13.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.289 . . . . 0.0 111.143 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.4 156.21 53.26 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.809 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.69 105.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.14 2.56 . . . . 0.0 112.891 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.45 21.45 17.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.155 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.8 22.1 78.56 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.62 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.527 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.84 125.19 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.139 0.47 . . . . 0.0 111.014 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.772 HD13 ' HB1' ' A' ' 146' ' ' ALA . 10.7 pt -64.35 111.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.1 p -75.07 156.56 35.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.46 -42.38 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.113 -179.25 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 164' ' ' LYS . 14.3 mt-10 -64.07 -27.65 69.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.1 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.0 m-20 -70.91 -49.6 44.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.897 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.845 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.28 -43.49 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.972 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -60.15 -49.43 77.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.881 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 17.5 ptt180 -62.95 -41.48 99.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.507 ' CG ' HG22 ' A' ' 149' ' ' VAL . 1.4 t-105 -67.39 -48.34 67.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.599 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.36 -44.33 71.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.393 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -61.35 -40.63 94.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.31 -29.24 63.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.995 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.7 p -66.61 -52.08 49.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.55 -27.06 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.748 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -35.16 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.81 92.9 6.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.7 p -91.4 168.63 11.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.097 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.3 m -159.57 31.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 128' ' ' GLU . 7.8 ttm180 -172.9 127.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 127' ' ' ARG . 18.2 tt0 83.55 -16.3 0.56 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.671 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.89 122.32 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -100.29 152.02 20.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.918 0.389 . . . . 0.0 111.004 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.51 94.77 2.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.796 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.412 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 13.2 ptp -46.48 166.92 0.16 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.061 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.06 -48.31 2.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.24 71.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.469 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.93 -34.27 68.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.462 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 2.7 mmm180 -68.69 -45.89 70.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.241 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -60.28 -55.66 30.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.953 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.824 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.54 -40.48 94.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.7 -37.51 73.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.383 . . . . 0.0 110.743 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -31.21 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.28 -25.4 36.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -91.62 -28.77 17.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.6 42.94 9.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.933 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.454 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.86 129.95 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.063 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -60.03 101.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.765 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.87 -40.0 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -49.25 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.135 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.27 -26.76 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 149' ' ' VAL . 45.7 t -84.52 85.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.88 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.67 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.566 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.615 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.22 144.64 48.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.647 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 1.35 11.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 111.163 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -62.14 152.5 43.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.457 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -44.54 118.68 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.043 2.495 . . . . 0.0 112.983 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.94 0.09 72.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 95.25 22.16 23.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.628 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -87.49 125.62 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 117.089 0.444 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.0 pt -64.74 111.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 69.2 p -75.15 156.5 35.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.59 0.71 . . . . 0.0 111.588 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.498 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.62 -41.96 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.273 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -64.61 -27.86 69.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.939 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.3 m-20 -69.3 -47.09 65.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.273 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.824 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -76.0 -34.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.091 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -64.08 -48.55 75.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.885 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 7.6 mtt180 -72.38 -41.29 66.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.279 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.706 ' O ' HG23 ' A' ' 170' ' ' THR . 1.9 t-105 -68.73 -43.67 75.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.573 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.43 74.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.51 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 12.2 pt-20 -69.09 -36.86 78.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.984 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 0.2 OUTLIER -58.93 -44.49 91.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.664 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 166' ' ' TRP . 9.5 p -56.05 -52.17 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.967 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.64 -23.79 58.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.296 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 169' ' ' GLU . 2.3 tptm -69.49 -35.21 75.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.7 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.23 126.19 35.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.044 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 p -79.1 -45.89 19.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.126 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.4 p -106.41 31.47 5.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.69 -171.31 3.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.22 150.7 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.12 135.02 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -86.14 154.77 21.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 110.875 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -154.68 96.33 1.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.904 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.614 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 11.8 ptp -45.36 165.68 0.16 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.614 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 48.5 Cg_endo -71.61 -32.35 12.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.072 1.848 . . . . 0.0 112.507 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.07 -51.5 63.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.749 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.4 -35.02 75.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.13 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 1.1 mtt180 -66.44 -48.56 69.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.323 0.582 . . . . 0.0 110.415 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -55.61 32.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.784 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.5 -41.31 98.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.59 -37.73 68.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -33.31 56.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -79.98 -19.96 46.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -96.7 -28.81 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.591 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.15 43.16 10.98 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.858 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.43 130.08 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.771 0.32 . . . . 0.0 111.058 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 5.1 t70 -58.74 101.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.73 -41.63 91.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.767 0.317 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -49.05 76.89 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.6 -27.34 62.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.506 HG22 ' CG ' ' A' ' 166' ' ' TRP . 41.8 t -84.35 86.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.73 92.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.561 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.548 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.02 139.88 36.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.683 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 14.29 13.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.71 156.7 52.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.41 104.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.511 . . . . 0.0 112.863 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.55 22.46 14.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.211 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.05 22.08 79.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.669 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -86.11 125.43 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 117.058 0.429 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.966 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.7 pt -63.64 111.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 74.6 p -75.12 156.54 35.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.493 0.663 . . . . 0.0 111.555 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.61 -42.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.144 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.7 mt-10 -63.9 -27.68 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.876 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.3 m-20 -69.9 -46.94 64.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.362 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.784 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.83 -36.8 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HG2' ' HG3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -63.35 -48.42 78.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.939 0.4 . . . . 0.0 110.908 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.462 ' HG3' ' HG2' ' A' ' 164' ' ' LYS . 6.3 mtt85 -71.12 -39.69 71.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.46 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.649 ' O ' HG23 ' A' ' 170' ' ' THR . 1.6 t-105 -70.35 -50.07 42.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.322 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.56 99.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.438 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.14 -41.36 90.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.941 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -57.61 -27.17 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.219 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 166' ' ' TRP . 2.7 p -71.91 -51.98 19.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.82 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.48 -28.75 66.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -31.56 72.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.54 -68.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.1 p -77.26 179.77 6.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.086 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.1 p -76.69 -31.3 57.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 110.967 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 -67.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -110.11 -175.14 2.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.11 115.1 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.61 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -81.1 151.23 28.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.79 95.73 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.464 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.7 ptp -46.55 167.47 0.15 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.746 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.51 -47.99 3.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.713 2.275 . . . . 0.0 112.902 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.82 66.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.52 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.62 -33.01 72.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.223 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -69.75 -47.81 61.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 110.325 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -57.51 -54.93 41.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.816 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.812 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.78 -41.09 99.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.56 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.15 75.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -29.95 55.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -83.49 -16.57 45.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -97.68 -28.84 13.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.94 33.68 8.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.944 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.6 tt -116.44 147.2 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.438 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -81.15 101.01 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.804 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.96 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.81 -34.06 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.33 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -63.7 -35.72 81.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.885 0.374 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -70.38 -19.93 62.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 144' ' ' ILE . 48.2 t -93.63 87.94 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.055 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -50.7 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.272 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -74.38 143.35 31.57 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.868 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.23 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.77 153.39 52.24 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.85 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.03 107.46 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.072 2.515 . . . . 0.0 112.848 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 18.64 26.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.263 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.61 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.16 21.96 74.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.66 125.89 40.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.892 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.96 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.1 pt -66.5 111.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.2 p -75.1 156.51 35.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.513 0.673 . . . . 0.0 111.489 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.97 -42.97 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.07 -179.192 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -27.58 69.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.075 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -70.83 -48.17 55.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.718 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.812 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.63 -41.9 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.428 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -59.46 -50.39 74.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -65.11 -42.09 94.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.636 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.3 t-105 -65.4 -37.99 88.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 170' ' ' THR . . . -74.08 -53.89 8.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.95 -38.19 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.054 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.66 -27.93 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 167' ' ' ALA . 3.4 p -70.66 -52.0 24.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.761 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.6 63.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.64 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -64.17 -31.78 73.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.7 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.7 94.32 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.4 p -105.48 -31.42 9.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.141 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.2 m -91.81 110.78 22.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -113.46 31.77 6.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.03 -167.68 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.6 128.81 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -91.96 155.15 18.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.827 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.57 95.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.971 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.689 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 18.4 ptm -46.65 167.89 0.14 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.611 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 49.2 Cg_endo -71.42 -33.56 10.82 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.112 1.874 . . . . 0.0 112.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.36 46.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.93 -33.16 71.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.69 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.15 -46.89 72.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.173 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -59.12 -55.58 33.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.731 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.766 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.7 -41.13 98.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.735 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.66 76.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -76.46 -29.85 57.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -81.1 -24.88 37.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.917 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -89.78 -28.89 19.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.45 12.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.967 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -110.52 146.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.386 . . . . 0.0 111.327 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -78.94 100.92 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.861 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.81 -32.33 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -34.43 77.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 109.93 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.46 -20.08 61.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -94.89 88.19 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.051 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -50.8 99.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -76.64 140.57 25.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.17 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 12.97 13.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 111.034 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.8 155.81 53.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.843 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.81 105.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.136 2.558 . . . . 0.0 112.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.55 20.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.142 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.592 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.5 22.05 77.91 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.657 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.42 125.11 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.109 0.454 . . . . 0.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -63.89 111.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 66.9 p -75.3 156.52 35.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.587 0.708 . . . . 0.0 111.802 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.01 -41.8 60.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.92 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -27.52 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.037 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -71.26 -49.77 39.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.44 -41.6 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.36 -49.77 75.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.082 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.425 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -66.03 -35.48 80.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.674 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.729 ' O ' HG23 ' A' ' 170' ' ' THR . 2.6 t-105 -70.59 -42.05 71.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.28 -39.16 89.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -45.43 77.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 166' ' ' TRP . 11.6 p -55.37 -52.13 64.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.0 61.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.47 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -37.49 80.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.789 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.79 3.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.012 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 66.0 p -79.09 150.51 31.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.134 -179.989 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -170.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.853 0.359 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.91 103.74 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -166.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.9 115.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.982 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -87.49 150.78 23.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.47 95.26 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.907 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 9.3 ptp -46.04 167.57 0.13 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.037 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.52 -48.12 3.52 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.801 2.334 . . . . 0.0 112.83 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.24 -50.48 67.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -70.54 -34.61 72.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 10.2 mmt180 -66.79 -46.74 74.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.3 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -60.05 -56.48 21.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.078 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.777 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.94 -41.81 96.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.01 -40.08 75.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -76.41 -29.76 57.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -81.96 -22.56 36.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.638 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.71 -28.88 16.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.1 30.09 10.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.104 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.599 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.1 tt -111.64 146.48 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.335 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -80.5 100.99 8.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.065 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.977 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -48.06 -34.04 8.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.273 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 72.4 m -63.69 -34.49 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.21 -19.73 61.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.204 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.599 ' CG2' HD13 ' A' ' 144' ' ' ILE . 53.1 t -94.95 88.61 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.081 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -50.72 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.514 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.86 142.26 28.44 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.745 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.34 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.29 153.79 51.16 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.83 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 108.62 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.145 2.563 . . . . 0.0 112.856 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.09 17.45 32.12 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.245 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 77.18 22.16 71.68 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.714 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.469 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.72 126.05 40.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.03 0.415 . . . . 0.0 110.935 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.977 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.7 pt -66.94 111.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.5 p -75.11 156.56 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.415 0.626 . . . . 0.0 111.374 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.95 -42.46 63.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.061 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -63.39 -27.68 69.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.6 m-20 -70.38 -53.84 14.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.648 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.777 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.34 -43.44 94.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.517 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -57.28 -48.4 79.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.816 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -63.13 -36.66 84.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.74 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 170' ' ' THR . 1.8 t-105 -70.94 -41.42 71.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.49 -48.74 59.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.168 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.13 -42.66 98.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.0 -27.93 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.038 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.3 p -70.1 -52.02 27.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.683 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.29 -27.06 60.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -34.45 74.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.812 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.53 104.17 0.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.9 p -131.29 135.7 47.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.053 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t -69.71 157.48 37.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -84.19 -76.5 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.88 153.74 43.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.95 122.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -106.24 153.56 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 110.888 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . . . -150.18 95.95 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.881 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.505 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 16.4 ptp -48.79 166.8 0.22 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.791 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.8 -48.05 3.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 112.962 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -50.52 66.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.51 75.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.165 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.572 ' NH1' ' HB3' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -67.97 -48.79 64.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.312 0.577 . . . . 0.0 110.41 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -55.59 32.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.981 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.825 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.01 -41.24 97.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.566 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.748 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.28 -39.49 69.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -77.07 -32.04 56.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -80.25 -19.61 46.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -97.7 -28.81 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.23 42.53 10.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.988 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.54 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.19 129.25 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.743 0.306 . . . . 0.0 111.107 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 144' ' ' ILE . 2.9 t70 -57.34 101.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.832 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.63 -42.21 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -48.47 78.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.98 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.427 ' HD2' ' NE1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -58.48 -26.93 63.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.519 HG22 ' CG ' ' A' ' 166' ' ' TRP . 41.7 t -84.5 85.9 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.15 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -50.76 96.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.558 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.58 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.31 140.61 32.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.802 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 14.2 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.724 0.297 . . . . 0.0 110.979 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.76 161.5 54.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.746 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.84 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.421 2.748 . . . . 0.0 112.887 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.28 24.82 11.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.218 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.4 22.22 78.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.646 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.505 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.17 124.14 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 117.097 0.448 . . . . 0.0 111.038 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.808 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -63.23 111.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.7 p -75.19 156.51 35.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.483 0.658 . . . . 0.0 111.481 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.17 -42.73 57.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.986 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -64.02 -27.73 69.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.928 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.4 m-20 -69.66 -48.04 61.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.517 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.825 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.29 -40.12 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 1.5 pttm -59.38 -48.41 81.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 111.131 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.412 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 1.6 ppt_? -71.12 -39.64 71.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.524 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.774 ' O ' HG23 ' A' ' 170' ' ' THR . 1.4 t-105 -69.11 -47.62 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.633 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.45 79.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.548 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 24.1 pt-20 -64.52 -41.87 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.65 -30.93 67.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 166' ' ' TRP . 6.9 p -71.62 -51.82 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.526 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -64.01 -31.34 72.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.691 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.19 -31.26 68.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 68.5 p -76.49 -65.69 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.096 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.138 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.23 116.83 28.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -90.36 -67.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.8 118.81 33.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.606 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.32 151.61 19.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 111.08 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.69 95.25 2.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.681 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.439 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.2 ptp -47.47 165.99 0.21 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.63 0.253 . . . . 0.0 110.875 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.73 -47.71 3.68 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.938 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -50.13 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.42 -34.11 73.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -48.47 63.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -57.21 -55.14 38.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.66 -40.24 94.22 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.451 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.745 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.77 -36.83 70.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.06 -33.2 57.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.872 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.64 -20.58 42.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.83 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -95.62 -28.65 14.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.24 12.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.903 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.42 129.42 74.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.73 0.3 . . . . 0.0 111.06 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -59.54 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.677 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.64 -40.46 79.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.946 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -49.93 72.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.218 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.469 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.24 -27.24 61.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 149' ' ' VAL . 46.1 t -84.3 85.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.168 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -50.74 94.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.546 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.69 140.42 36.68 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.741 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 12.95 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.982 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.94 156.49 53.26 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.697 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.27 104.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.097 2.532 . . . . 0.0 112.861 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.93 22.16 14.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.275 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.606 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.36 22.18 78.94 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.603 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.49 124.68 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 117.046 0.423 . . . . 0.0 111.068 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.889 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.8 pt -63.79 111.55 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 68.1 p -75.18 156.66 35.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.563 0.697 . . . . 0.0 111.684 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.443 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.1 -43.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.121 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.06 -27.65 68.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.006 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.9 m-20 -68.82 -46.99 67.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.806 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.35 -43.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.495 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -43.68 98.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.547 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -74.92 -40.12 61.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.26 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.469 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 t-105 -68.05 -42.9 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.18 61.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.374 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.94 -38.52 86.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.01 -29.07 65.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.154 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.4 p -68.56 -52.02 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.05 -23.78 58.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -73.12 -28.02 62.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.34 104.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.265 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.0 p 55.27 102.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.036 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 m -155.01 -171.41 3.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -58.45 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.69 158.22 21.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.66 117.84 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.98 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -97.25 152.5 18.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.966 0.413 . . . . 0.0 110.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.26 95.59 2.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 6.0 ptp -47.21 166.17 0.19 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.771 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.1 -48.02 3.03 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.819 2.346 . . . . 0.0 112.912 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -50.54 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.387 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.03 -34.92 76.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.238 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -49.13 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.623 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -54.74 43.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.77 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.31 -39.9 94.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.541 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.85 -36.69 72.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -77.03 -32.41 57.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.945 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -20.84 35.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -93.6 -27.61 16.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.588 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.34 42.63 18.09 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.736 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -116.84 132.56 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 111.09 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 144' ' ' ILE . 5.8 t70 -59.91 101.02 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -61.36 -41.93 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.532 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -47.43 80.73 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.456 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -59.21 -27.8 66.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 149' ' ' VAL . 43.0 t -83.8 85.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.82 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -50.83 90.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.711 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.599 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -57.92 137.64 49.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.74 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 15.01 13.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.65 158.03 48.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.754 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.9 102.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.183 2.588 . . . . 0.0 112.836 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.96 23.35 11.67 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.269 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.36 22.14 79.05 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.63 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.25 124.61 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 117.065 0.433 . . . . 0.0 111.108 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.789 HD13 ' HB1' ' A' ' 146' ' ' ALA . 13.7 pt -62.72 111.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.9 p -75.14 156.48 35.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.567 0.699 . . . . 0.0 111.635 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.34 -42.69 59.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.938 -179.233 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.06 -27.7 68.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.6 m-20 -68.99 -46.13 68.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.77 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.79 -43.67 46.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.323 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.43 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 45.2 mtp180 -74.65 -41.68 59.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.457 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.456 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 t-105 -66.95 -41.52 86.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.58 -45.46 62.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 111.391 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 12.5 pt-20 -61.77 -37.15 83.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.99 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 170' ' ' THR . 0.6 OUTLIER -54.83 -45.63 74.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.107 0.48 . . . . 0.0 110.764 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 166' ' ' TRP . 15.3 p -54.49 -52.0 63.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.4 -23.96 61.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.445 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -38.88 80.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.7 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.92 26.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.155 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 70.7 p -74.39 111.69 9.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.103 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -60.3 -66.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 60.19 98.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -84.51 158.03 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.55 150.32 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.531 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -86.84 159.05 19.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.895 0.379 . . . . 0.0 110.778 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.53 96.32 1.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.4 ptm -47.77 167.58 0.18 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.585 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.0 Cg_exo -65.3 -47.09 4.77 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.723 2.282 . . . . 0.0 112.786 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.9 63.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.463 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -68.95 -32.92 72.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -48.9 60.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 110.372 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -57.21 -54.32 48.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.762 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.15 -40.89 98.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.03 -36.73 73.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.66 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -77.11 -31.38 55.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -82.24 -21.78 36.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.07 -28.78 15.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.8 43.2 9.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.008 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.514 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.95 128.21 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.022 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -59.63 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.656 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.29 -40.85 78.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -50.16 70.84 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.05 61.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.556 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.466 HG22 ' CG ' ' A' ' 166' ' ' TRP . 49.5 t -83.24 85.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.88 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -50.77 92.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.281 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.64 142.33 41.98 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.964 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 13.56 13.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.64 156.34 51.86 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.806 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.62 103.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.174 2.583 . . . . 0.0 112.903 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.5 23.2 11.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.201 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.59 22.12 78.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.605 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.71 126.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.982 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.2 pt -64.52 112.02 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.7 p -75.28 156.56 35.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.424 0.631 . . . . 0.0 111.591 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.487 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.24 -42.71 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.115 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -64.02 -27.69 69.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -70.14 -47.39 61.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.497 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.08 -40.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -59.7 -49.41 77.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.099 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 1.0 OUTLIER -69.76 -40.83 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.532 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CG ' HG22 ' A' ' 149' ' ' VAL . 1.5 t-105 -67.56 -48.67 66.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.461 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.87 -46.26 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.371 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 10.8 pt-20 -58.88 -41.42 87.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.88 0.371 . . . . 0.0 110.724 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.66 -26.9 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.045 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.4 p -72.54 -52.13 16.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.612 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.57 58.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -77.14 -31.99 56.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.723 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.3 54.63 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.106 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.7 p -128.33 144.97 51.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.076 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.9 t -73.62 100.74 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -127.78 -169.5 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.51 134.41 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -92.26 114.56 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.636 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -92.81 149.82 21.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 111.242 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.93 94.41 1.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.6 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.561 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -45.56 165.47 0.17 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.978 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.5 -47.22 4.4 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.769 2.313 . . . . 0.0 112.809 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.78 63.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.488 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.87 -33.47 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -68.55 -49.58 58.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -58.51 -55.31 36.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.12 -40.77 95.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.759 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.11 -42.94 73.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 110.919 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -29.7 59.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -79.51 -24.42 42.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.8 mt -91.41 -28.85 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.745 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.88 34.5 6.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.073 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -117.84 147.15 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -82.22 101.15 10.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.101 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.89 -33.19 7.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.168 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -34.94 79.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.44 -18.68 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.386 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -96.94 88.08 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.271 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.74 98.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.1 142.16 35.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 11.23 12.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.92 153.35 49.88 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.718 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -45.56 112.91 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.129 2.552 . . . . 0.0 112.775 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.11 10.56 57.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.334 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.636 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.41 22.05 55.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.774 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.561 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -87.23 124.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 117.181 0.49 . . . . 0.0 111.207 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.7 pt -63.58 111.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 52.5 p -75.32 156.57 35.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.662 0.744 . . . . 0.0 111.89 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -41.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.941 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 164' ' ' LYS . 3.3 mt-10 -63.62 -27.84 69.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.304 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 78.1 m-20 -70.82 -52.1 22.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.099 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.24 -48.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.503 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -58.23 -51.21 70.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.286 -179.251 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 18.4 ptt180 -57.81 -37.9 74.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TRP . . . . . 0.713 ' O ' HG23 ' A' ' 170' ' ' THR . 2.7 t-105 -69.22 -48.06 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.908 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.96 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.07 -39.39 93.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -58.5 -31.27 67.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 166' ' ' TRP . 2.9 p -70.21 -51.98 26.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.639 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.6 68.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.414 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -63.67 -31.25 72.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.739 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.2 104.7 16.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 t -145.94 -50.53 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.111 -179.985 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.203 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.23 95.07 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.458 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -46.31 167.42 0.14 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.02 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.415 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.92 -48.5 2.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.816 2.344 . . . . 0.0 112.944 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.03 70.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.34 -34.19 70.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -67.99 -46.41 71.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.309 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.11 -56.0 27.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.82 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.81 -39.61 74.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -29.83 55.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -81.93 -25.35 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -90.52 -28.58 18.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.714 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.14 41.64 9.27 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.933 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.61 127.38 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.79 0.328 . . . . 0.0 110.949 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 103.12 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.59 -40.45 79.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -49.88 71.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.192 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -28.24 62.43 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 149' ' ' VAL . 49.7 t -83.54 85.29 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.992 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -50.92 92.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.638 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -65.49 141.98 43.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.796 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 13.41 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.696 0.284 . . . . 0.0 111.146 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.5 154.98 50.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.727 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.72 106.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.022 2.481 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.96 18.95 25.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.248 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.1 22.13 74.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.79 124.6 40.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.035 0.418 . . . . 0.0 111.053 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.2 pt -64.3 111.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 81.0 p -75.16 156.51 35.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.443 0.64 . . . . 0.0 111.439 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.28 -43.29 60.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.1 -179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -27.66 69.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.1 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -69.99 -48.17 59.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.82 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.81 -41.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.734 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.622 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.042 0.449 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.11 94.64 1.97 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.494 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -45.08 163.6 0.2 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.57 -49.83 2.19 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -48.3 71.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.17 -34.9 75.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.291 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -69.6 -49.5 53.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -57.03 -55.64 32.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.74 -39.54 89.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.503 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.02 -41.11 74.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -30.09 55.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.083 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.93 -18.71 39.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.66 -28.84 13.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.85 35.16 11.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.047 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.992 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -108.73 125.8 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.301 . . . . 0.0 110.578 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -60.32 101.07 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.69 -45.58 89.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.836 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -48.58 66.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.26 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.38 -33.44 67.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.644 HG21 HD12 ' A' ' 144' ' ' ILE . 55.1 t -79.37 82.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.856 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.82 92.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.02 139.46 43.44 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.356 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.4 13.86 13.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.648 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.22 157.28 46.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.34 106.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.129 2.552 . . . . 0.0 112.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.71 20.11 22.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.622 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.05 22.16 77.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.612 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.507 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.51 125.62 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.122 0.461 . . . . 0.0 111.331 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.0 pt -62.21 111.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 30.6 p -74.98 156.26 36.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.441 0.639 . . . . 0.0 111.641 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -55.26 -39.18 50.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.588 -178.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -67.45 -30.54 70.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.94 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 159' ' ' THR . 93.6 m-20 -65.37 -57.99 6.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.637 . . . . 0.0 110.1 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -56.68 -42.61 77.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.565 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.591 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.453 -0.276 0 CA-C-O 120.949 0.404 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -150.22 95.46 2.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.84 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 11.4 ptp -48.33 166.26 0.22 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.966 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.89 -47.65 3.56 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.878 2.386 . . . . 0.0 112.972 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.9 65.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.429 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.49 75.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.096 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -67.83 -48.58 65.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.231 0.539 . . . . 0.0 110.423 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -57.77 -55.94 28.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.037 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.18 -41.59 97.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.63 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.06 -38.44 70.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.916 0.388 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.35 56.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.006 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -81.91 -21.43 37.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 111.041 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -94.8 -28.8 15.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.601 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.03 42.8 10.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.856 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.541 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.16 129.23 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 111.057 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -56.52 101.07 0.05 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.39 -42.58 92.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -48.53 78.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.992 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.8 -25.72 63.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.517 HG12 ' O ' ' A' ' 149' ' ' VAL . 40.3 t -85.78 85.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -50.9 100.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.642 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -74.63 141.62 28.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.94 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 12.92 13.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.645 0.26 . . . . 0.0 111.155 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.43 156.67 53.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.854 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -44.68 104.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.103 2.535 . . . . 0.0 112.907 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.7 22.11 14.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.168 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.591 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.35 22.18 78.95 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.61 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.74 124.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.064 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.664 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.4 pt -63.61 111.49 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.2 p -75.25 156.57 35.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.648 0.737 . . . . 0.0 111.624 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.449 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.93 -42.83 55.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.118 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -64.57 -27.61 69.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.121 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 64.0 m-20 -69.5 -49.15 57.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.727 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.35 -46.83 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.871 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 mttp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.359 -179.44 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.617 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.232 0 CA-C-O 120.981 0.419 . . . . 0.0 110.715 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 158' ' ' ILE . . . -152.59 95.14 1.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.825 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 14.3 ptm -46.42 164.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.6 -49.29 2.47 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.774 2.316 . . . . 0.0 112.789 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.14 -49.12 69.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.407 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.2 -34.46 74.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.337 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.31 -49.33 56.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -57.79 -55.39 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.62 -38.66 85.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.396 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.74 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.09 -40.51 77.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -76.72 -29.82 56.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -85.11 -16.59 40.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.442 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -99.77 -28.82 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.66 10.0 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 1.003 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -111.36 126.41 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.634 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 3.2 t0 -61.78 100.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.457 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.29 -44.87 88.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.39 67.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.155 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.35 -33.37 65.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.616 HG21 HD12 ' A' ' 144' ' ' ILE . 54.8 t -79.34 84.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.084 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.96 91.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.31 138.22 46.2 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.241 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.37 13.9 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 159' ' ' THR . . . -76.28 159.09 49.97 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.85 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.166 2.577 . . . . 0.0 112.953 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.16 11.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.192 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.45 22.19 79.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.633 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.497 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.56 125.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.228 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.4 pt -61.04 110.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 24.2 p -75.19 156.54 35.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.337 0.589 . . . . 0.0 111.6 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.62 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.24 -40.47 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.423 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.67 -28.31 69.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.496 ' HB2' ' O ' ' A' ' 159' ' ' THR . 95.7 m-20 -68.91 -58.03 4.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.485 0.66 . . . . 0.0 109.821 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.003 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -57.38 -41.17 77.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.38 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.62 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.201 0 CA-C-O 121.035 0.445 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.31 94.55 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.638 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.426 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.9 ptm -47.11 167.77 0.15 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.5 Cg_exo -65.7 -45.78 6.09 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.837 2.358 . . . . 0.0 113.02 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.45 61.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.396 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.47 -32.97 72.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.79 -46.73 71.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.24 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -59.67 -55.5 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.134 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.38 -42.11 99.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.69 -38.99 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -76.87 -29.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -81.31 -25.31 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.056 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.29 -29.01 18.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.8 31.62 9.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.025 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.59 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -111.81 146.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.94 0.37 . . . . 0.0 111.323 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -79.81 101.01 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.098 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.986 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.22 -32.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -35.03 79.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.969 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.64 -19.32 61.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.59 ' CG2' HD13 ' A' ' 144' ' ' ILE . 54.8 t -95.54 88.08 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.064 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.78 100.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.22 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.594 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.41 141.91 28.41 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.954 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.03 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.579 0.228 . . . . 0.0 111.088 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.83 153.91 50.57 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 107.74 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.144 2.562 . . . . 0.0 112.811 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 18.41 27.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.205 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.62 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.38 22.08 73.93 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.659 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.44 124.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 117.069 0.435 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.986 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.8 pt -65.15 111.81 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.5 p -75.35 156.57 35.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.557 0.694 . . . . 0.0 111.586 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.46 -42.73 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.121 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -27.73 69.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.982 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 92.0 m-20 -70.36 -51.72 27.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -69.52 -38.84 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.78 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 8.5 pttt . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.166 -179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.217 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.41 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.8 94.86 2.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.766 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.517 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.5 ptp -46.82 167.08 0.16 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.028 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.3 Cg_exo -66.2 -48.04 2.9 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.904 2.403 . . . . 0.0 113.028 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -49.94 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.77 -34.57 73.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.028 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.41 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.34 -47.97 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.342 0.592 . . . . 0.0 110.369 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.6 -55.95 28.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.5 -41.54 97.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.39 -37.8 70.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -77.12 -31.43 55.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.33 -21.74 35.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.021 0.438 . . . . 0.0 111.048 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.57 -28.23 16.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.679 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.77 42.0 11.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.875 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.71 127.19 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -57.82 101.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.65 -40.82 80.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.43 -49.94 71.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.199 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.53 62.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 149' ' ' VAL . 50.6 t -83.2 85.82 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.806 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 1.1 ptpp? -50.81 91.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 111.814 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.679 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -59.08 138.51 49.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.69 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 15.09 13.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.44 156.81 47.12 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.79 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.7 104.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.159 2.573 . . . . 0.0 112.907 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.64 20.98 17.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.225 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.23 22.14 78.06 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.63 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.54 123.62 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.065 0.432 . . . . 0.0 111.189 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 9.1 pt -63.16 110.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.8 p -75.15 156.51 35.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 0.0 111.522 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.23 -42.82 58.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.156 -179.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -64.83 -27.52 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.138 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.4 m-20 -70.0 -48.7 57.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.721 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.07 -46.08 68.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.562 -179.193 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.76 95.65 2.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.972 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 ptp -46.35 166.75 0.16 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.961 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.59 -48.54 3.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.861 2.374 . . . . 0.0 112.829 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -49.87 68.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.355 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.74 -35.02 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.459 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -66.95 -48.87 67.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.231 0.538 . . . . 0.0 110.509 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -58.93 -54.23 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.928 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.781 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.32 -39.76 95.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -38.88 72.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.956 0.408 . . . . 0.0 110.729 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.98 -32.13 57.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.99 -21.52 40.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.01 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.23 -28.62 16.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 40.71 11.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.876 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.589 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.48 127.13 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 0.0 110.904 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.418 ' N ' HD13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -59.06 101.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.61 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.908 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.63 -41.13 80.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -50.2 68.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.199 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.411 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 149' ' ' VAL . 51.1 t -82.07 83.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.94 91.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 111.315 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.531 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -60.6 142.47 48.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.009 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.91 13.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 110.842 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.92 156.75 49.6 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.7 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -43.74 103.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.876 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.13 23.41 11.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.159 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.56 22.15 78.67 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.5 125.31 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.981 0.39 . . . . 0.0 111.001 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.9 pt -63.74 111.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 63.4 p -75.16 156.52 35.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.521 0.677 . . . . 0.0 111.474 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.98 -42.19 53.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.247 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -65.81 -27.75 68.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.2 m-20 -68.79 -46.73 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.31 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.781 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.96 -42.19 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.704 -178.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.635 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.264 0 CA-C-O 121.092 0.472 . . . . 0.0 111.216 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -150.66 94.1 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.59 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.512 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -46.28 166.46 0.16 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.089 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 20.9 Cg_exo -66.36 -48.43 2.45 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.938 2.425 . . . . 0.0 112.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.69 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.515 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.25 -35.09 73.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 26.2 mtt-85 -67.81 -47.27 69.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.302 0.572 . . . . 0.0 110.24 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -56.64 19.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.27 -40.74 95.22 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.63 -39.72 71.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -31.71 56.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.971 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.77 -20.65 42.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -96.19 -28.82 14.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.717 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.85 40.91 10.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.149 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.35 126.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 0.0 110.916 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.33 101.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.676 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.4 -40.41 78.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.857 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -49.91 70.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.196 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -28.5 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 149' ' ' VAL . 52.8 t -83.75 84.52 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.154 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -50.87 96.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.408 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.624 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.59 141.96 44.83 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.49 12.01 13.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.647 0.26 . . . . 0.0 111.113 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.75 155.66 51.21 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.779 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.76 106.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.123 2.549 . . . . 0.0 112.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.05 19.19 24.7 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.159 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.635 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.66 22.17 75.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.629 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.512 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.22 123.51 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.064 0.432 . . . . 0.0 111.177 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.6 pt -63.12 110.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.14 156.54 35.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.526 0.679 . . . . 0.0 111.724 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.459 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.14 -42.92 58.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.231 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -27.75 69.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.4 m-20 -69.54 -48.95 58.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.604 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.855 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.09 -46.11 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.817 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.487 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.576 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.27 0 CA-C-O 120.903 0.383 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.48 94.6 2.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 15.9 ptp -46.74 166.78 0.17 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.975 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.6 Cg_exo -66.25 -47.36 3.37 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.84 2.36 . . . . 0.0 112.772 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.13 65.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.455 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.59 -33.75 73.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.501 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -68.32 -47.82 66.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.415 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.01 -56.02 27.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.0 -40.57 94.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.676 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.28 -41.65 76.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -75.77 -29.95 58.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.87 -26.9 40.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -89.02 -29.01 19.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.13 33.9 7.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.238 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 149' ' ' VAL . 2.1 tt -115.81 146.88 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -79.93 100.92 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.976 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.39 -32.87 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -35.07 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.958 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.82 -20.39 61.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 144' ' ' ILE . 53.8 t -95.55 87.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.136 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -50.76 107.52 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 111.402 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.562 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -76.1 140.59 25.86 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.274 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 110.839 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.35 156.07 46.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.869 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 0.0 112.892 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 19.55 23.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.208 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.576 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.99 22.21 77.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.66 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.87 124.77 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 117.023 0.412 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.976 HD13 ' HB1' ' A' ' 146' ' ' ALA . 21.3 pt -64.17 111.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 49.3 p -75.32 156.54 35.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.625 0.726 . . . . 0.0 111.732 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -42.78 65.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.924 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.51 -27.68 69.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.5 m-20 -69.69 -49.33 54.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.21 -40.71 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.916 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.414 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.174 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.165 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.197 0 CA-C-O 120.916 0.388 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.74 95.38 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.808 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.527 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.3 ptp -47.02 167.25 0.17 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.88 -48.08 3.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.827 2.351 . . . . 0.0 112.906 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.13 67.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.442 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.64 -34.16 73.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.178 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -68.46 -47.94 65.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.382 0.61 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.37 -55.92 28.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.845 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.1 pp -61.97 -41.27 97.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.639 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.06 -40.38 70.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.364 . . . . 0.0 111.017 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -31.46 56.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.989 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -80.45 -21.54 41.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.92 0.39 . . . . 0.0 111.015 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -95.92 -28.68 14.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.664 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.02 42.64 10.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.503 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.26 129.7 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 0.0 111.037 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.07 101.03 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.772 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.91 -42.85 94.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -48.76 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.97 -27.33 63.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 149' ' ' VAL . 42.2 t -84.17 85.89 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.013 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 95.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.654 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.6 140.92 32.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.651 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.83 13.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.289 . . . . 0.0 111.143 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.4 156.21 53.26 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.809 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.69 105.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.14 2.56 . . . . 0.0 112.891 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.45 21.45 17.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.155 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.8 22.1 78.56 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.62 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.527 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.84 125.19 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.139 0.47 . . . . 0.0 111.014 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.772 HD13 ' HB1' ' A' ' 146' ' ' ALA . 10.7 pt -64.35 111.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.1 p -75.07 156.56 35.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.46 -42.38 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.113 -179.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 164' ' ' LYS . 14.3 mt-10 -64.07 -27.65 69.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.1 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.0 m-20 -70.91 -49.6 44.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.897 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.845 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.28 -43.49 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.972 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.404 ' NZ ' ' HG2' ' A' ' 161' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.881 -179.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.241 0 CA-C-O 120.918 0.389 . . . . 0.0 111.004 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.51 94.77 2.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.796 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.412 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 13.2 ptp -46.48 166.92 0.16 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.061 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.06 -48.31 2.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.24 71.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.469 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.93 -34.27 68.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.462 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 2.7 mmm180 -68.69 -45.89 70.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.241 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -60.28 -55.66 30.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.953 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.824 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.54 -40.48 94.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.7 -37.51 73.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.383 . . . . 0.0 110.743 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -31.21 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.28 -25.4 36.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -91.62 -28.77 17.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.6 42.94 9.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.933 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.454 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.86 129.95 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.063 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -60.03 101.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.765 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.87 -40.0 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -49.25 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.135 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.27 -26.76 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 149' ' ' VAL . 45.7 t -84.52 85.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.88 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.67 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.566 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.615 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.22 144.64 48.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.647 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 1.35 11.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 111.163 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -62.14 152.5 43.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.457 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -44.54 118.68 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.043 2.495 . . . . 0.0 112.983 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.94 0.09 72.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 95.25 22.16 23.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.628 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -87.49 125.62 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 117.089 0.444 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.0 pt -64.74 111.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 69.2 p -75.15 156.5 35.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.59 0.71 . . . . 0.0 111.588 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.498 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.62 -41.96 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.273 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.61 -27.86 69.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.939 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.3 m-20 -69.3 -47.09 65.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.273 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.824 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -76.0 -34.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.091 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.885 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.059 0.456 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -154.68 96.33 1.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.904 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.614 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 11.8 ptp -45.36 165.68 0.16 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.614 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 48.5 Cg_endo -71.61 -32.35 12.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.072 1.848 . . . . 0.0 112.507 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.07 -51.5 63.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.749 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.4 -35.02 75.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.13 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 1.1 mtt180 -66.44 -48.56 69.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.323 0.582 . . . . 0.0 110.415 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -55.61 32.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.784 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.5 -41.31 98.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.59 -37.73 68.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -33.31 56.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -79.98 -19.96 46.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -96.7 -28.81 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.591 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.15 43.16 10.98 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.858 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.43 130.08 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.771 0.32 . . . . 0.0 111.058 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 5.1 t70 -58.74 101.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.73 -41.63 91.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.767 0.317 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -49.05 76.89 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.6 -27.34 62.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 149' ' ' VAL . 41.8 t -84.35 86.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.73 92.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.561 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.548 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.02 139.88 36.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.683 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 14.29 13.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.71 156.7 52.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.41 104.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.511 . . . . 0.0 112.863 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.55 22.46 14.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.211 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.05 22.08 79.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.669 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -86.11 125.43 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 117.058 0.429 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.966 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.7 pt -63.64 111.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 74.6 p -75.12 156.54 35.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.493 0.663 . . . . 0.0 111.555 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.61 -42.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.144 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.9 -27.68 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.876 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.3 m-20 -69.9 -46.94 64.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.362 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.784 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.83 -36.8 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.939 0.4 . . . . 0.0 110.908 -179.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.61 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.946 0.403 . . . . 0.0 110.688 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.79 95.73 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.464 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.7 ptp -46.55 167.47 0.15 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.746 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.51 -47.99 3.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.713 2.275 . . . . 0.0 112.902 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.82 66.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.52 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.62 -33.01 72.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.223 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -69.75 -47.81 61.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 110.325 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -57.51 -54.93 41.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.816 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.812 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.78 -41.09 99.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.56 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.15 75.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -29.95 55.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -83.49 -16.57 45.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -97.68 -28.84 13.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.94 33.68 8.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.944 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.6 tt -116.44 147.2 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.438 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -81.15 101.01 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.804 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.96 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.81 -34.06 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.33 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -63.7 -35.72 81.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.885 0.374 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -70.38 -19.93 62.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 144' ' ' ILE . 48.2 t -93.63 87.94 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.055 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -50.7 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.272 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -74.38 143.35 31.57 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.868 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.23 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.77 153.39 52.24 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.85 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.03 107.46 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.072 2.515 . . . . 0.0 112.848 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 18.64 26.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.263 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.61 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.16 21.96 74.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.66 125.89 40.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.892 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.96 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.1 pt -66.5 111.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.2 p -75.1 156.51 35.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.513 0.673 . . . . 0.0 111.489 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.97 -42.97 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.07 -179.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -27.58 69.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.075 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -70.83 -48.17 55.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.718 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.812 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.63 -41.9 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 C--O 1.232 0.18 0 CA-C-O 120.925 0.393 . . . . 0.0 110.827 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.57 95.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.971 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.689 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 18.4 ptm -46.65 167.89 0.14 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.611 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 49.2 Cg_endo -71.42 -33.56 10.82 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.112 1.874 . . . . 0.0 112.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.36 46.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.93 -33.16 71.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.69 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.15 -46.89 72.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.173 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -59.12 -55.58 33.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.731 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.766 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.7 -41.13 98.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.735 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.66 76.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -76.46 -29.85 57.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -81.1 -24.88 37.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.917 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -89.78 -28.89 19.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.45 12.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.967 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -110.52 146.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.386 . . . . 0.0 111.327 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -78.94 100.92 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.861 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.81 -32.33 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -34.43 77.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 109.93 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.46 -20.08 61.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -94.89 88.19 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.051 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -50.8 99.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -76.64 140.57 25.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.17 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 12.97 13.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 111.034 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.8 155.81 53.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.843 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.81 105.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.136 2.558 . . . . 0.0 112.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.55 20.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.142 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.592 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.5 22.05 77.91 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.657 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.42 125.11 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.109 0.454 . . . . 0.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -63.89 111.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 66.9 p -75.3 156.52 35.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.587 0.708 . . . . 0.0 111.802 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.01 -41.8 60.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.92 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -27.52 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.037 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -71.26 -49.77 39.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.44 -41.6 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.406 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.334 -0.104 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.082 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.177 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.47 95.26 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.907 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 9.3 ptp -46.04 167.57 0.13 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.037 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.52 -48.12 3.52 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.801 2.334 . . . . 0.0 112.83 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.24 -50.48 67.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -70.54 -34.61 72.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 10.2 mmt180 -66.79 -46.74 74.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.3 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -60.05 -56.48 21.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.078 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.777 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.94 -41.81 96.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.01 -40.08 75.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -76.41 -29.76 57.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -81.96 -22.56 36.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.638 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.71 -28.88 16.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.1 30.09 10.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.104 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.599 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.1 tt -111.64 146.48 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.335 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -80.5 100.99 8.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.065 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.977 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -48.06 -34.04 8.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.273 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 72.4 m -63.69 -34.49 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.21 -19.73 61.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.599 ' CG2' HD13 ' A' ' 144' ' ' ILE . 53.1 t -94.95 88.61 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.081 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -50.72 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.514 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.86 142.26 28.44 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.745 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.34 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.29 153.79 51.16 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.83 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 108.62 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.145 2.563 . . . . 0.0 112.856 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.09 17.45 32.12 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.245 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 77.18 22.16 71.68 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.714 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.469 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.72 126.05 40.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.03 0.415 . . . . 0.0 110.935 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.977 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.7 pt -66.94 111.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.5 p -75.11 156.56 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.415 0.626 . . . . 0.0 111.374 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.95 -42.46 63.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.061 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -63.39 -27.68 69.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.6 m-20 -70.38 -53.84 14.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.648 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.777 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.34 -43.44 94.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.517 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.816 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.97 0.414 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . . . -150.18 95.95 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.881 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.505 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 16.4 ptp -48.79 166.8 0.22 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.791 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.8 -48.05 3.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 112.962 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -50.52 66.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.51 75.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.165 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . 0.572 ' NH1' ' HB3' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -67.97 -48.79 64.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.312 0.577 . . . . 0.0 110.41 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -55.59 32.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.981 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.825 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.01 -41.24 97.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.566 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.748 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.28 -39.49 69.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -77.07 -32.04 56.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -80.25 -19.61 46.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -97.7 -28.81 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.23 42.53 10.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.988 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.54 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.19 129.25 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.743 0.306 . . . . 0.0 111.107 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 144' ' ' ILE . 2.9 t70 -57.34 101.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.832 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.63 -42.21 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -48.47 78.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.98 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.48 -26.93 63.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 149' ' ' VAL . 41.7 t -84.5 85.9 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.15 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -50.76 96.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.558 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.58 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.31 140.61 32.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.802 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 14.2 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.724 0.297 . . . . 0.0 110.979 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.76 161.5 54.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.746 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.84 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.421 2.748 . . . . 0.0 112.887 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.28 24.82 11.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.218 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.4 22.22 78.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.646 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.505 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.17 124.14 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 117.097 0.448 . . . . 0.0 111.038 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.808 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -63.23 111.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.7 p -75.19 156.51 35.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.483 0.658 . . . . 0.0 111.481 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.17 -42.73 57.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.986 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -64.02 -27.73 69.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.928 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.4 m-20 -69.66 -48.04 61.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.517 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.825 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.29 -40.12 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.411 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 1.5 pttm . . . . . 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 111.131 -179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.606 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.187 0 CA-C-O 121.108 0.48 . . . . 0.0 111.08 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.69 95.25 2.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.681 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.439 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.2 ptp -47.47 165.99 0.21 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.63 0.253 . . . . 0.0 110.875 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.73 -47.71 3.68 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.938 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -50.13 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.42 -34.11 73.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -48.47 63.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -57.21 -55.14 38.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.66 -40.24 94.22 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.451 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.745 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.77 -36.83 70.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.06 -33.2 57.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.872 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.64 -20.58 42.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.83 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -95.62 -28.65 14.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.24 12.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.903 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.42 129.42 74.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.73 0.3 . . . . 0.0 111.06 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -59.54 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.677 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.64 -40.46 79.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.946 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -49.93 72.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.218 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.403 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.24 -27.24 61.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 149' ' ' VAL . 46.1 t -84.3 85.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.168 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -50.74 94.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.546 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.69 140.42 36.68 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.741 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 12.95 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.982 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.94 156.49 53.26 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.697 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.27 104.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.097 2.532 . . . . 0.0 112.861 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.93 22.16 14.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.275 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.606 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.36 22.18 78.94 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.603 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.49 124.68 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 117.046 0.423 . . . . 0.0 111.068 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.889 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.8 pt -63.79 111.55 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 68.1 p -75.18 156.66 35.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.563 0.697 . . . . 0.0 111.684 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.443 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.1 -43.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.121 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.06 -27.65 68.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.006 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.9 m-20 -68.82 -46.99 67.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.806 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.35 -43.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.495 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.547 -178.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.966 0.413 . . . . 0.0 110.957 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.26 95.59 2.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 6.0 ptp -47.21 166.17 0.19 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.771 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.1 -48.02 3.03 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.819 2.346 . . . . 0.0 112.912 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -50.54 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.387 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.03 -34.92 76.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.238 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -49.13 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.623 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -54.74 43.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.77 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.31 -39.9 94.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.541 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.85 -36.69 72.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -77.03 -32.41 57.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.945 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -20.84 35.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -93.6 -27.61 16.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.588 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.34 42.63 18.09 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.736 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -116.84 132.56 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 111.09 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 144' ' ' ILE . 5.8 t70 -59.91 101.02 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -61.36 -41.93 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.532 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -47.43 80.73 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.21 -27.8 66.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 149' ' ' VAL . 43.0 t -83.8 85.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.82 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -50.83 90.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.711 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.599 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -57.92 137.64 49.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.74 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 15.01 13.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.65 158.03 48.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.754 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.9 102.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.183 2.588 . . . . 0.0 112.836 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.96 23.35 11.67 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.269 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.36 22.14 79.05 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.63 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.25 124.61 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 117.065 0.433 . . . . 0.0 111.108 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.789 HD13 ' HB1' ' A' ' 146' ' ' ALA . 13.7 pt -62.72 111.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.9 p -75.14 156.48 35.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.567 0.699 . . . . 0.0 111.635 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.34 -42.69 59.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.938 -179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -27.7 68.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 179.196 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.6 m-20 -68.99 -46.13 68.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.77 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.79 -43.67 46.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.323 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mttm . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.43 -178.795 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.531 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.456 -0.144 0 CA-C-O 120.895 0.379 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.53 96.32 1.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.4 ptm -47.77 167.58 0.18 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.585 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.0 Cg_exo -65.3 -47.09 4.77 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.723 2.282 . . . . 0.0 112.786 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.9 63.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.463 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -68.95 -32.92 72.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -48.9 60.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 110.372 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -57.21 -54.32 48.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.762 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.15 -40.89 98.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.03 -36.73 73.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.66 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -77.11 -31.38 55.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -82.24 -21.78 36.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.07 -28.78 15.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.8 43.2 9.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.008 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.514 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.95 128.21 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.022 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -59.63 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.656 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.29 -40.85 78.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -50.16 70.84 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.05 61.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 149' ' ' VAL . 49.5 t -83.24 85.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.88 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -50.77 92.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.281 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.64 142.33 41.98 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.964 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 13.56 13.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.64 156.34 51.86 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.806 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.62 103.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.174 2.583 . . . . 0.0 112.903 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.5 23.2 11.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.201 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.59 22.12 78.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.605 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.71 126.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.982 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.2 pt -64.52 112.02 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.7 p -75.28 156.56 35.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.424 0.631 . . . . 0.0 111.591 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.487 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.24 -42.71 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.115 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -64.02 -27.69 69.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -70.14 -47.39 61.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.497 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.08 -40.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.099 -179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.636 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . . . . . . 0 N--CA 1.455 -0.211 0 CA-C-O 121.175 0.512 . . . . 0.0 111.242 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.93 94.41 1.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.6 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.561 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -45.56 165.47 0.17 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.978 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.5 -47.22 4.4 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.769 2.313 . . . . 0.0 112.809 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.78 63.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.488 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.87 -33.47 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -68.55 -49.58 58.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -58.51 -55.31 36.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.12 -40.77 95.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.759 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.11 -42.94 73.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 110.919 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -29.7 59.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -79.51 -24.42 42.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.8 mt -91.41 -28.85 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.745 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.88 34.5 6.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.073 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -117.84 147.15 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -82.22 101.15 10.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.101 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.89 -33.19 7.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.168 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -34.94 79.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.44 -18.68 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -96.94 88.08 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.271 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.74 98.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.1 142.16 35.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 11.23 12.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.92 153.35 49.88 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.718 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -45.56 112.91 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.129 2.552 . . . . 0.0 112.775 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.11 10.56 57.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.334 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.636 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.41 22.05 55.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.774 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.561 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -87.23 124.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 117.181 0.49 . . . . 0.0 111.207 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.7 pt -63.58 111.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 52.5 p -75.32 156.57 35.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.662 0.744 . . . . 0.0 111.89 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -41.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.941 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 164' ' ' LYS . 3.3 mt-10 -63.62 -27.84 69.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.304 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 78.1 m-20 -70.82 -52.1 22.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.099 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.24 -48.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.503 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.286 -179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 p -131.18 143.34 50.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.803 0.335 . . . . 0.0 110.943 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -99.7 22.69 10.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.026 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 56.57 169.63 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.018 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -77.79 125.96 37.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.831 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -97.97 151.79 19.93 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.019 0.438 . . . . 0.0 111.293 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.413 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.23 95.07 2.01 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.673 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.458 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -46.31 167.42 0.14 Allowed Pre-proline 0 CA--C 1.533 0.298 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.02 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.415 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.0 Cg_exo -65.92 -48.5 2.81 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.816 2.344 . . . . 0.0 112.944 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -49.03 70.53 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.506 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.34 -34.19 70.28 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.857 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.413 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.3 OUTLIER -67.99 -46.41 71.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.309 179.405 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.4 ttt-85 -60.11 -56.0 27.03 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.892 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.82 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.41 -40.72 95.44 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.631 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.738 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.81 -39.61 74.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.891 0.377 . . . . 0.0 110.855 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.03 -29.83 55.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.115 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -81.93 -25.35 34.98 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.518 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.4 mt -90.52 -28.58 18.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.714 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 82.14 41.64 9.27 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.933 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.42 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.61 127.38 75.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.79 0.328 . . . . 0.0 110.949 -179.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -58.94 103.12 0.15 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.865 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.59 -40.45 79.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.073 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.52 -49.88 71.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.192 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.46 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.08 -28.24 62.43 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 178.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 149' ' ' VAL . 49.7 t -83.54 85.29 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 CA-C-N 115.562 -0.744 . . . . 0.0 109.992 178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.8 ttmm -50.92 92.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.338 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.638 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -65.49 141.98 43.41 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.928 -0.654 . . . . 0.0 112.796 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 13.41 13.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.696 0.284 . . . . 0.0 111.146 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.456 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.5 154.98 50.92 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.727 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_exo -44.72 106.83 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.022 2.481 . . . . 0.0 112.871 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.96 18.95 25.61 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.248 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.1 22.13 74.53 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.668 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.471 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.79 124.6 40.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 117.035 0.418 . . . . 0.0 111.053 -179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.865 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.2 pt -64.3 111.32 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.538 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 81.0 p -75.16 156.51 35.82 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.443 0.64 . . . . 0.0 111.439 -177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.466 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.28 -43.29 60.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.1 -179.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -63.98 -27.66 69.28 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.1 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.538 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -69.99 -48.17 59.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.579 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.82 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.81 -41.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.734 -179.806 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -58.91 -48.43 81.47 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.952 0.406 . . . . 0.0 111.034 -179.678 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 28.7 ptt180 -68.42 -42.64 78.64 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.297 -179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.613 ' O ' HG23 ' A' ' 170' ' ' THR . 1.6 t-105 -65.4 -49.16 70.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.656 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.94 -43.85 94.64 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.544 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.41 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 11.6 pt-20 -64.13 -36.32 83.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.717 0.294 . . . . 0.0 110.851 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.91 -44.98 91.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.138 0.494 . . . . 0.0 110.48 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 166' ' ' TRP . 10.6 p -54.97 -52.06 64.24 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.738 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.4 -26.57 64.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.0 110.292 179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.15 -34.42 78.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.596 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.31 113.31 2.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.164 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -106.19 -31.39 8.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.209 -0.9 . . . . 0.0 111.129 179.936 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.506 -0.238 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 16.7 m 60.54 177.98 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.912 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 111.65 24.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.4 mm-40 -65.62 -57.06 9.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.824 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.83 88.5 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.898 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.622 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -80.39 149.89 30.03 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.042 0.449 . . . . 0.0 110.853 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -152.11 94.64 1.97 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.8 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.494 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -45.08 163.6 0.2 Allowed Pre-proline 0 N--CA 1.465 0.286 0 CA-C-O 120.661 0.267 . . . . 0.0 110.818 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_exo -65.57 -49.83 2.19 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.767 2.311 . . . . 0.0 112.804 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -48.3 71.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.587 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.17 -34.9 75.66 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.291 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 11.2 mtt180 -69.6 -49.5 53.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.519 179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -57.03 -55.64 32.06 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.918 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.826 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.74 -39.54 89.08 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.503 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.02 -41.11 74.41 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.995 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -30.09 55.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.083 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -82.93 -18.71 39.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.832 0.348 . . . . 0.0 111.36 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -98.66 -28.84 13.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.885 -179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.85 35.16 11.74 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.047 -179.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.992 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -108.73 125.8 65.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.731 0.301 . . . . 0.0 110.578 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -60.32 101.07 0.11 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.584 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.69 -45.58 89.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.836 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -52.79 -48.58 66.77 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.26 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.38 -33.44 67.82 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.516 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.921 HG13 ' NE1' ' A' ' 166' ' ' TRP . 55.1 t -79.37 82.81 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.856 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.82 92.48 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.137 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.02 139.46 43.44 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.032 -0.604 . . . . 0.0 113.356 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.4 13.86 13.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.777 0.322 . . . . 0.0 110.648 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -77.22 157.28 46.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.783 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -44.34 106.14 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.129 2.552 . . . . 0.0 112.904 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.71 20.11 22.8 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.304 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.622 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.05 22.16 77.09 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.612 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.507 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.51 125.62 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 117.122 0.461 . . . . 0.0 111.331 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.0 pt -62.21 111.1 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 30.6 p -74.98 156.26 36.48 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.441 0.639 . . . . 0.0 111.641 -177.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.6 OUTLIER -55.26 -39.18 50.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 115.13 -0.941 . . . . 0.0 111.588 -178.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.474 ' O ' ' CG ' ' A' ' 165' ' ' ARG . 3.4 mt-10 -67.45 -30.54 70.29 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.94 179.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' O ' ' HD1' ' A' ' 166' ' ' TRP . 93.6 m-20 -65.37 -57.99 6.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.439 0.637 . . . . 0.0 110.1 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.992 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -56.68 -42.61 77.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.395 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.565 -179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.49 -35.4 75.83 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.474 ' CG ' ' O ' ' A' ' 161' ' ' GLU . 5.7 mmt85 -65.91 -49.87 66.48 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.615 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 1.071 ' O ' HG23 ' A' ' 170' ' ' THR . 14.5 m95 -73.9 -50.97 17.7 Favored 'General case' 0 CA--C 1.508 -0.672 0 C-N-CA 119.519 -0.872 . . . . 0.0 109.84 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.543 ' N ' HG13 ' A' ' 144' ' ' ILE . . . -50.1 -34.38 21.73 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.852 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 5.3 pt-20 -77.47 -36.99 52.32 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.773 177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.469 ' HA ' ' HB2' ' A' ' 172' ' ' LYS . 0.1 OUTLIER -74.26 -42.42 59.68 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.868 179.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.071 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.3 p -53.52 -52.14 60.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.975 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.83 -29.11 61.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.131 0.491 . . . . 0.0 110.461 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.469 ' HB2' ' HA ' ' A' ' 169' ' ' GLU . 13.1 mmtt -61.12 -33.4 73.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.591 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -71.35 108.16 4.67 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.164 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 22.3 p 53.22 79.1 0.13 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.102 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.065 -179.917 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 N-CA-C 112.512 -0.235 . . . . 0.0 112.512 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m 61.18 31.78 19.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.814 0.34 . . . . 0.0 110.922 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -114.14 -59.39 2.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.856 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -129.98 132.71 46.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.43 111.46 23.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.032 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.591 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.92 151.98 19.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.949 0.404 . . . . 0.0 110.87 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.409 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -150.22 95.46 2.27 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.84 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 11.4 ptp -48.33 166.26 0.22 Allowed Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.966 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -65.89 -47.65 3.56 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.878 2.386 . . . . 0.0 112.972 -179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.16 -50.9 65.93 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.0 0.429 . . . . 0.0 111.361 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.49 75.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.096 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.4 OUTLIER -67.83 -48.58 65.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.231 0.539 . . . . 0.0 110.423 179.558 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 11.9 ttm-85 -57.77 -55.94 28.37 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.037 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.18 -41.59 97.06 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.63 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.75 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.06 -38.44 70.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.916 0.388 . . . . 0.0 110.918 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -31.35 56.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.006 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -81.91 -21.43 37.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.002 0.429 . . . . 0.0 111.041 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -94.8 -28.8 15.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.601 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.03 42.8 10.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.856 -179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.541 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.16 129.23 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.715 0.293 . . . . 0.0 111.057 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -56.52 101.07 0.05 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.909 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.664 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.39 -42.58 92.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.822 0.344 . . . . 0.0 110.767 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.38 -48.53 78.82 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.992 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -58.8 -25.72 63.41 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.537 HG22 ' CG ' ' A' ' 166' ' ' TRP . 40.3 t -85.78 85.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.135 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.2 tppt? -50.9 100.97 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.348 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.642 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -74.63 141.62 28.82 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.94 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.58 12.92 13.3 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 120.645 0.26 . . . . 0.0 111.155 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.438 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.43 156.67 53.4 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.854 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -44.68 104.4 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 123.103 2.535 . . . . 0.0 112.907 -179.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.7 22.11 14.77 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.168 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.591 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.35 22.18 78.95 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.61 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.74 124.66 40.59 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.064 -179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.664 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.4 pt -63.61 111.49 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.2 p -75.25 156.57 35.56 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.648 0.737 . . . . 0.0 111.624 -177.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.449 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.93 -42.83 55.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.118 -179.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -64.57 -27.61 69.07 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.121 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 64.0 m-20 -69.5 -49.15 57.35 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.727 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.35 -46.83 69.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.871 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 5.4 mttp -56.68 -46.09 81.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.359 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 8.9 ptm180 -68.26 -41.33 81.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.537 ' CG ' HG22 ' A' ' 149' ' ' VAL . 1.3 t-105 -65.42 -49.62 68.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.488 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -61.29 -48.92 79.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.33 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -60.58 -36.37 78.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.895 0.378 . . . . 0.0 110.739 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -61.91 -27.44 68.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.987 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 166' ' ' TRP . 5.9 p -68.71 -52.01 35.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.694 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.21 -24.3 43.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.69 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.39 -29.11 64.55 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.887 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -55.37 -68.45 0.19 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.301 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 81.8 p -123.73 -74.84 0.6 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.957 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.19 -0.91 . . . . 0.0 111.141 179.972 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.173 0 N-CA-C 112.532 -0.227 . . . . 0.0 112.532 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 p -100.7 -34.53 9.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.884 0.374 . . . . 0.0 110.899 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.36 124.51 29.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.892 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -65.62 144.64 56.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.88 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.55 98.17 7.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.13 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.617 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -81.83 151.55 27.31 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.981 0.419 . . . . 0.0 110.715 179.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' CB ' HG12 ' A' ' 158' ' ' ILE . . . -152.59 95.14 1.98 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.825 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 14.3 ptm -46.42 164.64 0.21 Allowed Pre-proline 0 CA--C 1.532 0.267 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.853 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -65.6 -49.29 2.47 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.774 2.316 . . . . 0.0 112.789 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.14 -49.12 69.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.407 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.598 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.2 -34.46 74.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.337 -179.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -69.31 -49.33 56.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.671 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 38.7 ttt180 -57.79 -55.39 35.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.897 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.62 -38.66 85.46 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.396 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.74 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.09 -40.51 77.11 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.867 0.365 . . . . 0.0 110.855 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.7 ttpp -76.72 -29.82 56.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.13 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -85.11 -16.59 40.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.442 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -99.77 -28.82 12.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.961 -179.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.89 36.66 10.0 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.916 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 1.003 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -111.36 126.41 68.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.772 0.32 . . . . 0.0 110.634 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.465 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 3.2 t0 -61.78 100.95 0.17 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.457 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.863 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -58.29 -44.87 88.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.332 . . . . 0.0 110.904 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.33 -49.39 67.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.155 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.465 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.35 -33.37 65.59 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 178.375 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.934 HG13 ' NE1' ' A' ' 166' ' ' TRP . 54.8 t -79.34 84.21 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.084 179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -50.96 91.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.917 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.539 ' CA ' ' HA ' ' A' ' 158' ' ' ILE . . . -56.31 138.22 46.2 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.847 -0.692 . . . . 0.0 113.241 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.37 13.9 13.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.734 0.302 . . . . 0.0 110.801 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.463 ' HA3' HG23 ' A' ' 159' ' ' THR . . . -76.28 159.09 49.97 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_exo -43.85 102.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.166 2.577 . . . . 0.0 112.953 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.91 23.16 11.96 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.192 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.617 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.45 22.19 79.06 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.633 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.497 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.1 m -85.56 125.15 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 C-N-CA 120.676 -0.41 . . . . 0.0 111.228 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.863 HD13 ' HB1' ' A' ' 146' ' ' ALA . 11.4 pt -61.04 110.9 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.436 -0.949 . . . . 0.0 108.436 178.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.496 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 24.2 p -75.19 156.54 35.73 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.337 0.589 . . . . 0.0 111.6 -177.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.62 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.24 -40.47 56.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.423 -178.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -65.67 -28.31 69.0 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.13 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.61 ' O ' ' CD1' ' A' ' 166' ' ' TRP . 95.7 m-20 -68.91 -58.03 4.71 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.485 0.66 . . . . 0.0 109.821 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.003 HG12 HG21 ' A' ' 144' ' ' ILE . 0.1 OUTLIER -57.38 -41.17 77.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.38 -179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -58.43 -45.38 88.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.908 179.819 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.55 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -62.61 -47.37 84.09 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.313 0.486 . . . . 0.0 112.313 -178.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 1.099 ' O ' HG23 ' A' ' 170' ' ' THR . 19.5 m95 -72.78 -50.96 21.05 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 119.222 -0.991 . . . . 0.0 109.92 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.516 ' N ' HG13 ' A' ' 144' ' ' ILE . . . -50.18 -35.11 24.91 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.213 -178.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.437 ' HG3' ' N ' ' A' ' 169' ' ' GLU . 15.7 pt-20 -77.62 -38.26 48.44 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.438 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 41.0 mt-10 -76.95 -26.84 54.47 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.418 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 1.099 HG23 ' O ' ' A' ' 166' ' ' TRP . 29.0 p -62.87 -52.13 64.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.752 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.46 -26.32 51.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.497 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.438 ' HB3' ' HA ' ' A' ' 169' ' ' GLU . 8.1 tttt -65.54 -36.14 82.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.777 179.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.57 69.09 5.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.23 164.49 20.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.905 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.071 179.947 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 m -79.39 80.5 5.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.801 0.334 . . . . 0.0 110.956 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -125.85 -65.07 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.909 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -118.78 -40.42 2.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.959 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -91.12 102.55 13.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.038 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.62 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.71 149.6 21.98 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.035 0.445 . . . . 0.0 110.962 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -151.31 94.55 2.04 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.638 179.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.426 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.9 ptm -47.11 167.77 0.15 Allowed Pre-proline 0 CA--C 1.533 0.324 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.928 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.426 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.5 Cg_exo -65.7 -45.78 6.09 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.837 2.358 . . . . 0.0 113.02 -178.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.28 -52.45 61.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.396 -179.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.649 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.47 -32.97 72.2 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.915 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.79 -46.73 71.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.24 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 21.9 tpt180 -59.67 -55.5 33.65 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.134 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.805 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.38 -42.11 99.16 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.773 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.69 -38.99 73.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.907 0.384 . . . . 0.0 110.971 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 1.3 mptt -76.87 -29.94 56.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.908 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -81.31 -25.31 36.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.056 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -90.29 -29.01 18.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.8 31.62 9.91 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.025 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.59 HD13 ' CG2' ' A' ' 149' ' ' VAL . 1.9 tt -111.81 146.56 16.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.94 0.37 . . . . 0.0 111.323 179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.9 OUTLIER -79.81 101.01 8.25 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.098 179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.986 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.22 -32.82 11.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.764 0.316 . . . . 0.0 110.942 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 45.2 t -63.75 -35.03 79.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.969 179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.453 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.64 -19.32 61.47 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 178.402 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.59 ' CG2' HD13 ' A' ' 144' ' ' ILE . 54.8 t -95.54 88.08 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.064 178.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -50.78 100.27 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.22 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.594 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.41 141.91 28.41 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.954 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.03 13.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.579 0.228 . . . . 0.0 111.088 179.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.475 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.83 153.91 50.57 Favored Glycine 0 CA--C 1.52 0.371 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.91 107.74 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.144 2.562 . . . . 0.0 112.811 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.72 18.41 27.77 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.205 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.62 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.38 22.08 73.93 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.659 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.475 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.44 124.63 40.49 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 CA-C-N 117.069 0.435 . . . . 0.0 110.883 -179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.986 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.8 pt -65.15 111.81 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.5 p -75.35 156.57 35.35 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.557 0.694 . . . . 0.0 111.586 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.46 -42.73 69.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.121 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.92 -27.73 69.58 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.982 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 159' ' ' THR . 92.0 m-20 -70.36 -51.72 27.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.54 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.805 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -69.52 -38.84 77.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.78 -179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 8.5 pttt -61.39 -49.88 75.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.166 -179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.415 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.1 OUTLIER -67.44 -35.83 80.0 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.014 -179.696 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 170' ' ' THR . 2.1 t-105 -71.96 -38.19 69.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.819 0.342 . . . . 0.0 111.071 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -72.52 -45.27 60.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.191 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -63.29 -41.32 98.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.762 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -53.58 -27.21 25.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.048 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 166' ' ' TRP . 5.1 p -73.2 -51.95 15.9 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.795 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.88 -30.44 63.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.62 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -30.68 71.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.656 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -83.64 115.35 22.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.121 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 68.8 p -104.98 -36.04 7.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.276 -0.869 . . . . 0.0 111.105 -179.97 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 112.558 -0.217 . . . . 0.0 112.558 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.68 -55.03 0.51 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.842 0.354 . . . . 0.0 110.855 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.11 -63.25 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.808 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -149.39 -81.82 0.11 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.88 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.8 t -118.77 119.32 60.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.616 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -96.86 150.09 21.12 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.978 0.418 . . . . 0.0 110.983 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.41 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.8 94.86 2.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.766 179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.517 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.5 ptp -46.82 167.08 0.16 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.028 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.404 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.3 Cg_exo -66.2 -48.04 2.9 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.904 2.403 . . . . 0.0 113.028 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -49.94 68.49 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.358 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.61 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.77 -34.57 73.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.028 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.41 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -67.34 -47.97 68.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.342 0.592 . . . . 0.0 110.369 179.446 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.1 tpt85 -58.6 -55.95 28.41 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.024 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.828 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.5 -41.54 97.44 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.699 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.746 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.39 -37.8 70.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.956 0.408 . . . . 0.0 110.792 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.4 tttp -77.12 -31.43 55.76 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.073 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -82.33 -21.74 35.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.021 0.438 . . . . 0.0 111.048 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.57 -28.23 16.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.679 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.77 42.0 11.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.875 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.484 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.71 127.19 75.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.326 . . . . 0.0 110.907 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.7 OUTLIER -57.82 101.07 0.07 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.612 179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.818 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.65 -40.82 80.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.001 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.43 -49.94 71.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.199 179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.447 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -56.9 -28.53 62.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.452 HG12 ' O ' ' A' ' 149' ' ' VAL . 50.6 t -83.2 85.82 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.806 178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.444 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 1.1 ptpp? -50.81 91.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.042 0.448 . . . . 0.0 111.814 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.679 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -59.08 138.51 49.51 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.69 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.46 15.09 13.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.862 0.363 . . . . 0.0 111.007 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.44 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.44 156.81 47.12 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.79 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -44.7 104.92 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 123.159 2.573 . . . . 0.0 112.907 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.64 20.98 17.73 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.225 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.616 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.23 22.14 78.06 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.63 -179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.517 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.54 123.62 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.197 0 CA-C-N 117.065 0.432 . . . . 0.0 111.189 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.818 HD13 ' HB1' ' A' ' 146' ' ' ALA . 9.1 pt -63.16 110.78 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.531 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.8 p -75.15 156.51 35.84 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.497 0.665 . . . . 0.0 111.522 -177.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.452 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.23 -42.82 58.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.397 -0.819 . . . . 0.0 111.156 -179.177 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -64.83 -27.52 68.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.138 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.531 ' HB2' ' O ' ' A' ' 159' ' ' THR . 82.4 m-20 -70.0 -48.7 57.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.721 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.828 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.07 -46.08 68.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.827 -179.747 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 6.3 mtmt -58.6 -46.56 86.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.562 -179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.406 ' HG3' ' O ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -70.19 -37.25 75.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.206 -179.673 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.693 ' O ' HG23 ' A' ' 170' ' ' THR . 1.9 t-105 -70.3 -46.18 64.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.592 -179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -66.98 -40.79 87.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.429 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -68.41 -39.36 81.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.388 . . . . 0.0 110.886 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -58.72 -29.97 67.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.018 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.693 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.2 p -68.34 -52.12 36.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.568 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -73.3 -24.61 60.42 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.747 179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 5.0 mttp -71.94 -31.32 66.23 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.899 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.14 -30.5 64.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.271 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -82.95 107.25 15.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.917 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.016 -179.96 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.27 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.67 -56.07 0.43 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.775 0.322 . . . . 0.0 110.861 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.419 ' O ' ' CG ' ' A' ' 128' ' ' GLU . 69.3 mtm180 -87.93 -28.46 21.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.978 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.419 ' CG ' ' O ' ' A' ' 127' ' ' ARG . 7.1 pt-20 48.24 -176.43 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.473 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 3.1 t -122.24 132.42 71.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.02 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.583 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.95 153.9 19.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.844 0.354 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.459 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -152.76 95.65 2.02 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.972 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . . . . . . . . . 7.4 ptp -46.35 166.75 0.16 Allowed Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.654 -0.248 . . . . 0.0 110.961 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -65.59 -48.54 3.06 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.861 2.374 . . . . 0.0 112.829 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -49.87 68.57 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.355 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.563 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.74 -35.02 74.63 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.203 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.459 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -66.95 -48.87 67.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.231 0.538 . . . . 0.0 110.509 179.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 7.1 ttt85 -58.93 -54.23 49.43 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.928 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.781 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.32 -39.76 95.45 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.487 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.763 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.49 -38.88 72.35 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.956 0.408 . . . . 0.0 110.729 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 73.0 tttt -76.98 -32.13 57.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.931 179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.99 -21.52 40.22 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.01 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.499 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.0 OUTLIER -93.23 -28.62 16.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.619 -179.943 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.16 40.71 11.06 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.876 -179.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.589 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.48 127.13 74.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-O 120.814 0.34 . . . . 0.0 110.904 -179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.418 ' N ' HD13 ' A' ' 144' ' ' ILE . 0.3 OUTLIER -59.06 101.02 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.61 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.908 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.63 -41.13 80.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.839 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.62 -50.2 68.66 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.199 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.461 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -56.9 -29.66 63.22 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 149' ' ' VAL . 51.1 t -82.07 83.99 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.093 178.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -50.94 91.34 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.852 0.358 . . . . 0.0 111.315 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.531 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -60.6 142.47 48.1 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.009 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.91 13.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.755 0.312 . . . . 0.0 110.842 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.45 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -74.92 156.75 49.6 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.7 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_exo -43.74 103.53 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.125 2.55 . . . . 0.0 112.876 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.13 23.41 11.43 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.159 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.583 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.56 22.15 78.67 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.679 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.47 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.5 125.31 40.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.981 0.39 . . . . 0.0 111.001 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.908 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.9 pt -63.74 111.69 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 63.4 p -75.16 156.52 35.83 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.521 0.677 . . . . 0.0 111.474 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.493 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.98 -42.19 53.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.247 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.428 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 2.9 mm-40 -65.81 -27.75 68.49 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.069 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 83.2 m-20 -68.79 -46.73 67.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.31 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.781 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.96 -42.19 52.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.498 -179.874 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.28 -47.9 84.05 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.704 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 73.8 mtp180 -73.68 -41.85 62.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.571 -179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.519 ' O ' HG23 ' A' ' 170' ' ' THR . 2.0 t90 -67.1 -45.08 78.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.321 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.64 -47.09 70.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.317 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.5 pt-20 -60.75 -37.7 82.71 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.908 0.385 . . . . 0.0 110.721 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -30.67 67.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.954 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 166' ' ' TRP . 7.0 p -68.49 -52.08 36.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.745 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.12 -28.45 66.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.49 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.22 -31.53 72.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.631 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.16 115.76 21.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.5 t -147.46 121.94 9.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.161 180.0 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.4 p -158.1 146.56 18.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.766 0.317 . . . . 0.0 110.905 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 149.33 35.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.907 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -77.73 -80.08 0.11 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.922 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -88.49 100.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.88 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.635 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.47 148.09 22.85 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.092 0.472 . . . . 0.0 111.216 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 136' ' ' ARG . . . -150.66 94.1 2.05 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.59 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.512 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 18.3 ptp -46.28 166.46 0.16 Allowed Pre-proline 0 CA--C 1.533 0.32 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.089 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 20.9 Cg_exo -66.36 -48.43 2.45 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.938 2.425 . . . . 0.0 112.977 -178.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.26 -48.69 70.9 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.515 -179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.623 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -70.25 -35.09 73.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.089 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.422 ' CZ ' ' HB3' ' A' ' 131' ' ' ALA . 26.2 mtt-85 -67.81 -47.27 69.56 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.302 0.572 . . . . 0.0 110.24 179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -58.04 -56.64 19.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.88 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.855 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.27 -40.74 95.22 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.594 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.63 -39.72 71.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.835 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.08 -31.71 56.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.971 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -80.77 -20.65 42.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.093 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.492 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -96.19 -28.82 14.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.717 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 81.85 40.91 10.09 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.149 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.502 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.35 126.96 74.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 120.721 0.296 . . . . 0.0 110.916 -179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.33 101.15 0.07 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.676 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.4 -40.41 78.21 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.857 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.09 -49.91 70.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.196 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.508 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.52 -28.5 63.53 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 149' ' ' VAL . 52.8 t -83.75 84.52 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.154 178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.8 ptpt -50.87 96.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.944 0.402 . . . . 0.0 111.408 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.624 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.59 141.96 44.83 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.49 12.01 13.11 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.647 0.26 . . . . 0.0 111.113 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.461 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.75 155.66 51.21 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.779 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -44.76 106.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 123.123 2.549 . . . . 0.0 112.905 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.05 19.19 24.7 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.159 -179.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.635 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 75.66 22.17 75.54 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.629 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.512 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.22 123.51 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-N 117.064 0.432 . . . . 0.0 111.177 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 12.6 pt -63.12 110.93 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.523 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.2 p -75.14 156.54 35.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.526 0.679 . . . . 0.0 111.724 -177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.459 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.14 -42.92 58.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.166 -0.925 . . . . 0.0 111.231 -179.126 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.88 -27.75 69.07 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.15 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.523 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.4 m-20 -69.54 -48.95 58.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.604 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.855 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -71.09 -46.11 68.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.817 -179.929 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -45.41 82.93 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.487 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.402 ' O ' ' HG2' ' A' ' 168' ' ' GLU . 2.3 ptm180 -69.69 -43.48 72.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.866 0.365 . . . . 0.0 111.277 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.508 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 1.7 t-105 -65.45 -49.84 67.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.551 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.11 -45.92 75.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.574 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.402 ' HG2' ' O ' ' A' ' 165' ' ' ARG . 10.6 pt-20 -59.98 -38.74 83.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.86 0.362 . . . . 0.0 110.797 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -59.58 -27.73 66.53 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.915 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.455 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.1 p -69.74 -52.12 28.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.745 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.74 -28.51 65.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.562 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.22 -31.65 72.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.639 179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -84.7 -68.85 0.69 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.1 p -62.47 130.42 45.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.924 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.199 -0.905 . . . . 0.0 111.1 179.971 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.499 -0.24 . . . . 0.0 112.499 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 34.6 m 59.41 27.5 16.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.753 0.311 . . . . 0.0 111.009 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 15.6 mmt180 -113.29 -29.03 7.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.016 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 62.73 156.87 0.06 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.819 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -83.21 106.85 14.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.948 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.576 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -90.67 150.73 21.55 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.903 0.383 . . . . 0.0 110.843 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.501 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.48 94.6 2.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.894 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 15.9 ptp -46.74 166.78 0.17 Allowed Pre-proline 0 N--CA 1.464 0.263 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.975 -179.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.401 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.6 Cg_exo -66.25 -47.36 3.37 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.84 2.36 . . . . 0.0 112.772 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -51.13 65.64 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.455 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.622 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.59 -33.75 73.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.959 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.501 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 9.0 mmm180 -68.32 -47.82 66.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.415 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.7 ttm180 -59.01 -56.02 27.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.027 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.831 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.0 -40.57 94.05 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.676 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.741 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.28 -41.65 76.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.37 . . . . 0.0 110.871 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -75.77 -29.95 58.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -79.87 -26.9 40.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.049 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.7 mt -89.02 -29.01 19.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.872 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.13 33.9 7.46 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.661 -0.78 . . . . 0.0 113.238 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 149' ' ' VAL . 2.1 tt -115.81 146.88 19.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.86 0.362 . . . . 0.0 111.306 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.448 ' N ' HG12 ' A' ' 144' ' ' ILE . 1.0 OUTLIER -79.93 100.92 8.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.142 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.976 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.39 -32.87 12.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.869 0.366 . . . . 0.0 110.846 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -62.94 -35.07 78.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.958 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.436 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.82 -20.39 61.15 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 178.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 144' ' ' ILE . 53.8 t -95.55 87.03 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.136 178.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.433 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.9 OUTLIER -50.76 107.52 0.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.107 0.48 . . . . 0.0 111.402 -179.331 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.562 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -76.1 140.59 25.86 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.927 -0.654 . . . . 0.0 113.274 -179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 13.66 13.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.74 0.305 . . . . 0.0 110.839 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.35 156.07 46.35 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.869 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -44.37 106.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 123.098 2.532 . . . . 0.0 112.892 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 19.55 23.53 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.208 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.576 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.99 22.21 77.15 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.66 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.464 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.87 124.77 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 CA-C-N 117.023 0.412 . . . . 0.0 111.033 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.976 HD13 ' HB1' ' A' ' 146' ' ' ALA . 21.3 pt -64.17 111.72 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 178.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.558 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 49.3 p -75.32 156.54 35.45 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.625 0.726 . . . . 0.0 111.732 -177.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -42.78 65.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.924 -179.342 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.51 -27.68 69.43 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.035 179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.558 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.5 m-20 -69.69 -49.33 54.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.505 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.831 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.21 -40.71 66.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.916 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.421 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -59.02 -50.23 74.88 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.165 -179.601 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.421 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -67.44 -39.93 85.4 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.862 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.658 ' O ' HG23 ' A' ' 170' ' ' THR . 1.9 t-105 -66.71 -37.37 84.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.083 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -74.52 -48.52 26.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.292 -179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.417 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 22.4 pt-20 -58.62 -37.26 75.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.964 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.25 -44.74 88.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.131 0.491 . . . . 0.0 110.542 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.5 p -58.93 -52.24 66.62 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.781 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.45 -28.61 66.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.272 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 6.8 mttt -62.93 -31.34 72.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.622 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -82.75 98.12 8.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.057 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.31 -33.03 17.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.905 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.109 -179.966 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.5 m -96.58 110.3 22.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.853 0.358 . . . . 0.0 110.84 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.66 30.88 6.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.908 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.67 179.4 5.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.56 122.6 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.955 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -93.7 153.07 18.54 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.916 0.388 . . . . 0.0 110.952 179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.74 95.38 2.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.808 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.527 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.3 ptp -47.02 167.25 0.17 Allowed Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.909 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.408 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.2 Cg_exo -65.88 -48.08 3.2 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.827 2.351 . . . . 0.0 112.906 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.13 67.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.442 -179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.645 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.64 -34.16 73.65 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.178 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -68.46 -47.94 65.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.382 0.61 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.37 -55.92 28.58 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.183 -0.917 . . . . 0.0 110.913 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.845 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.1 pp -61.97 -41.27 97.82 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.639 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.731 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.06 -40.38 70.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.863 0.364 . . . . 0.0 111.017 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.07 -31.46 56.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.989 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -80.45 -21.54 41.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.92 0.39 . . . . 0.0 111.015 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -95.92 -28.68 14.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.664 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.02 42.64 10.65 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.866 -179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.503 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.26 129.7 73.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.717 0.294 . . . . 0.0 111.037 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 15.8 t0 -57.07 101.03 0.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.893 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.772 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.91 -42.85 94.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.687 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.79 -48.76 77.19 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.447 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.97 -27.33 63.35 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.507 HG22 ' CG ' ' A' ' 166' ' ' TRP . 42.2 t -84.17 85.89 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.013 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.72 95.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.646 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.654 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.6 140.92 32.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.651 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.57 13.83 13.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.706 0.289 . . . . 0.0 111.143 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.4 156.21 53.26 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.809 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -44.69 105.0 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 123.14 2.56 . . . . 0.0 112.891 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.45 21.45 17.03 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.155 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.8 22.1 78.56 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.62 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.527 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -86.84 125.19 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 117.139 0.47 . . . . 0.0 111.014 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.772 HD13 ' HB1' ' A' ' 146' ' ' ALA . 10.7 pt -64.35 111.22 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 178.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.525 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 82.1 p -75.07 156.56 35.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.411 0.624 . . . . 0.0 111.454 -177.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.46 -42.38 58.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.113 -179.25 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.404 ' HG2' ' NZ ' ' A' ' 164' ' ' LYS . 14.3 mt-10 -64.07 -27.65 69.24 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.1 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.0 m-20 -70.91 -49.6 44.03 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.897 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.845 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.28 -43.49 78.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.972 -179.684 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -60.15 -49.43 77.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.857 0.36 . . . . 0.0 110.881 -179.663 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.408 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 17.5 ptt180 -62.95 -41.48 99.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.924 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.507 ' CG ' HG22 ' A' ' 149' ' ' VAL . 1.4 t-105 -67.39 -48.34 67.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.599 -179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.36 -44.33 71.79 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.393 -179.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -61.35 -40.63 94.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.876 0.369 . . . . 0.0 110.832 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -57.31 -29.24 63.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.995 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.471 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.7 p -66.61 -52.08 49.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.55 -27.06 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.748 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.35 -35.16 79.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.894 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -81.81 92.9 6.74 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.081 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.7 p -91.4 168.63 11.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.908 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.241 -0.885 . . . . 0.0 111.097 179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.476 -0.249 . . . . 0.0 112.476 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.3 m -159.57 31.31 0.19 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.854 0.359 . . . . 0.0 110.914 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.434 ' O ' ' CB ' ' A' ' 128' ' ' GLU . 7.8 ttm180 -172.9 127.1 0.47 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.868 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.434 ' CB ' ' O ' ' A' ' 127' ' ' ARG . 18.2 tt0 83.55 -16.3 0.56 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.671 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.89 122.32 26.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.741 0.305 . . . . 0.0 111.022 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -100.29 152.02 20.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.918 0.389 . . . . 0.0 111.004 179.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.462 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -150.51 94.77 2.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.796 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.412 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 13.2 ptp -46.48 166.92 0.16 Allowed Pre-proline 0 CA--C 1.532 0.288 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.061 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.412 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 21.7 Cg_exo -66.06 -48.31 2.83 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.819 2.346 . . . . 0.0 112.836 -178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.27 -48.24 71.42 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.469 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.655 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -71.93 -34.27 68.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.938 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.462 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 2.7 mmm180 -68.69 -45.89 70.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.241 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.6 ttm-85 -60.28 -55.66 30.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.953 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.824 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -61.54 -40.48 94.81 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.488 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.7 -37.51 73.63 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.903 0.383 . . . . 0.0 110.743 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -31.21 55.59 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.959 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -81.28 -25.4 36.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.936 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.531 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -91.62 -28.77 17.29 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.635 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.6 42.94 9.58 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.933 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.454 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.86 129.95 73.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.791 0.329 . . . . 0.0 111.063 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.482 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -60.03 101.08 0.11 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.765 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.911 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.87 -40.0 79.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.932 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.38 -49.25 74.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.418 -0.356 . . . . 0.0 110.135 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.482 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -58.27 -26.76 63.34 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.564 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 149' ' ' VAL . 45.7 t -84.52 85.82 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.88 178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.67 94.64 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.566 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.615 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -64.22 144.64 48.87 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.647 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -118.43 1.35 11.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.612 0.244 . . . . 0.0 111.163 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.459 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -62.14 152.5 43.64 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.457 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.496 ' O ' HG13 ' A' ' 157' ' ' VAL . 86.5 Cg_exo -44.54 118.68 1.89 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 123.043 2.495 . . . . 0.0 112.983 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 91.94 0.09 72.13 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.543 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 95.25 22.16 23.08 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.628 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 154' ' ' PRO . 1.2 m -87.49 125.62 41.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 CA-C-N 117.089 0.444 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.911 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.0 pt -64.74 111.48 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.512 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 69.2 p -75.15 156.5 35.86 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.59 0.71 . . . . 0.0 111.588 -177.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.498 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.62 -41.96 58.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.225 -0.898 . . . . 0.0 111.273 -179.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.499 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.4 OUTLIER -64.61 -27.86 69.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.939 179.394 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.3 m-20 -69.3 -47.09 65.53 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.273 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.824 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -76.0 -34.23 26.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.091 -179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 160' ' ' VAL . 0.0 OUTLIER -64.08 -48.55 75.77 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.952 0.406 . . . . 0.0 110.885 -179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.499 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 7.6 mtt180 -72.38 -41.29 66.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.279 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.706 ' O ' HG23 ' A' ' 170' ' ' THR . 1.9 t-105 -68.73 -43.67 75.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.573 -179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.59 -38.43 74.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.51 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 12.2 pt-20 -69.09 -36.86 78.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.984 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.411 ' HA ' ' HB3' ' A' ' 172' ' ' LYS . 0.2 OUTLIER -58.93 -44.49 91.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.171 0.51 . . . . 0.0 110.664 179.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.706 HG23 ' O ' ' A' ' 166' ' ' TRP . 9.5 p -56.05 -52.17 65.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.967 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.64 -23.79 58.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.101 0.477 . . . . 0.0 110.296 179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . 0.411 ' HB3' ' HA ' ' A' ' 169' ' ' GLU . 2.3 tptm -69.49 -35.21 75.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.7 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -90.23 126.19 35.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.044 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 8.8 p -79.1 -45.89 19.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.126 179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.52 -0.232 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.4 p -106.41 31.47 5.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.833 0.349 . . . . 0.0 110.854 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -149.69 -171.31 3.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.765 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -136.22 150.7 49.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.002 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.3 t -94.12 135.02 29.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.905 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.605 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -86.14 154.77 21.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.059 0.456 . . . . 0.0 110.875 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 136' ' ' ARG . . . -154.68 96.33 1.87 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.904 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.614 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 11.8 ptp -45.36 165.68 0.16 Allowed Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.488 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.614 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 48.5 Cg_endo -71.61 -32.35 12.11 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 122.072 1.848 . . . . 0.0 112.507 -178.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.07 -51.5 63.78 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.749 179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.617 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.4 -35.02 75.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.13 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 131' ' ' ALA . 1.1 mtt180 -66.44 -48.56 69.58 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.323 0.582 . . . . 0.0 110.415 179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -57.79 -55.61 32.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.846 179.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.784 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.5 -41.31 98.73 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.601 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.749 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.59 -37.73 68.48 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.896 0.379 . . . . 0.0 110.841 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.12 -33.31 56.84 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.778 179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -79.98 -19.96 46.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.047 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.483 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.2 mt -96.7 -28.81 14.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.591 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.15 43.16 10.98 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.858 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -117.43 130.08 72.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.771 0.32 . . . . 0.0 111.058 -179.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.431 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 5.1 t70 -58.74 101.1 0.08 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.727 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.966 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.73 -41.63 91.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.767 0.317 . . . . 0.0 110.761 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -56.97 -49.05 76.89 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.929 -0.397 . . . . 0.0 109.929 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -57.6 -27.34 62.66 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 178.307 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.506 HG22 ' CG ' ' A' ' 166' ' ' TRP . 41.8 t -84.35 86.77 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.913 178.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 ttpp -50.73 92.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.561 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.548 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.02 139.88 36.99 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.683 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.48 14.29 13.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.728 0.299 . . . . 0.0 110.926 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.71 156.7 52.83 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.659 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -44.41 104.19 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.067 2.511 . . . . 0.0 112.863 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.55 22.46 14.21 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.211 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.605 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.05 22.08 79.34 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.669 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.3 m -86.11 125.43 40.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 CA-C-N 117.058 0.429 . . . . 0.0 111.074 -179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.966 HD13 ' HB1' ' A' ' 146' ' ' ALA . 16.7 pt -63.64 111.65 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.544 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 74.6 p -75.12 156.54 35.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.493 0.663 . . . . 0.0 111.555 -177.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.497 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.61 -42.62 61.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.144 -179.366 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.412 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 1.7 mt-10 -63.9 -27.68 69.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.876 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.544 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.3 m-20 -69.9 -46.94 64.36 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.362 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.784 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.83 -36.8 40.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.26 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.462 ' HG2' ' HG3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -63.35 -48.42 78.06 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.939 0.4 . . . . 0.0 110.908 -179.38 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.462 ' HG3' ' HG2' ' A' ' 164' ' ' LYS . 6.3 mtt85 -71.12 -39.69 71.89 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.46 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.649 ' O ' HG23 ' A' ' 170' ' ' THR . 1.6 t-105 -70.35 -50.07 42.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.322 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.56 99.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.438 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -66.14 -41.36 90.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.965 0.412 . . . . 0.0 110.941 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -57.61 -27.17 62.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.219 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 166' ' ' TRP . 2.7 p -71.91 -51.98 19.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.82 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.48 -28.75 66.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.591 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.1 -31.56 72.83 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.672 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -79.54 -68.73 0.64 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.096 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 25.1 p -77.26 179.77 6.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.086 179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.1 p -76.69 -31.3 57.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 110.967 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.83 -67.98 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.936 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -110.11 -175.14 2.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.941 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.11 115.1 13.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.953 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.61 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -81.1 151.23 28.42 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.946 0.403 . . . . 0.0 110.688 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -150.79 95.73 2.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.464 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.7 ptp -46.55 167.47 0.15 Allowed Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.746 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.4 Cg_exo -65.51 -47.99 3.65 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.713 2.275 . . . . 0.0 112.902 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.22 -50.82 66.25 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.99 0.424 . . . . 0.0 111.52 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.63 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.62 -33.01 72.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.223 -179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 26.1 mtt180 -69.75 -47.81 61.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.293 0.568 . . . . 0.0 110.325 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 3.2 ttp180 -57.51 -54.93 41.26 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.816 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.812 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.78 -41.09 99.09 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.56 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.733 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.15 75.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.939 0.399 . . . . 0.0 110.943 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.03 -29.95 55.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.703 179.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -83.49 -16.57 45.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.096 179.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.592 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -97.68 -28.84 13.72 Favored 'General case' 0 N--CA 1.454 -0.242 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.718 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 90.94 33.68 8.13 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.944 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.602 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.6 tt -116.44 147.2 19.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.907 0.384 . . . . 0.0 111.438 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.449 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.9 OUTLIER -81.15 101.01 9.38 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.804 179.185 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.96 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.81 -34.06 8.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.33 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 35.0 t -63.7 -35.72 81.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.885 0.374 . . . . 0.0 109.998 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -70.38 -19.93 62.99 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.422 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.602 ' CG2' HD13 ' A' ' 144' ' ' ILE . 48.2 t -93.63 87.94 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.055 178.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.2 tppp? -50.7 94.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.272 -179.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.605 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -74.38 143.35 31.57 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.868 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.23 13.44 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.713 0.292 . . . . 0.0 111.122 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.478 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.77 153.39 52.24 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.85 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -45.03 107.46 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.072 2.515 . . . . 0.0 112.848 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.09 18.64 26.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.263 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.61 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 76.16 21.96 74.71 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.643 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.478 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.66 125.89 40.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 C-N-CA 120.644 -0.422 . . . . 0.0 110.892 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.96 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.1 pt -66.5 111.73 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 75.2 p -75.1 156.51 35.96 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.513 0.673 . . . . 0.0 111.489 -177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -53.97 -42.97 56.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.07 -179.192 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -27.58 69.35 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.075 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 159' ' ' THR . 87.3 m-20 -70.83 -48.17 55.45 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.718 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.812 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -72.63 -41.9 62.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.743 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.428 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -59.46 -50.39 74.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.018 -179.633 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.428 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -65.11 -42.09 94.3 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.636 179.963 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.437 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.3 t-105 -65.4 -37.99 88.64 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.093 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.448 ' O ' HG23 ' A' ' 170' ' ' THR . . . -74.08 -53.89 8.99 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.339 -179.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -54.95 -38.19 67.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.054 -179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -56.66 -27.93 59.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.023 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.448 HG23 ' O ' ' A' ' 167' ' ' ALA . 3.4 p -70.66 -52.0 24.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.761 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.72 -29.6 63.49 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.64 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -64.17 -31.78 73.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.7 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.7 94.32 8.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.124 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 3.4 p -105.48 -31.42 9.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.949 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.213 -0.899 . . . . 0.0 111.141 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.161 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 72.2 m -91.81 110.78 22.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.858 0.361 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -113.46 31.77 6.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.884 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.03 -167.68 0.17 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.6 128.81 41.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.954 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -91.96 155.15 18.34 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.925 0.393 . . . . 0.0 110.827 179.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.57 95.69 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.971 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.689 ' HB2' ' HD2' ' A' ' 133' ' ' PRO . 18.4 ptm -46.65 167.89 0.14 Allowed Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.611 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.689 ' HD2' ' HB2' ' A' ' 132' ' ' MET . 49.2 Cg_endo -71.42 -33.56 10.82 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 122.112 1.874 . . . . 0.0 112.521 -178.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.08 -54.36 46.87 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.669 179.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.647 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.93 -33.16 71.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.69 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.2 mtp180 -67.15 -46.89 72.69 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.173 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.3 tpt180 -59.12 -55.58 33.21 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.731 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.766 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.7 -41.13 98.98 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.6 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.735 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.25 -39.66 76.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.881 0.372 . . . . 0.0 110.794 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.0 ttpt -76.46 -29.85 57.09 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.6 tp10 -81.1 -24.88 37.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.917 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -89.78 -28.89 19.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.701 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.99 30.45 12.82 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.967 179.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.574 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -110.52 146.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.912 0.386 . . . . 0.0 111.327 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.8 OUTLIER -78.94 100.92 7.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.861 179.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.018 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -49.81 -32.33 13.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.757 0.313 . . . . 0.0 111.039 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.82 -34.43 77.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.956 0.407 . . . . 0.0 109.93 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.46 -20.08 61.45 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.285 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.574 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -94.89 88.19 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.051 178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 9.3 ttpp -50.8 99.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.388 -179.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -76.64 140.57 25.34 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.17 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.52 12.97 13.36 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.616 0.246 . . . . 0.0 111.034 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.439 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -69.8 155.81 53.33 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.607 -0.806 . . . . 0.0 112.843 -179.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -44.81 105.72 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 123.136 2.558 . . . . 0.0 112.893 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.22 20.55 20.18 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.142 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.592 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 74.5 22.05 77.91 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.657 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.477 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.42 125.11 40.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 CA-C-N 117.109 0.454 . . . . 0.0 110.899 -179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.018 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.3 pt -63.89 111.74 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 178.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 66.9 p -75.3 156.52 35.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.587 0.708 . . . . 0.0 111.802 -177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.465 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -55.01 -41.8 60.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.92 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.84 -27.52 69.23 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.037 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.7 m-20 -71.26 -49.77 39.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.766 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -70.44 -41.6 78.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.76 -179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.425 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -61.36 -49.77 75.6 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.082 -179.541 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.425 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -66.03 -35.48 80.66 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.674 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.729 ' O ' HG23 ' A' ' 170' ' ' THR . 2.6 t-105 -70.59 -42.05 71.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.048 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -65.17 -44.03 89.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.218 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -66.28 -39.16 89.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -55.51 -45.43 77.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.137 0.494 . . . . 0.0 110.722 179.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.729 HG23 ' O ' ' A' ' 166' ' ' TRP . 11.6 p -55.37 -52.13 64.55 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.871 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.31 -24.0 61.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.47 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -37.49 80.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.789 179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -74.16 100.79 3.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.012 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 66.0 p -79.09 150.51 31.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.919 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.134 -179.989 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.33 -170.47 0.8 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.853 0.359 . . . . 0.0 110.827 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -156.91 103.74 2.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.925 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.4 -166.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.927 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.9 115.22 13.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.982 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.593 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -87.49 150.78 23.52 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.937 0.398 . . . . 0.0 110.834 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.46 ' HB1' ' HG2' ' A' ' 136' ' ' ARG . . . -149.47 95.26 2.32 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.907 179.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.421 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 9.3 ptp -46.04 167.57 0.13 Allowed Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.57 -0.286 . . . . 0.0 111.037 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.417 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 22.8 Cg_exo -65.52 -48.12 3.52 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.801 2.334 . . . . 0.0 112.83 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.457 ' HB3' HG22 ' A' ' 160' ' ' VAL . . . -54.24 -50.48 67.07 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.356 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.608 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -70.54 -34.61 72.46 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.887 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.46 ' HG2' ' HB1' ' A' ' 131' ' ' ALA . 10.2 mmt180 -66.79 -46.74 74.32 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.3 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 4.9 ttt180 -60.05 -56.48 21.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.329 -0.851 . . . . 0.0 111.078 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.777 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -60.94 -41.81 96.99 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.732 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.01 -40.08 75.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.902 0.382 . . . . 0.0 110.886 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -76.41 -29.76 57.19 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.878 179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -81.96 -22.56 36.57 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.105 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.638 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.6 mt -92.71 -28.88 16.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.829 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.1 30.09 10.64 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.104 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.599 HD13 ' CG2' ' A' ' 149' ' ' VAL . 2.1 tt -111.64 146.48 16.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.929 0.395 . . . . 0.0 111.335 179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.435 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.5 OUTLIER -80.5 100.99 8.83 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.065 179.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.977 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -48.06 -34.04 8.97 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.273 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 72.4 m -63.69 -34.49 77.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.055 179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.21 -19.73 61.68 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.204 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.599 ' CG2' HD13 ' A' ' 144' ' ' ILE . 53.1 t -94.95 88.61 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 CA-C-N 115.223 -0.898 . . . . 0.0 110.081 178.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -50.72 98.11 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.514 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.6 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -75.86 142.26 28.44 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.745 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 13.34 13.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.653 0.264 . . . . 0.0 111.096 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.469 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.29 153.79 51.16 Favored Glycine 0 CA--C 1.519 0.343 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.83 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -44.74 108.62 0.14 Allowed 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.145 2.563 . . . . 0.0 112.856 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.09 17.45 32.12 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.245 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.593 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 77.18 22.16 71.68 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.714 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.469 HG22 ' HA3' ' A' ' 153' ' ' GLY . 1.2 m -86.72 126.05 40.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 117.03 0.415 . . . . 0.0 110.935 -179.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.977 HD13 ' HB1' ' A' ' 146' ' ' ALA . 15.7 pt -66.94 111.69 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.54 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 62.5 p -75.11 156.56 35.9 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.415 0.626 . . . . 0.0 111.374 -177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.479 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.95 -42.46 63.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.061 -179.261 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 11.2 mt-10 -63.39 -27.68 69.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.958 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.54 ' HB2' ' O ' ' A' ' 159' ' ' THR . 88.6 m-20 -70.38 -53.84 14.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.648 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.777 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -65.34 -43.44 94.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.517 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -57.28 -48.4 79.0 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.816 -179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.499 ' HG3' ' N ' ' A' ' 166' ' ' TRP . 0.9 OUTLIER -63.13 -36.66 84.36 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.74 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.645 ' O ' HG23 ' A' ' 170' ' ' THR . 1.8 t-105 -70.94 -41.42 71.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.116 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -69.49 -48.74 59.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.168 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -61.13 -42.66 98.95 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.863 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -55.0 -27.93 48.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.038 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.645 HG23 ' O ' ' A' ' 166' ' ' TRP . 4.3 p -70.1 -52.02 27.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.911 0.386 . . . . 0.0 110.683 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.29 -27.06 60.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.742 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.38 -34.45 74.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.812 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -59.53 104.17 0.25 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.103 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 1.9 p -131.29 135.7 47.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.953 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.21 -0.9 . . . . 0.0 111.053 -179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.434 -0.266 . . . . 0.0 112.434 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.9 t -69.71 157.48 37.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.731 0.3 . . . . 0.0 110.923 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -84.19 -76.5 0.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.933 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -68.88 153.74 43.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.822 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 1.9 t -90.95 122.48 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.052 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.57 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -106.24 153.56 21.98 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.97 0.414 . . . . 0.0 110.888 179.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.572 ' HB3' ' NH1' ' A' ' 136' ' ' ARG . . . -150.18 95.95 2.35 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.881 179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.505 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 16.4 ptp -48.79 166.8 0.22 Allowed Pre-proline 0 CA--C 1.533 0.306 0 CA-C-N 116.728 -0.215 . . . . 0.0 110.791 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.8 -48.05 3.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.898 2.399 . . . . 0.0 112.962 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.17 -50.52 66.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.389 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.597 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.93 -34.51 75.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.165 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.572 ' NH1' ' HB3' ' A' ' 131' ' ' ALA . 0.5 OUTLIER -67.97 -48.79 64.86 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.312 0.577 . . . . 0.0 110.41 179.523 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -57.42 -55.59 32.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.981 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.825 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.2 pp -62.01 -41.24 97.85 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.566 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.748 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.28 -39.49 69.91 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.813 0.339 . . . . 0.0 110.929 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.2 mttp -77.07 -32.04 56.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.908 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -80.25 -19.61 46.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.939 0.399 . . . . 0.0 111.039 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.496 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.3 mt -97.7 -28.81 13.73 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.584 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.23 42.53 10.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.871 -0.681 . . . . 0.0 111.988 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.54 HG21 HG12 ' A' ' 163' ' ' VAL . 0.1 OUTLIER -117.19 129.25 74.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.743 0.306 . . . . 0.0 111.107 -179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.413 ' N ' HD13 ' A' ' 144' ' ' ILE . 2.9 t70 -57.34 101.15 0.06 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.832 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.808 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -59.63 -42.21 92.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.72 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.01 -48.47 78.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.301 -0.409 . . . . 0.0 109.98 179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.427 ' HD2' ' NE1' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -58.48 -26.93 63.94 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.432 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.519 HG22 ' CG ' ' A' ' 166' ' ' TRP . 41.7 t -84.5 85.9 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.15 178.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.0 ttpt -50.76 96.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.558 -179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.58 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.31 140.61 32.6 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.802 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.5 14.2 13.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.724 0.297 . . . . 0.0 110.979 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.494 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.76 161.5 54.26 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.746 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -44.84 101.48 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.421 2.748 . . . . 0.0 112.887 -179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 97.28 24.82 11.87 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.218 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.57 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.4 22.22 78.85 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.646 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.505 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -85.17 124.14 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 CA-C-N 117.097 0.448 . . . . 0.0 111.038 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.808 HD13 ' HB1' ' A' ' 146' ' ' ALA . 17.6 pt -63.23 111.36 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.555 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 71.7 p -75.19 156.51 35.75 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.483 0.658 . . . . 0.0 111.481 -177.594 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.17 -42.73 57.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.986 -179.284 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -64.02 -27.73 69.31 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.928 179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.555 ' HB2' ' O ' ' A' ' 159' ' ' THR . 89.4 m-20 -69.66 -48.04 61.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.517 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.825 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.29 -40.12 56.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.877 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.412 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 1.5 pttm -59.38 -48.41 81.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.896 0.379 . . . . 0.0 111.131 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.412 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 1.6 ppt_? -71.12 -39.64 71.92 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.524 -179.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.774 ' O ' HG23 ' A' ' 170' ' ' THR . 1.4 t-105 -69.11 -47.62 64.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.633 -179.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.67 -41.45 79.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.548 -179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 24.1 pt-20 -64.52 -41.87 96.12 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.891 0.377 . . . . 0.0 110.9 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -58.65 -30.93 67.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.958 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.774 HG23 ' O ' ' A' ' 166' ' ' TRP . 6.9 p -71.62 -51.82 21.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.663 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.39 -28.99 65.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.526 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -64.01 -31.34 72.5 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.691 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -70.19 -31.26 68.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.114 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 68.5 p -76.49 -65.69 0.9 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.915 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.282 -0.866 . . . . 0.0 111.096 179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.138 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -117.23 116.83 28.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.871 0.367 . . . . 0.0 110.877 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 10.7 ttm180 -90.36 -67.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.88 -44.96 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.853 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.1 t -85.8 118.81 33.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.841 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.606 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -95.32 151.61 19.11 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.108 0.48 . . . . 0.0 111.08 179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.69 95.25 2.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.681 179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.439 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 19.2 ptp -47.47 165.99 0.21 Allowed Pre-proline 0 CA--C 1.532 0.278 0 CA-C-O 120.63 0.253 . . . . 0.0 110.875 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.73 -47.71 3.68 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.819 2.346 . . . . 0.0 112.938 -178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.31 -50.13 68.07 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.496 -179.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -69.42 -34.11 73.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.226 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.96 -48.47 63.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.255 0.55 . . . . 0.0 110.398 179.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 25.3 ttm-85 -57.21 -55.14 38.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.9 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.806 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -61.66 -40.24 94.22 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.451 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.745 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.77 -36.83 70.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.828 0.347 . . . . 0.0 110.589 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -77.06 -33.2 57.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.872 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -80.64 -20.58 42.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.83 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.498 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.1 mt -95.62 -28.65 14.73 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.63 -179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.53 43.24 12.6 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.764 -0.731 . . . . 0.0 111.903 -179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.468 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.42 129.42 74.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.73 0.3 . . . . 0.0 111.06 -179.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.403 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.6 OUTLIER -59.54 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.677 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.889 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.64 -40.46 79.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.946 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.99 -49.93 72.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.218 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.469 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -57.24 -27.24 61.88 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 149' ' ' VAL . 46.1 t -84.3 85.69 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.168 178.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 11.7 ttpp -50.74 94.92 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.546 -179.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.59 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -67.69 140.42 36.68 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.741 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 12.95 13.41 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.678 0.275 . . . . 0.0 110.982 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.451 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -70.94 156.49 53.26 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.697 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -44.27 104.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.097 2.532 . . . . 0.0 112.861 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.93 22.16 14.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.275 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.606 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 73.36 22.18 78.94 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.603 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.49 124.68 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 CA-C-N 117.046 0.423 . . . . 0.0 111.068 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.889 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.8 pt -63.79 111.55 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.548 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 68.1 p -75.18 156.66 35.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.563 0.697 . . . . 0.0 111.684 -177.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.443 HG13 HD23 ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.1 -43.04 58.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.121 -179.215 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -65.06 -27.65 68.93 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.006 179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 159' ' ' THR . 81.9 m-20 -68.82 -46.99 67.17 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.425 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.806 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.35 -43.69 49.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.495 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -43.68 98.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.547 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -74.92 -40.12 61.03 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.26 -179.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.469 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 t-105 -68.05 -42.9 79.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.384 -179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -70.62 -47.18 61.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.374 -179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -60.94 -38.52 86.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.869 0.366 . . . . 0.0 110.823 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -58.01 -29.07 65.0 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.154 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 166' ' ' TRP . 3.4 p -68.56 -52.02 36.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.732 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.05 -23.78 58.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.794 179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 8.7 mttp -73.12 -28.02 62.03 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.037 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -54.34 104.61 0.11 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.265 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 12.0 p 55.27 102.28 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.08 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.284 -0.865 . . . . 0.0 111.036 179.974 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.578 -0.209 . . . . 0.0 112.578 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.4 m -155.01 -171.41 3.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.9 0.381 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.04 -58.45 3.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.833 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.69 158.22 21.9 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.839 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.0 t -84.66 117.84 30.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.98 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.585 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -97.25 152.5 18.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.966 0.413 . . . . 0.0 110.957 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.26 95.59 2.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.809 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.401 ' HG2' ' O ' ' A' ' 158' ' ' ILE . 6.0 ptp -47.21 166.17 0.19 Allowed Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.693 -0.231 . . . . 0.0 110.771 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo -66.1 -48.02 3.03 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 122.819 2.346 . . . . 0.0 112.912 -178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.2 -50.54 66.86 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.387 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.562 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -69.03 -34.92 76.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.238 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -67.45 -49.13 65.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.623 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -54.74 43.6 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.868 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.77 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -62.31 -39.9 94.54 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.541 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.755 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -57.85 -36.69 72.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.989 0.423 . . . . 0.0 110.67 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -77.03 -32.41 57.03 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.945 179.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.61 -20.84 35.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.922 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 138' ' ' LEU . 0.9 OUTLIER -93.6 -27.61 16.5 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.588 -179.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.34 42.63 18.09 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.803 -0.713 . . . . 0.0 111.736 -179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.564 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -116.84 132.56 66.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.695 0.283 . . . . 0.0 111.09 -179.564 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.473 ' N ' HD13 ' A' ' 144' ' ' ILE . 5.8 t70 -59.91 101.02 0.1 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.632 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.789 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -61.36 -41.93 97.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.881 0.372 . . . . 0.0 110.532 179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -56.96 -47.43 80.73 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.456 ' HD2' ' CE2' ' A' ' 166' ' ' TRP . 0.0 OUTLIER -59.21 -27.8 66.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 178.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.477 HG12 ' O ' ' A' ' 149' ' ' VAL . 43.0 t -83.8 85.9 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.82 178.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -50.83 90.53 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.711 -179.229 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.599 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -57.92 137.64 49.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.74 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.43 15.01 13.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.827 0.346 . . . . 0.0 110.911 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.425 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -76.65 158.03 48.24 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.754 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_exo -43.9 102.98 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 123.183 2.588 . . . . 0.0 112.836 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 98.96 23.35 11.67 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.269 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.585 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 72.36 22.14 79.05 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.63 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.478 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -86.25 124.61 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 CA-C-N 117.065 0.433 . . . . 0.0 111.108 -179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.789 HD13 ' HB1' ' A' ' 146' ' ' ALA . 13.7 pt -62.72 111.13 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 178.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 72.9 p -75.14 156.48 35.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.567 0.699 . . . . 0.0 111.635 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.462 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.34 -42.69 59.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.938 -179.233 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.45 ' O ' ' HG3' ' A' ' 165' ' ' ARG . 0.0 OUTLIER -65.06 -27.7 68.96 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.014 179.196 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 77.6 m-20 -68.99 -46.13 68.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.428 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.77 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -74.79 -43.67 46.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.323 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -60.04 -45.37 93.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.43 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.45 ' HG3' ' O ' ' A' ' 161' ' ' GLU . 45.2 mtp180 -74.65 -41.68 59.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.493 . . . . 0.0 111.457 -179.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.456 ' CE2' ' HD2' ' A' ' 148' ' ' LYS . 2.0 t-105 -66.95 -41.52 86.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.373 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.58 -45.46 62.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.708 0.289 . . . . 0.0 111.391 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 12.5 pt-20 -61.77 -37.15 83.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.778 0.323 . . . . 0.0 110.99 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.405 ' CG ' ' N ' ' A' ' 170' ' ' THR . 0.6 OUTLIER -54.83 -45.63 74.47 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.107 0.48 . . . . 0.0 110.764 179.708 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.429 HG23 ' O ' ' A' ' 166' ' ' TRP . 15.3 p -54.49 -52.0 63.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.841 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -72.4 -23.96 61.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.445 179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.83 -38.88 80.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.7 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -76.86 -45.92 26.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.155 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 70.7 p -74.39 111.69 9.82 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.945 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.176 -0.916 . . . . 0.0 111.103 179.996 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 80.2 p -60.3 -66.32 0.54 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.845 0.355 . . . . 0.0 110.872 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 1.5 ttt180 60.19 98.79 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.925 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -84.51 158.03 21.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.896 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -108.55 150.32 11.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.957 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.531 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -86.84 159.05 19.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.895 0.379 . . . . 0.0 110.778 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -155.53 96.32 1.76 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.021 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.407 ' HB2' ' CD ' ' A' ' 133' ' ' PRO . 8.4 ptm -47.77 167.58 0.18 Allowed Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.585 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.407 ' CD ' ' HB2' ' A' ' 132' ' ' MET . 23.0 Cg_exo -65.3 -47.09 4.77 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.723 2.282 . . . . 0.0 112.786 -179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.24 -51.9 63.04 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.463 -179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.574 ' HB1' HG21 ' A' ' 163' ' ' VAL . . . -68.95 -32.92 72.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.368 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.22 -48.9 60.67 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.251 0.548 . . . . 0.0 110.372 179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -57.21 -54.32 48.1 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.862 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.762 HD11 ' HB ' ' A' ' 163' ' ' VAL . 4.3 pp -63.15 -40.89 98.88 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.744 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -58.03 -36.73 73.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.935 0.398 . . . . 0.0 110.66 179.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 5.4 ttpp -77.11 -31.38 55.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.786 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -82.24 -21.78 36.14 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.912 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.568 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.5 mt -94.07 -28.78 15.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.601 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 80.8 43.2 9.17 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.846 -0.693 . . . . 0.0 112.008 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.514 HG21 HG12 ' A' ' 163' ' ' VAL . 0.0 OUTLIER -118.95 128.21 75.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.672 0.272 . . . . 0.0 111.022 -179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.438 ' HB3' ' HB3' ' A' ' 148' ' ' LYS . 0.5 OUTLIER -59.63 101.11 0.1 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.656 -179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.982 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -57.29 -40.85 78.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.003 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.59 -50.16 70.84 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -56.9 -28.05 61.47 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 178.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.466 HG22 ' CG ' ' A' ' 166' ' ' TRP . 49.5 t -83.24 85.71 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.88 178.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 8.9 ttmt -50.77 92.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.281 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 158' ' ' ILE . . . -66.64 142.33 41.98 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.964 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.41 13.56 13.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.737 0.303 . . . . 0.0 110.928 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.441 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -72.64 156.34 51.86 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.806 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_exo -43.62 103.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 123.174 2.583 . . . . 0.0 112.903 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 99.5 23.2 11.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.201 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.531 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 71.59 22.12 78.69 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.605 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.455 ' HA ' ' C ' ' A' ' 130' ' ' ALA . 1.2 m -85.71 126.58 40.5 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 C-N-CA 120.768 -0.373 . . . . 0.0 110.837 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.982 HD13 ' HB1' ' A' ' 146' ' ' ALA . 19.2 pt -64.52 112.02 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 57.7 p -75.28 156.56 35.52 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.424 0.631 . . . . 0.0 111.591 -177.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.487 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.24 -42.71 58.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.115 -179.285 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -64.02 -27.69 69.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.016 179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.542 ' HB2' ' O ' ' A' ' 159' ' ' THR . 85.4 m-20 -70.14 -47.39 61.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.497 179.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.762 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -73.08 -40.03 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.761 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.426 ' CG ' ' N ' ' A' ' 165' ' ' ARG . 0.1 OUTLIER -59.7 -49.41 77.85 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.099 -179.559 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.426 ' N ' ' CG ' ' A' ' 164' ' ' LYS . 1.0 OUTLIER -69.76 -40.83 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.532 -179.444 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.466 ' CG ' HG22 ' A' ' 149' ' ' VAL . 1.5 t-105 -67.56 -48.67 66.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.461 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -67.87 -46.26 72.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.371 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.403 ' HG2' ' HA ' ' A' ' 165' ' ' ARG . 10.8 pt-20 -58.88 -41.42 87.1 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.88 0.371 . . . . 0.0 110.724 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -51.66 -26.9 10.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.045 179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 5.4 p -72.54 -52.13 16.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.612 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.41 -17.57 58.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.737 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 23.7 tttt -77.14 -31.99 56.04 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.723 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -91.3 54.63 2.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.106 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 6.7 p -128.33 144.97 51.19 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.219 -0.896 . . . . 0.0 111.076 179.977 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.9 t -73.62 100.74 3.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.792 0.329 . . . . 0.0 110.859 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.5 mtp180 -127.78 -169.5 2.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -90.51 134.41 34.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.961 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.2 t -92.26 114.56 29.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.636 ' HB3' ' C ' ' A' ' 156' ' ' GLY . . . -92.81 149.82 21.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.175 0.512 . . . . 0.0 111.242 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -151.93 94.41 1.96 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.6 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.561 ' HE3' ' CG2' ' A' ' 157' ' ' VAL . 17.5 ptp -45.56 165.47 0.17 Allowed Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.978 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.5 -47.22 4.4 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.769 2.313 . . . . 0.0 112.809 -178.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.25 -51.78 63.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.488 -179.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.554 ' HB1' ' CG2' ' A' ' 163' ' ' VAL . . . -68.87 -33.47 73.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.194 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 27.0 mtt180 -68.55 -49.58 58.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.607 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 2.4 ttt180 -58.51 -55.31 36.72 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.759 HD12 ' N ' ' A' ' 139' ' ' ALA . 4.4 pp -61.12 -40.77 95.02 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.749 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.759 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -55.11 -42.94 73.56 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.033 0.444 . . . . 0.0 110.919 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.46 -29.7 59.72 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.912 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -79.51 -24.42 42.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.064 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.611 HD12 ' O ' ' A' ' 138' ' ' LEU . 1.8 mt -91.41 -28.85 17.4 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.745 -179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 93.88 34.5 6.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.766 -0.73 . . . . 0.0 113.073 179.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.604 HD13 HG21 ' A' ' 149' ' ' VAL . 2.3 tt -117.84 147.15 21.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.919 0.39 . . . . 0.0 111.446 179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.434 ' N ' HG12 ' A' ' 144' ' ' ILE . 0.6 OUTLIER -82.22 101.15 10.3 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.101 179.358 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.002 ' HB1' HD13 ' A' ' 158' ' ' ILE . . . -47.89 -33.19 7.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.786 0.327 . . . . 0.0 111.168 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.87 -34.94 79.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.038 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 145' ' ' ASP . 0.0 OUTLIER -72.44 -18.68 61.68 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.386 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.604 HG21 HD13 ' A' ' 144' ' ' ILE . 55.1 t -96.94 88.08 1.82 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.271 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.74 98.87 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.356 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . 0.602 ' CA ' HG22 ' A' ' 158' ' ' ILE . . . -70.1 142.16 35.57 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.011 -0.614 . . . . 0.0 113.199 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.56 11.23 12.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.592 0.234 . . . . 0.0 111.09 179.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' A' ' 157' ' ' VAL . . . -71.92 153.35 49.88 Favored Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.718 -179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.419 ' O ' HG13 ' A' ' 157' ' ' VAL . 82.4 Cg_exo -45.56 112.91 0.46 Allowed 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 123.129 2.552 . . . . 0.0 112.775 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 95.11 10.56 57.23 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.334 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.636 ' C ' ' HB3' ' A' ' 130' ' ' ALA . . . 84.41 22.05 55.05 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.774 179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.561 ' CG2' ' HE3' ' A' ' 132' ' ' MET . 1.2 m -87.23 124.18 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 CA-C-N 117.181 0.49 . . . . 0.0 111.207 -179.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.002 HD13 ' HB1' ' A' ' 146' ' ' ALA . 14.7 pt -63.58 111.51 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' ASP . 52.5 p -75.32 156.57 35.42 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.662 0.744 . . . . 0.0 111.89 -177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.512 HG13 ' CD2' ' A' ' 138' ' ' LEU . 0.2 OUTLIER -54.92 -41.81 60.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.941 -179.429 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLU . . . . . 0.503 ' HA ' ' CG ' ' A' ' 164' ' ' LYS . 3.3 mt-10 -63.62 -27.84 69.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.304 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 159' ' ' THR . 78.1 m-20 -70.82 -52.1 22.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.099 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.719 ' HB ' HD11 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -64.24 -48.75 84.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.934 -179.207 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.503 ' CG ' ' HA ' ' A' ' 161' ' ' GLU . 0.0 OUTLIER -58.23 -51.21 70.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.286 -179.251 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.442 ' HG2' ' O ' ' A' ' 162' ' ' ASP . 18.4 ptt180 -57.81 -37.9 74.61 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.54 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TRP . . . . . 0.713 ' O ' HG23 ' A' ' 170' ' ' THR . 2.7 t-105 -69.22 -48.06 63.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.908 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -59.21 -45.96 89.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.348 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 23.0 pt-20 -65.07 -39.39 93.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.904 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -58.5 -31.27 67.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.944 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.713 HG23 ' O ' ' A' ' 166' ' ' TRP . 2.9 p -70.21 -51.98 26.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.639 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.6 68.02 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.414 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 31.4 mtpt -63.67 -31.25 72.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.739 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -95.2 104.7 16.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.082 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' THR . . . . . . . . . . . . . 2.1 t -145.94 -50.53 0.23 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.886 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.111 -179.985 . . . . . . . . 0 0 . 1 stop_ save_